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Abstract
Skeletal muscle lends itself to the central tenet of tissue engineering in that myoblasts 
isolated from skeletal muscle tissue are able to recapitulate the exact processes that 
occur in vitro during muscle development (Shah et al., 2005). In vitro skeletal muscle 
engineering involves the culture of isolated primary myogenic cells in an environment 
conducive to the formation of a three-dimensional (3D) tissue construct, containing 
differentiated myotubes, capable of generating force. The aim of this thesis was to 
test the effect o f mechanical and biological cues on the development of a tissue 
engineered craniofacial masseter muscle construct. For the first time primary 
myogenic, non myogenic and heterogenous (mixture of myogenic and non-myogenic) 
cells were tested in a 3D collagen scaffold to define parameters for in vitro 
engineering of human masseter muscle.
The cytomechanical properties of the human masseter muscle derived cells (MDCs) 
in 3D were quantified over 24 hours using a culture force monitor (CFM) and the 
results showed a synergistic response, the heterogenous mixture generated 
significantly (p<0.01) more force than the sum of the individual components of 
separated cells. Further, muscle specific (myogenin, myosin heavy chain (MYHC)) 
and matrix remodeling (MMP-2) gene expressions were upregulated relative to the 
separated individual cell types.
To study mechanical (cell-matrix) cues MDCs were subject to external loading and 
increased matrix stiffness. The results showed no significant change in gene 
expression. To study biological (cell-cell) cues, MDCs were cultured at high densities 
and for an extended period of time (6 days). The results showed an upregulation of
muscle specific (myogenin, MYHC-IIX/D, MYHC-P) gene expression. However, 
MMP-2 gene expression remained unchanged. These results indicated that cell-cell 
signals are more important than cell-matrix signals in 3D myogenic cell 
differentiation. This study highlights the importance o f non-myogenic cells in force 
generation and the effect o f increasing substrate stiffness and cell density in control of 
construct maturation. These are the first parameters defined towards successful 3D 
human muscle engineering.
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Skeletal Muscle
Skeletal muscle is the most abundant type of muscle in the body (Williams et aL, 
1989) and is responsible for control of voluntary movement and maintenance of 
structural contours of the body (Riboldi et al., 2005). The human body contains more 
than 300 muscles that differ widely in size, shape, strength, and resistance to fatigue 
(Pedrosa-Domello et al., 2000). In the craniofacial area, skeletal muscle allows for 
facial expression and tongue, eye and jaw mobility (Alsberg et al., 2001).
Bone Perimysium Blood V essel
Muscle fibre (cell)
Tendon Epimysium Endomysium Fascicle
Figure 1: Skeletal muscle is a bundle within a bundle structure. Each muscle 
fibre is wrapped with a delicate connective tissue sheath, the endomysium. The 
perimysium is a collagenic sheath which surrounds bundles (or fascicles) of 
myofibres. The entire muscle is strengthened by a coarse épimysium sheath.
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Blood vessels penetrate through the connective tissue to provide the muscle with 
essential nutrients (Adapted from Marieb, 1998).
Each skeletal muscle is a discrete organ composed of bundles of muscle fibres 
(Marieb, 1998; Figure 1). Muscle fibres are the cellular units of skeletal muscle, they 
are long multinucleated cells usually rounded or polygonal in cross-section varying 
from a diameter o f 10-100pm in mature muscle (Lewis et al., 2001).
In mammals the muscles o f the head have a different embryological origin to the limb 
musculature (Goldspink, 1998). Jaw-closing muscles originate from the mesoderm of 
the first branchial arch and are innervated by the mandibular division of the fifth 
cranial nerve, while limb muscles originate from the somites and are innervated by 
spinal nerves (Sperber, 1989; Yu et al., 2003). Further, Pax-3 is not detectable in 
skeletal muscle progenitors of the head, suggesting that myogenic regulatory circuits 
in the head and body are distinct (Tajbakhsh et al., 1997). Knowledge about the 
developmental events that give rise to more specialized muscles is scarce, particularly 
in humans (Pedrosa-Domello et al., 2000). However, it is known that because o f 
their anterior position and the infant's need to suckle just after birth, craniofacial 
musculature develops earlier than the other skeletal muscles (Goldspink, 1998).
Muscles of the craniofacial region are structurally and functionally more specialized 
than the limb muscles (Pedrosa-Domello et al., 2000). Jaw muscles are active during 
a large variety of motor tasks, like mastication, biting, speech, and swallowing. To 
execute this variety o f tasks, they must be able to control the position of the mandible
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precisely, and instantaneously apply changing forces to it (Goldspink, 1998; Korfage 
et al., 2005a).
The masseter is one of the mandibular elevator muscles and can be divided into a 
superficial, intermediate and deep portion (Soussi-Yanicostas et al., 1990; Figure 2). 
The masseter muscle arises from the zygomatic arch (cheek bone). It has three heads 
which are fused together on the arch. The superficial part of the muscle is the largest. 
It arises from the anterior two-thirds of the lower border of the zygomatic process of 
the maxilla. Its fibres slope downwards and backwards and are inserted into a wide 
area; from the angle of the mandible (jaw bone) forwards along the lower border, and 
upwards to include the lower part of the ramus (McMinn, 1994).
Masseteric nerve 
from Vc
AAosseteric ortery 
from superficial 
temporal
MASSETER
Origin: 3 heods from zygomatic arch
1. Superficial - anterior 2/3
2. Intermediate • middle 1/3
3. Deep - Deep surface of posterior arch 
Insertion: Ramus/ongle of mandible
Action: Closes jaw
Nerve: Masseteric branch of mandibular division of trigeminal (Vc)
Figure 2: The masseter muscle has three heads which originate on the zygomatic 
arch. The superficial part of the muscle is the largest, followed by the 
intermediate, then deep. The muscle fibres insert along the mandible and ramus.
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The masseter is innervated by the masseteric branch of the anterior division of 
the mandibular nerve. Its blood supply is via a branch of the superficial 
temporal facial artery (Source: http://www.instantanatomy.net/head
neck/areas/parotidmasseter.html).
The intermediate part of the muscle arises from the middle third of the arch and the 
deep part from the deep surface of the arch in continuity. The fibres pass vertically 
downwards to be inserted into the ramus o f the mandible. Their insertions fuse with 
each other and with the superficial fibres at the anterior border of the ramus, but are 
separate posteriorly. The masseter is supplied by the masseteric branch of the 
anterior division of the mandibular nerve. Its blood supply is via a branch of the 
superficial temporal or tranverse facial artery (McMinn, 1994). The masseter muscle 
closes the jaw by elevating and drawing forwards the angle of the mandible.
The jaw muscles have to be able to produce strong forces rapidly during incision, 
slow repetitive movements during mastication and isometric contraction for the 
maintenance of lower jaw  and facial posture (Goldspink, 1998). The jaw muscles can 
meet these different requirements because of their complex architecture, in 
combination with a heterogeneous composition of fibres capable of producing a 
variety o f forces at different contraction speeds (Korfage et al., 2005a).
Skeletal muscle is a highly ordered structure from gross anatomy down to the 
molecular level (Stâl, 1994). At the gross anatomy level, each muscle fibre is 
surrounded by connective tissue, and this is termed the endomysium. Bundles of 
endomysia are in turn surrounded by connective tissue termed the perimysium, which
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in turn are encapsulated by the épimysium. The connective tissue surrounding the 
fibres allows for movement between fibres and transmits force to the tendon.
fibre
myofibril
myosin
sarcomere
Figure 3: Skeletal muscle is highly organised at the molecular level. This 
diagram shows the level of order from a single fibre to a myofibril to a 
sarcomere and then individual myofilaments (myosin and actin) (Adapted from 
Korfage et al., 2005a).
As well as being rich in connective tissue, skeletal muscles are highly vascularised to 
provide essential nutrients for muscle function (Chargé and Rudnicki, 2004).
At the molecular level order continues and muscle fibres are composed of myofibrils, 
which consist of aligned sarcomeres (Figure 3). A single sarcomere is the smallest 
contractile unit of a muscle fibre (about 2pm long) and is in turn divisible into thick 
and thin myofilaments, myosin and actin respectively.
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Myosin is the dominating contractile protein in muscle fibres, and it is the molecular 
motor that converts free energy derived from the hydrolysis of ATP into mechanical 
work (Yu et al., 2003). Sarcomeric myosin is a complex hexameric protein consisting 
o f two anti-parallel myosin heavy chain (MyHC) subunits with a molecular weight of 
200-220 kDa each and four myosin light chains (MyLC) with a molecular weight of 
17-23 kDa each (Weiss and Leinwand, 1996; Figure 4). The MyLC molecules play a 
part in the conversion o f the chemical energy into movement (Lowey et a l,  1993). At 
the ends of the rod are two globular heads, which contain the mATPase and the 
binding sites for actin (Stâl et al., 1994).
Essential iigM chain 
Regulalory light chain
Figure 4: The sarcomeric myosin molecule is composed of 4 light-chain (MyLC) 
molecules (2 essential (yellow) and 2 regulatory (orange)) and 2 myosin heavy- 
chain (MyHC (blue)) subunits (Modified from httD://fig.cox.miami.edu/~cmall 
erv/150/neu ro/mvosin. i pgL
Desmin is a type 111 intermediate filament protein characteristic of muscle cells. 
Desmin filaments appear to form a structural lattice that provides support for the
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contractile machinery (Lazarides, 1980). They play an important part in maintaining 
the relative positions of myofibrils, and also lying parallel to them in a manner 
suggesting that they may participate in transducing contractile forces longitudinally 
through the muscle cell (Tippet, 1997).
Skeletal Muscle Contraction
Huxley HE and Hanson (1954) and Huxley AE (not related) and Niedergerke (1954) 
published back to back papers in Nature independently demonstrating that muscle 
shortens by relative sliding between two sets of subcellular filaments containing the 
proteins myosin and actin. This formed the basis of ‘the sliding filament theory’ 
which is now well accepted as the mechanism for muscle contraction.
Each thick filament within a sarcomere contains about 200 myosin molecules. The 
myosin molecules are bundled together so that their tails form the central part of the 
filament and their globular heads face outward and in opposite directions at each end. 
The heads, sometimes called cross bridges, link the thick and thin myofilaments 
together during contraction (Marieb, 1998).
The thin filaments composed chiefly of actin, bear the active sites to which the 
myosin cross bridges attach during contraction. Several regulatory proteins are also 
present in the thin filament. Two strands of tropomyosin a rod shaped protein spiral 
about the actin core and help to stiffen it and successive tropomyosin molecules are 
arranged end to end along the actin filament. In a relaxed muscle fibre they block 
actins active sites so that the myosin heads cannot bind to the thin filaments (Marieb, 
1998).
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The other major protein in the thin filament is troponin, a three-polypeptide complex. 
One of these polypeptides is an inhibitory subunit that binds to actin. Another binds 
to tropomyosin and helps to position it on actin. The third polypeptide binds calcium 
ions (Marieb, 1998).
Troponin Tropomyosin
Filament slides /
— Calcium
u Wm I Wm “ Myosin binding site
_ _ A o p - t - p f ^M yosin >
Figure 5: The sliding filament theory states that in the presence of Ca^  ^ myosin 
binding sites on the thin actin filament are exposed. Energised myosin binds to 
actin and the hydrolysis of ATP causes a power-stroke of the myosin head 
resulting in the thin filament sliding towards the centre of the sarcomere. The 
combined sliding of all the thin filaments within the muscle fibre results in 
contraction of the cell (Adapted from Matthews, 2001).
In the absence of calcium ions, tropomyosin blocks access to the myosin binding site 
of actin (Ganong, 1989). Initiation o f contraction in skeletal muscle begins with a 
nerve impulse generating an action potential in the muscle fibres. The action potential 
causes releases of calcium ions which then bind to troponin. When calcium binds to 
troponin, the positions of troponin and tropomyosin are altered on the thin filament 
and myosin then has access to its binding site on actin (Matthews, 2001; Figure 5).
23
Introduction
Myosin hydrolyses adenosine triphosphate (ATP) and undergoes a conformational 
change into a high-energy state. The head group o f myosin binds to actin forming a 
cross-bridge between the thick and thin filaments. The energy stored by myosin is 
released, and adenosine diphosphate (ADP) and inorganic phosphate (Pi) dissociate 
from myosin. The resulting relaxation o f the myosin molecule entails rotation o f the 
globular head, which induces longitudinal sliding of the filaments. When the calcium 
level decreases, troponin locks tropomyosin in the blocking position and the thin 
filament slides back to the resting state (Matthews, 2001).
Skeletal Muscle Development
Most o f our current knowledge about skeletal muscle development is based on studies 
o f limb muscles, which originate from the somites and are innervated by spinal nerves 
(Pedrosa-Domello et al., 2000). The first skeletal muscle to differentiate in the 
embryo is the myotome, a sheet o f differentiated skeletal muscle cells that lies 
between the dermomyotome and the sclerotome (Maroto et al., 1997).
Signals from the neural tube, notochord and paraxial mesoderm are involved in 
regulating somatic myogenesis (Rong et al., 1992; Buffmger and Stockdale, 1994; 
Cossu et al., 1995). The paracrine factors, Wnts and Sonic hedgehogs (Shh), in 
combination instruct the myotome cells to become myogenic by inducing them to 
synthesize key transcription factors; Pax-3, Myf5 and MyoD (Maroto et al., 1997; 
Tajbakhsh et al., 1997).
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Wnts 
& Shhs —> Myf5 and/or MyoD -----^ Myogenin >. MFR4
Myotome ceUs Dividing myobieets Ce# alignment Myotut>e formetion Muscle fiber
o
.■■y-:.-:
Somite Determinetion MuitipUcation Muttipication stops Fusion, dNferentiation Maturation
Figure 6: Skeletal muscle development from somite to muscle fibre. Paracrine 
factors (Wnts and Shhs) determine the myotome cells, which then become 
committed myoblasts (expressing MyfS and/or MyoD) which proliferate in the 
presence of growth factors. When the myoblasts cease dividing, they align and 
fuse into myotubes (expressing myogenin). The myotubes become organized into 
muscle fibers (expressing MRF4) that spontaneously contract (Adapted from 
Gilbert, 2006).
Proliferative Myf5 and/or MyoD positive myogenic cells are termed myoblasts. 
Myoblasts withdraw from the cell cycle to become terminally differentiated 
myocytes, which fuse to form myotubes, expressing the “late” myogenic regulatory 
factors, myogenin and MRF4 (Chargé and Rudnicki, 2004; Figure 6).
The myogenic regulatory factors (MRFs) belong to subfamily A of the basic helix 
loop helix (bHLH) transcriptional regulators (Atchely et al., 1997). The MRFs 
include myf5, MyoD, myogenin, and MRF4 they are considered master muscle 
regulatory proteins because of their ability to induce skeletal myogenesis. These 
proteins function as heterodimeric transcriptional activators that bind a sequence
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motif termed an E-box that contains a CANNTG (N, any nucleotide) consensus found 
in the regulatory regions o f many muscle-specific genes (Weiss and Leinwand, 1996). 
Myotubes eventually mature into contracting muscle fibres and subsequently express 
muscle specific genes such as myosin heavy chain (MyHC) (Chargé and Rudnicki, 
2004).
The primary pathways involved in myoblast differentiation in vitro (2D) and in vivo 
have been characterized (Pedrotty et al., 2005). In vitro, skeletal muscle precursor 
cells express MyoD or Myf-5 in the committed state and turn on transcription of 
myogenin when induced to differentiate (Hollenberg et al., 1993; Ohkawa et al., 
2006). Chargé and Rudnicki (2004) reported that myoblast terminal differentiation is 
characterised by the upregulation o f the MRFs myogenin and MRF4.
In summary, during embryonic development, skeletal muscle precursor cells called 
myoblasts exit the proliferative cycle, initiate biochemical differentiation, and fuse to 
form multinucleated myotubes. One of the major proteins expressed during the 
differentiation o f myoblasts and myotubes is sarcomeric MyHC (Weiss and 
Leinwand, 1996; Allen and Leinwand, 2001). Myogenin and MyHC are markers o f 
differentiated skeletal muscle (Tajbakhsh et al., 1997). In the thesis to follow, the 
gene expression of myogenin and MyHC were monitored to mark myoblast terminal 
differentiation.
Myosin Heavy Chain isoforms
Myosin heavy chain is the main component o f the thick filament of the sarcomere. 
The myosin heavy chain is both a structural protein and an enzyme (Sciote and 
Morris, 2000). It enzymatically hydrolyses ATP and is therefore the key factor in
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determining the nature o f excitation-contraction coupling and moving (Barany, 1967). 
There are several isoforms, i.e. proteins which have the same function but are encoded 
by a different gene, of the MyHC molecule. The different isoforms of MyHC are 
functionally unique and cannot be substituted for one another (Allen et al., 2000; 
Allen and Leinwand, 2001). Further they are transcriptionally competent and capable 
o f being expressed simultaneously (Horton et al., 2001). There is general agreement 
that the heavy chains determine the force-velocity characteristics o f skeletal muscle 
fibres (Pedrosa-Domello et al., 2000, Sciote and Morris, 2000).
The sarcomeric MyHC isoform genes found in humans include a-cardiac, p/I, HA, 
IIX, IIB, extraocular (expressed in the extrinsic eye and some pharyngeal muscles), 
and 2 developmental forms, namely, neonatal (also named foetal, perinatal, or 
developmental) and embryonic (Sartore et a l ,  1987; Butler-Browne et a l ,  1988; 
Smerdu et a l ,  1994; Stâl et a l ,  1994; Weiss and Leinwand, 1996; Sciote and Morris, 
2000; Horton et al., 2001). Embryonic and neonatal MyHCs are typically expressed 
during muscle development. MyHC- p/l is the slow contracting isoform and the three 
‘type IT MyHCs are fast contracting isoforms (Sciote and Morris, 2000). Another 
fast contracting MyHC isoform is a-cardiac primarily expressed in cardiac muscle; it 
also has rare tissue-specific expression in skeletal muscle, being identified in the 
human masseter (Bredman et al., 1991; Stâl, 1994; Sciote et a l ,  1994).
The main difference between the MyHC isoforms is their rate of converting ATP into 
energy, which determines the speed o f actin-myosin detachment. Bottinelli et al. 
(1996) established a good correlation between the MyHC isoforms and the maximum 
contraction velocity. At present the reported comparable shortening speeds o f adult
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skeletal MyHCs is extra-ocular > IIB > IIX > HA > a-cardiac > I (Sciote and Morris, 
2000). The functional differences among the various MyHC isoforms contribute to or 
result in changes in the physiology o f the muscle in which they are expressed (Weiss 
and Leinwand, 1996).
Each different MyHC gene displays a pattern of expression that is tissue specific and 
developmentally regulated (Butler-Browne et al., 1988). In the masseter MyHC gene 
expression is quite unusual. In addition to the typical MyHC isoforms found in 
healthy adult muscle (type I/p and type II), the masseter also expresses neonatal, 
embryonic and/or a-cardiac myosin heavy chains (Sciote et ah, 1994). Further, 
individual fibres in the masseter co-expressed up to four different MyHC isoforms 
(Stâl et al., 1994). Yu et al. (2003) later reported that up to five different MyHC 
isoforms could be observed in the same masseter muscle fibre. A unique myofibrillar 
protein isoform expression has been observed in the human masseter muscle fibers, 
suggesting significant differences in structural and functional properties between 
muscle fibres from human masseter and limb muscles (Yu et al., 2003).
Skeletal Muscle Fibre Types
Skeletal muscle cell fibres have been systematically classified into types (Sciote and 
Morris, 2000). According to the major MyHC found in adult skeletal muscle the 
following pure fibre types exist (see Table 1): slow type 1 with MyHC-I/p, and two 
fast types, namely HA with MyHC-HA and HX with MyHC-HX (Pette and Staron,
2000). Skeletal muscle fibres are distinguished by different contractile velocities, 
metabolic properties, and structural protein compositions, including varying MyHC 
isoform profiles (Talmadge and Roy, 1993).
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Classifications:
Mvosin based 
classification Slow 1/p Fast IIA Fast IIX
Classification based on 
metabolism
Slow
Oxidative Fast Oxidative Fast glycolytic
Classification based on 
fatisue resistance
Slow fatigue 
resistant
Fast fatigue 
resistant Fast fatigable
Properties:
Myosin isoforms MyHC-l/p MyHC-IIA MyHC-IIX
ATPase activity Low High Very High
Resistance to fatigue High Intermediate Low
Metabolism Oxidative Oxidativeglycolytic Glycolytic
Table 1: Classification of human skeletal muscle fîbres and properties of each 
fibre type (adapted from Polla et al., 2004)
Pure muscle fibres express only one MyHC isoform, fibres which express more than 
one MyHC isoform are called hybrid fibres (for example, type I + IIX, or type IIA + 
IIX). Compared to other skeletal muscles, cranial muscles have a wider repertoire of 
contractile protein expression and function (Sciote et al., 2003). Studies have shown 
that the fibre composition of the human masseter muscle differs from that o f 
limb/trunk muscles and has certain characteristics that can be linked to its activity 
(Ringqvist, 1971; 1974; Eriksson, 1982; Eriksson and Thomell, 1983; Thomell et al., 
1984; Butler-Browne et al., 1988; Soussi-Yanicostas et al., 1990; Bredman et al., 
1991; Tuxen et al., 1992; Sciote et al., 1994; Stâl et al., 1994; Monemi et al., 1996; 
Korfage and Van Eijden, 1999, 2003; Korfage et al., 2005).
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A large range of contractile properties exists among hybrid fibres containing a 
particular combination o f MyHC isoforms. The shortening velocity o f hybrid fibers is 
said to lie between the individual MyHC isoforms they express (Pette & Staron, 1997; 
Larsson and Moss, 1993; Bottinelli et al., 1996). The existence of different MyHCs 
in a fibre allows a smooth transition of force regulation needed in movements o f the 
jaw  muscles (Butler-Browne et al, 1988).
The masseter muscle contains a significant proportion of hybrid fibres, termed IM and 
l ie  which co-express slow and a "fast B like" MyHC in the masseter (Stâl, 1994). 
However, the precise MyHC content o f these fibre types is not yet fully clear 
(Korfage and Van Eijden, 1999). Stâl (1994) reported that up to eight fibre types 
could be distinguished in the masseter on the basis o f their pattern o f expression o f 
MyHC isoforms.
Histochemical staining of healthy adult limb muscle has demonstrated that skeletal 
muscle is composed o f a mosaic o f type I and II fibres, with the type II fibres being of 
larger diameter (Sciote and Morris, 2000). Human jaw-closing muscles are 
predominantly composed of type I fibres (60-70%) in the adult (Soussi-Y anicostas et 
al., 1990) and the type II fibres are much smaller in diameter than limb muscle fibres 
(Ringqvist, 1971; Eriksson, 1982; Eriksson and Thomell, 1983).
There have been several attempts to explain the variety of hybrid muscle fibres o f the 
masseter muscle;
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1. Transition: hybrid fibres are thought to arise when there is an alteration from 
one type into another type o f muscle fibre (Korfage and Van Eijden, 1999). 
They can change their phenotype in response to several influences by 
switching different iso form genes on or off (Goldspink, 1998). During 
transition, the fibres will change from a pure fiber type, into another pure fiber 
type, via hybrid fibre types that express the old as well as the new MyHC 
isoforms. A suggestion was made of the following transition pathway of 
MyHC iso forms: Ip ^  ip/IIA IIA <-> IIA/IIX ^  IIX (Gorza, 1990;
DeNardi et al. 1993). It might therefore be concluded that the jaw muscles are 
continuously switching from one fiber type to another (Korfage et al., 2005b).
2. Innervation: another possible explanation for the many hybrid fibers in the 
jaw muscles could be due to a difference in innervation as compared with limb 
and trunk muscles, i.e., branchial V5. spinal (Stâl et a l,  1987).
3. Development: the many hybrid fibers in adult jaw  muscles could also be 
regarded as a characteristic of development. During development fibres can 
change their phenotype, during which hybrid fibres arise (Butler-Browne et 
a l,  1988).
4. Regeneration: during the regeneration process, fibers transiently start to 
express MyHC-foetal and MyHC-I (Yang et a l,  1997). The continued 
expression o f these fibre types in adult jaw  muscles might indicate a longer 
time period for jaw  muscles to heal. The masseter is known to heal badly after 
an injury (Pavlath et a l ,  1998).
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5. Allotype: alternatively, hybrid fibers can be seen as a legitimate stable 
phenotype, or an allotype, as named by Hob (1991), and not as a transitional 
phenotype (Stephenson, 1999; Lutz and Lieber, 2000). A fibre integrates 
several of the stimuli it receives (like neural activity, hormones, stretch, etc.) 
and produces a response to them that signals the expression of MyHC gene 
transcription (Korfage et al., 2005b).
Skeletal Muscle Regeneration
a c.
Figure 7: Model of satellite cell dynamics (adapted from Collins et al., 2005). (a) 
Quiescent satellite cells reside beneath the basal lamina (orange) of a myofiber. 
Satellite cells are activated after injury (b). Daughter cells migrate from beneath 
the basal lamina and the satellite cell progeny proliferate extensively (c). The 
progeny adapt alternative fates and either commit to differentiation (blue) or
32
Introduction
remain undifferentiated (yellow) (d). Cells committed to differentiation fuse to 
repair of replace damaged myofibers (e). Undifferentiated progenitors continue 
proliferating to derive the next cohort of myoblasts or are captured beneath the 
basal lamina of newly formed myofibers and renew the satellite cell population
(f).
Skeletal muscle has a remarkable ability to regenerate following damage (Chargé and 
Rudnicki, 2004). The capacity to regenerate resides in a population o f mononucleated 
satellite cells (Beauchamp et al., 2000). The satellite cell is a quiescent muscle 
precursor forming a small population beneath the basal lamina o f each myofiber 
(Mauro, 1961). Upon injury satellite cells are activated, the muscle precursor cells 
then form a pool o f myoblasts, which differentiate and fuse to provide the myo-nuclei 
required to repair or replace damaged myofibers (Moss and Leblond, 1971; Snow, 
1978; Boudreault et al., 2001; Collins et al., 2005; Figure 7). The cellular processes 
seen during skeletal muscle regeneration and adaptation recapitulate those evident 
during development (Lewis et al., 2001).
Further, there is overwhelming evidence of the instructional capacity o f the 
extracellular matrix (ECM), particularly in relation to skeletal muscle regeneration 
(Lewis et al., 2001). Cell-matrix interactions mediated by specific cell receptors and 
cell binding epitopes on many matrix molecules not only play a dominant role in cell 
attachment and migration, but also regulate or promote cellular differentiation and 
gene expression levels (Gelse et al, 2003).
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Skeletal Muscle ECM Remodeling
The primary function of the ECM is to endow tissues with their specific mechanical 
and biochemical properties. For many years, the ECM was thought to be created by 
connective tissue cells and surround those cells as a mere structural scaffold 
(Velleman, 1998). However, this is now regarded as an oversimplification as resident 
cells are responsible for the synthesis and maintenance of the ECM, which in turn, has 
an impact on cellular functions (Gelse et al, 2003).
ECM molecules are thought to serve as more than a mechanical link of 
ECM/integrin/cytoskeleton in the transduction of forces into and out of cells. 
Physical distortion o f the ECM results in cytoskeletal remodeling and signals 
alterations in intracellular biochemistry such as cell proliferation. The inverse also 
holds: changes in cytoskeletal tension results in remodeling o f structural scaffolds 
within the ECM and within neighboring cells, thereby altering biochemistry outside 
the cell (Ingber, 2002; Pattison et al., 2003).
The connective tissue component of skeletal muscle plays an important role in 
maintaining the structure of the muscle and also in providing an environment in which 
the contractile muscle fibres can function (Grounds et al., 1998). In vivo, individual 
muscle fibres are elongated and are embedded in a protein- and carbohydrate-rich 
ECM. The ECM of skeletal muscles needs to adapt continually to changing 
environmental demands. Changes in masticatory muscle structure and function may 
be developmental, as seen in anomalies o f facial form, or adaptive as a result o f 
surgical prodecures such as orthognathic surgery or after use o f orthodontic 
appliances (Carmeli et al., 2004).
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The remodeling o f connective tissue is an integral feature o f normal growth and 
development (Reynolds et al., 1994; Reynolds and Meikle, 1997). The mechanisms 
underlying remodeling of intramuscular connective tissue are complex and 
multifactorial and involve ECM molecules (collagenous glycoproteins, non- 
collagenous glycoproteins, proteoglycans and elastin), receptors for the ECM 
(integrins) and enzymes that remodel the ECM (matrix metalloproteinases) (Lewis et 
al., 2001). Further, tissue remodeling is usually tightly regulated by the interplay o f 
cell-cell and cell-matrix interactions involving the production of enzymes, activators, 
inhibitors and regulatory molecules such as cytokines and growth factors (Reynolds 
and Meikle, 1997).
The matrix metalloproteinases (MMPs) are a family of zinc-dependent matrix- 
degrading enzymes that appear to be obligatory for the maintenance of tissue ECM 
homeostasis (Matrisian, 1990; Woessner, 1991; Corcoran et al., 1996). In the last 
decade, MMPs have been shown to have a role in the maintenance o f the extracellular 
matrix in a wide range o f normal and pathological tissues, although relatively little is 
known regarding their role in muscle (Carmeli et al., 2004). In normal biology, these 
enzymes are involved in a great number of cellular processes including motility, 
migration and invasion (Lewis et al., 2001). Regulating the activity of the MMPs at 
both mRNA and/or protein levels modulates the degradation o f the ECM components 
(Corcoran et al., 1996). The MMPs can be inhibited by a special class of specific 
tissue inhibitors of metalloproteinases (TIMPS) (Matrisian, 1992). The activity of 
MMPs on ECM substrate is dependent on the balance between the enzymes and their 
inhibitors (Lewis et al., 2001).
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One o f the most important MMPs associated with skeletal muscle function and 
dysfunction appears to be MMP2, also known as gelatinase A, or 72kDa type IV 
collagenase. MMP2, by regulating the integrity and composition o f the ECM in 
skeletal muscle, plays essential roles in myofiber proliferation, differentiation, fiber 
healing after injury, and maintenance o f surrounding connective tissue (Matrisian, 
1992; Carmeli et al., 2004). Investigations have shown the expression of MMP-2 
activity and mRNA in all phases o f the differentiation o f myoblasts to myotubes 
(Lewis et al., 2001).
Craniofacial tissue loss
Craniofacial tissue loss due to congenital defects, disease, and traumatic injury is a 
major clinical problem (Alsberg et al., 2001; Bach et al., 2004). These and other 
complex craniofacial problems can have a profound physiological and psychological 
effect; therefore, many techniques have been developed to effectively and 
aesthetically rebuild the head and face including methods that require both scaffolding 
and competent cell populations for effective tissue regeneration (Warren et al., 2003; 
Shah et al., 2005).
Contemporary dental practice is largely based on conventional, non-cell-based 
therapies that rely on durable materials from outside the patient's body. Amalgam, 
composites, metallic implants, synthetic materials, and tissue grafts from human 
cadavers and other species have been the mainstream choices for the restoration o f 
dental, oral, and craniofacial structures (Mao et al., 2006). Despite various levels o f 
clinical success, conventional therapies possess inherent limitations, such as donor 
site morbidity, an obligatory graft resorption phase, disease transmission, major histo-
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incompatibility, graft-versus-host disease, immunosuppression, structural failure, 
stress shielding, and infection of foreign material (Warren et al., 2003).
The current technique to replace missing craniofacial skeletal muscle is the surgical 
transfer o f local or free flaps (Shah et al., 2005). Muscle transfers are needed to 
rehabilitate the paralyzed mouth, re-animate the eye and restore masticatory function 
(Tardy and Kastenbauer, 1995). However, surgical harvesting o f a significant mass of 
muscle causes functional loss and volume deficiency and increases the susceptibility 
to infection at the donor site, moreover, the transferred tissue typically is not designed 
to function in its new capacity and may degenerate prior to integration into its new 
site (Bach et al., 2003a). The lack of availability o f functional substitutes o f skeletal 
muscle hampers the reconstruction o f this native tissue (Beier et al., 2006). 
Therefore, there is a significant craniofacial clinical need for skeletal muscle that has 
only begun to be addressed by the tissue engineering field (Alsberg et al., 2001).
Tissue Engineering
Recently Williams (2006) defined tissue engineering as “the creation o f new tissue for 
the therapeutic reconstruction o f the human body, by the deliberate and controlled 
stimulation o f selected target cells, through a systematic combination of molecular 
and mechanical signals”. The field o f tissue engineering, through the application of 
engineering and biological principles, has the potential to create functional 
replacements for damaged or pathologic tissues (Alsberg et al., 2001). Specifically, 
craniofacial tissue engineering promises the regeneration or de novo formation of 
dental, oral, and craniofacial structures (Mao et al., 2006). To date cells have been 
seeded onto natural (e.g., collagen, alginate, agarose, hyaluronic acid derivatives, 
chitosan, and fibrin glue), synthetic (e.g., polyglycolide (PGA), polylactides (PLLA,
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PDLA), polycaprolactone (PCL), and polydioxanone (PDS)), and minerai 
(polycrystalline ceramic (hydroxyl apatite)) scaffolds (Warren et al., 2003).
To date three main approaches to tissue engineering have been pursued conduction, 
induction, and cell transplantation (Langer and Vacanti, 1993; Putnam and Mooney, 
1996; Figure 8). In the conduction approach a naturally derived or synthetic matrix 
acts as a passive three-dimensional mechanical scaffold on which cells can attach, 
proliferate, migrate, and differentiate (Alsberg et al., 2001).
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Figure 8: Three approaches to tissue engineering: conduction, in which a 
scaffold acts as a barrier controlling which cells can infiltrate the area; 
induction, in which cells are induced to migrate to desired location by controlling 
the surrounding matrix or cell-cell interactions; and cell transplantation, where
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donor cells are seeded directly onto a scaffold in vitro and the cell-scaffold 
construct can be implanted to a defect site (Source: Alsberg et aL, 2001).
The induction approach is based on the premise that adherent cells receive signals 
from the surrounding cell-matrix and these signals can be controlled (Alsberg et al.,
2001). Some induction approaches from the literature include: attaching specific 
peptides or proteins to a scaffold (Peppas and Langer, 1994; Tamura et al., 1997), 
controlling the mechanical properties o f the scaffold (Opas, 1989; Karamichos et al., 
2006) and manipulating cell-cell interactions (Putnam and Mooney, 1996).
Cell transplantation typically involves taking a biopsy from a donor source, isolating 
and expanding the donor cells in vitro, and seeding the cells directly onto polymers 
fabricated into the physical forms o f a fiberbased mesh, a sponge, or a hydrogel 
(Mooney and Mikos, 1999). The cells attach to the scaffold and ultimately form a 
new tissue. This new tissue may then be implanted into the recipient in the area o f 
need (Alsberg et al., 2001). Upon neogenesis o f tissues or organs derived from cells, 
scaffolds should undergo degradation (Mao et al., 2006).
Skeletal muscle tissue engineering represents a scientific approach that attempts to 
create and regenerate skeletal muscle tissue. In vitro skeletal muscle tissue 
engineering involves culturing isolated primary myoblasts in an environment leading 
to the formation o f a three-dimensional differentiated muscle tissue construct. 
Success depends on the regenerative properties of the satellite cells and their potential 
for proliferation and differentiation. Differentiation is the fusion of single muscle 
cells to form multinucleated myotubes. It is necessary to investigate novel
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approaches for culturing functional, differentiated 3D skeletal muscle constructs in 
vitro using primary myoblasts. Further, an understanding o f the molecular control 
mechanisms of muscle development, differentiation and maturation is important.
Skeletal Muscle Constructs
To date there have been a number o f attempts to tissue engineer skeletal muscle in 
vitro (Vandenburgh, 1983 onwards; Dennis and Kosnik, 2000; Dennis et al., 2001; 
Kosnik et al., 2001; Okano et al., 1997; Mulder et al., 1998; Okano and Matsuda, 
1998a; 1998b; Acartuk et al., 1999; Saxena et al., 1999, 2001; Powell et al., 1999; 
2002; Cheema et al., 2003; 2004; Bach et al., 2003; 2004; 2006; Riboldi et al., 2005; 
Huang et al., 2005; Shah et al., 2005). However, progress has been slow and to date a 
fully functional tissue engineered skeletal muscle construct has not yet been 
developed.
Vandenburgh (1983) pioneered skeletal muscle tissue engineering and reported the 
first 3D model of skeletal muscle, providing a 3D environment for myogenic cell 
growth and application of mechanical strain to the muscle culture. It is understood 
that complex mechanical forces generated in the growing embryo play a crucial role 
in organogenesis. During embryogenesis, the continuous passive tension applied to 
skeletal muscle by bone growth directs the initial phases of organogenesis (Stewart, 
1972; Powell et al., 2002). Therefore subsequent groups have used mechanical cues 
to tissue engineer skeletal muscle. Okano et al. (1997) and Cheema et al. (2003) used 
a 3D type I collagen gel seeded with a high density of C2C12 myoblasts and 
mechanically stretched these constructs to produce tissue engineered muscle. Okano 
et al. (1997) used a process of cellular packing through centrifugation, which helped 
increase the cell density in the collagen gels (Okano et al. 1998 (a)). Cyclic stretching
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was employed which resulted in a highly orientated hybrid muscular tissue in which 
both the cells and the collagen fibres were aligned in the direction of stretch (Okano et 
a l 1998 (a)). In addition to this, a capillary network was introduced to the muscular 
tissues by implanting the in vitro muscular tissue grafts into nude mice (Okano et al. 
1998 (b)). Cheema et al. (2003) seeded C2C12s at a high cell density (20 million/5ml 
collagen gel) to create a differentiated skeletal muscle construct. Mechanical 
stimulation of the 3D collagen constructs containing fused C2C12 myoblasts resulted 
in up-regulation o f lGF-1 gene splicing and production, and it is likely that changes in 
myofibre size may be affected through this mechanism (Cheema et al., 2004).
Dennis et al. (2000; 2001) have engineered 3D skeletal muscle tissue ‘myooids’ from 
different primary muscle cultures. A myooid is a three-dimensional skeletal muscle 
construct cultured from mammalian myoblasts and fibroblasts (Kosnik et al., 2001). 
Their sources of primary myoblasts included adult mouse, neonatal mouse and adult 
rat. Alongside these primary cultures, co-cultures of mouse cell line myoblasts 
(C2C12) and fibroblasts were used (Dennis et a l 2000, 2001). The C2C 12-fibroblast 
co-cultures contracted singly and sporadically, whereas myooids produced from 
primary cells contracted regularly and vigorously as a syncytium (Dennis et a l 2001). 
Further, C2C 12-fibroblast myooids generated the least amount of force when excited 
by transverse electrical stimulation. Co-cultures o f the myoblast and the fibroblast 
cell lines indicated that fibroblasts provide important cues, promoting myooid 
formation (Dennis et a l 2001). The major limitations of these tissue engineered 
cultures was the lack o f further progression o f myotubes to express adult phenotype in 
terms of sarcomere structure, excitability and contractility (Vandenburgh et a l ,  1989; 
1990; 1991).
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Powell et al. (1999; 2002) reported the tissue engineering of human bioartificial 
muscles (HBAMs) by suspending muscle cells (derived from the human vastus 
lateralis) in collagen/MATRIGEL, casting in a silicone mold containing end 
attachment sites, and allowing the cells to differentiate. The resulting HBAMs were 
representative o f skeletal muscle in that they contained parallel arrays o f postmitotic 
myofibers; however, they differ in many other morphological characteristics (Powell 
et al., 1999). However, they fall short o f actual skeletal muscle in many aspects, 
including small diameter muscle fibers, low myofiber density, and excessive ECM. 
To be used for structural/functional skeletal muscle repair or replacement, HBAMs 
need to be engineered with properties more similar to in vivo skeletal muscle (Powell 
et al., 2002).
For in vitro skeletal muscle tissue engineering to become a reality, cells need to 
interact with a scaffold material that can provide physical support particularly in the 
early stages o f tissue formation until the tissue is able to supports its own growth and 
development by the production o f growth factors and extracellular matrix components 
(Shah et al., 2005). Many researchers have focused attention on exploring and 
developing biomaterial scaffolds for skeletal muscle constructs; including elastomeric 
materials and salinised glass. Acartuk et al. (1999) examined the initial attachment, 
morphological characteristics, and proliferative behaviour of murine C2C12 
myoblasts on glass substrata to control myotube alignment for tissue engineering 
skeletal muscle reporting the use of glass as a viable biomaterial scaffold. Similarly, 
Shah et al. (2005) used a 3D phosphate glass fibre construct to tissue engineer 
craniofacial muscle demonstrating that phosphate-based glass fibres could support the 
in vitro attachment, proliferation and differentiation of primary human muscle derived 
cells.
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To determine the utility of elastomeric materials as substrates for tissue engineering 
skeletal muscle constructs Mulder et al. (1998) cultured G8 skeletal myoblasts on 
commercially available polyurethane Tecoflex®. The myoblasts attached, 
proliferated, displayed migratory activity and differentiated into multinucleated 
myotubes which expressed myosin heavy chain, indicative that the myotubes had 
reached a state of terminal differentiation. The results of the study suggested that it 
was indeed feasible to engineer bioartificial muscle constructs consisting of skeletal 
myoblasts cultivated on a 3-D elastomeric substrate (Mulder et al., 1998). Riboldi et 
al. (2005) similarly investigated an elastomeric stubstrate as a scaffold for skeletal 
muscle tissue engineering applications, testing the suitability of a known 
biodegradable block copolymer (DegraPol®) processed by electrospinning in the 
novel form of microfibrous membranes, as scaffold for skeletal muscle tissue 
engineering. Cell viability, adhesion and differentiation on coated and uncoated 
DegraPol® slides were investigated using the cell lines, C2C12 (mouse myogenic cell 
line) and L6 (rat myogenic cell line)) and primary human satellite cells (HSCs). 
Positive staining for myosin heavy chain expression indicated that differentiation of 
C2C12 multinucleated cells had occurred. Suggesting that the results of their study 
provided significant evidence o f the suitability of electrospun DegraPol® membranes 
as scaffolds for skeletal muscle constructs (Riboldi et al., 2005).
Clearly, many attempts have been made so far to construct skeletal muscle tissue in 
vitro, together the results of these studies suggest that it is indeed feasible to engineer 
bioartificial muscles; nonetheless, with current technology, tissue-engineered skeletal 
muscle analogues are far from being a clinical reality (Riboldi et al., 2005). These 3D
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engineered muscle constructs can be used to determine the effects o f specific stimuli 
on both the functional (force production, endurance capacity, and contractile 
dynamics) and molecular (level and isoform o f contractile and regulatory proteins) 
development of skeletal muscle (Huang et al., 2005) as well as future applications in 
therapeutic replacement of tissues lost to damage due to disease and/or trauma (Lewis 
et al., 2008).
Thesis Overview
Although progress has been made in the construction of muscle organoids tissue 
engineering of skeletal muscle still remains a major challenge (Bach et al., 2006). 
The purpose o f this study was to develop an in vitro craniofacial skeletal muscle 
construct using primary human muscle derived cells from the masseter seeded within 
a 3D type I collagen gel scaffold. This study investigated the effect of mechanical 
and biological cues as the myogenic cells were induced to differentiate within the 
construct.
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Materials and Methods
1. Primary Cell Culture
As part of on-going research at the Eastman Dental Hospital and Institute, masseter 
muscle samples were previously obtained from patients undergoing the following 
surgical procedures under general anaesthesia:
• Bimaxillary orthognathic surgery
• Mandibular orthognothic surgery
•  Removal of mandibular third molars
The removal o f biopsy tissue was approved by, and in accordance with, the guidelines 
of the Human Subjects Ethics Committee. Samples were only taken from healthy 
adult patients and informed consent was obtained prior to all biopsies.
Biopsies were taken from the deep surface of the anterior border of the superficial 
belly o f the masseter muscle via an intra-oral incision at the time of surgery (Boyd et 
a i,  1984). Biopsies were washed with antibiotic (penicillin, lOOOu/ml; streptomycin, 
100//g/ml; fungizone, 2.5 //g/ml; Invitrogen, Scotland, UK)-supplemented Dulbecco’s 
modified Eagle’s medium (DMEM; Invitrogen, Scotland, UK), scissor-minced and 
any visible pieces o f connective tissue were removed in order to prevent fibroblast 
overgrowth.
The tissue fragments were plated into 0.2% gelatin coated flasks with a surface area 
of 80 cm^, incubated in standard growth medium (20% fetal calf serum (PCS, First 
Link Ltd, Birmingham, UK), 1% penicillin ( 1 OOOu/ml)/streptomycin( 1 OOpg/ml) (P/S;
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Gibco Chemicals, Paisley, UK) in DMEM) and maintained at 37°C in a humidified 
atmosphere o f 5% CO2 in air. The standard growth medium used in this study has 
high levels o f serum, which are typically used to allow myogenic cells to proliferate 
in culture (Yaffe, 1971). The first wave o f migration of mononuclear cells from the 
explant was designated the ‘a-wave’, and this population was used throughout this 
study (Lewis et a l, 2000).
The expanded cells were stored under cryogenic conditions. The cryogenic storage of 
cells is the ability to store small aliquots o f frozen cells in liquid nitrogen (-196°C) 
without loss of proliferative or differentiative capacity. This allows replication of 
experiments and comparative studies (Blau and Webster, 1981). Freezing is 
facilitated by dimethylsulphoxide (DMSO), which is a cryopreservative that reduces 
the formation o f ice crystals in the cells. The cells used in this study were retrieved 
from cryogenic storage.
Gelatin coating of flasks and coverslips
All anchorage dependent cells need to attach to a solid substrate in order to 
proliferate. Tissue culture flasks are made from polystyrene, which is manufactured 
to produce a negative surface charge in order to aid cell adhesion, but this surface will 
not support myoblast proliferation (Freshney, 1992). Myoblasts adhere more 
efficiently when there is a net positive charge, therefore all tissue flasks and cover­
slips were coated with gelatin. A 0.2% working solution of gelatin was made up from 
a stock 2% gelatin solution (Sigma, Poole, UK) diluted with phosphate buffered saline 
(PBS). All flasks and coverslips were coated under sterile conditions with sufficient 
substrate (lOmls per flask and 0.5ml per coverslip) and left for 30 minutes to allow 
substrate attachment. Excess substrate was poured off and flasks were ready for use.
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Subculture
As primary cell cultures become established the cells become densely populated and 
thus closely associated with one another (confluent). Cells were closely monitored 
using light microscopy and when 70-80% confluency was reached subculturing was 
carried out. Subculture allows expansion o f the culture, the possibility of cloning and 
characterization, but leads to the loss of any cells that have already differentiated.
Routine subculture was as follows: growth medium was removed from the culture 
vessels and discarded. All reagents were warmed at 37°C. The cell layer was washed 
twice with lOmls of PBS. Washing the cell layer with PBS removed most o f the 
serum proteins and diluted those that were left, thus minimizing the inhibitory effects 
the proteins would have on trypsin activity.
The cells were then incubated in 7mls o f 0.05% trypsin in 0.53mM EOT A (Gibco, 
Paisley, UK) for 5 minutes. Trypsin digests extracellular matrix links, and EOT A was 
used as a chelating agent to sequester calcium and magnesium. During this period the 
cells become detached from the substrate. The action of trypsin was inhibited by 
addition of lOmls o f serum containing growth medium. The uniform cells suspension 
was then centrifuged at 2000rpm for 5 minutes and the supernatant discarded.
The cell pellet was disrupted by firmly tapping the tube several times and the cells 
were resuspended in lOmls o f standard growth medium. A 1:3 split was achieved by 
adding an equal amount o f the cell suspension to each o f the three gelatin coated 
flasks prepared. The first subculture was defined as passage one, denoted Pi, with 
ensuing subcultures denoted P2, P3 etc. The cell number was determined using a
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haemocytometer and the trypan blue exclusion method. 20pl o f cell suspension was 
placed in a sterile eppendorf tube and 20pl o f trypan blue dye added in a ratio o f 1:1. 
The trypan blue dye was taken up by the dead cells and these cells were not counted.
2. The Culture Force Monitor
The Culture Force Monitor (CFM) is a force monitoring device which enables the 
pattern of forces generated by cells embedded in a 3D collagen matrix to be quantified 
and correlated with cell motility/traction, contraction and fibril remodeling (Eastwood 
et al., 1994; Brown et al., 1998; Karamichos, 2006). The CFM monitors cell-matrix 
interactions as a real time force contraction profile (force plotted against time). This 
instrument enables the characterisation of the cytomechanical properties o f different 
cell types within a 3D collagen construct. The CFM was designed and developed by 
Dr. Mark Eastwood (Eastwood et al., 1994).
Collagen construct preparation
Collagen gels were cast between 2 floatation bars, which were in turn attached to 
stainless steel wire A-ffames (Figure 9). For collagen construct preparation, 0.7 ml of 
IQx minimum essential medium (MEM) Eagles solution (Invitrogen, Scotland, UK) 
was added to 6ml of rat-tail type I collagen (First Link, Birmingham, UK) (in O.IM 
acetic acid, protein concentration = 2.035 mg/g), then neutralized by titration with 5M 
and IM NaOH, until a colour change (yellow to cirrus pink) was observed (Prajapati 
et al., 2000). 1ml of this gel was then used to pre-coat 2 polyethylene mesh 
floatation bars. 4.5mls was added to 5x10^ cells suspended in 0.5mls DMEM giving 
a 5ml gel which was poured into a 75x25xl5mm^ polyethylene mould, containing the 
pre-coated mesh floatation bars attached to A-ffames, and set within 30 minutes in an 
incubator maintained at 37°C in a humidified atmosphere o f 5% CO2. The gel was
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then physically detached from the base o f the mould and floated in 20mls of standard 
growth medium.
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Figure 9: A schematic diagram showing the contraction of the cell seeded 
collagen construct, (a) The collagen gel was set between two floatation bars in a 
rectangular shaped well. The floatation bars were in turn connected to A-frames 
which facilitated attachment to the CFM. (b) As the collagen gel contracted (over 
24 hours) the bars were pulled inwards and the displacement was measured.
The cell-seeded collagen construct was then tethered to the CFM and cell mediated 
matrix contraction was quantified (Figure 10). The ability of the CFM to measure 
very early force generation with great accuracy, reproducibility and with little 
background noise makes it ideal for investigating the mechanisms by which force is 
generated by cells in this system.
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Figure 10: A schematic diagram representing the set-up of the CFM (courtesy of 
Dr. Ali Soueid). The collagen gel pulls in the floatation bars, one of which is 
attached to the force transducer. The force is transmitted to a microprocessor, 
the signal is amplified and converted for analysis using LabView software. 
Contraction profiles are plotted over 24 hours.
The CFM consists of highly sensitive force transducers (movements as small as 1 pm 
are detectable) that are connected to a personal computer (PC) via an analogue-to- 
digital converter (ADC). Displacement was converted into a force reading and stored 
on the PC. This apparatus provides a continuous and precise measure of force 
generated by living cells in a 3-D collagen matrix (Eastwood et al., 1998). Further, 
the phases of contraction from the cells over 24 hours represent a reproducible 
framework for interpretation of the cell behaviour (Eastwood et al., 1996). The CFM 
was utilised in this study to monitor the force contraction profiles of craniofacial 
muscle derived cells embedded in collagen constructs (Figure 11).
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Figure 11: The CFM instrument set up is shown in this picture. The cell seeded 
collagen gel is tethered between a fixed point and a displacement force 
transducer. The CFM is used in a humidified, 37°C, CO2 incubator. The cell- 
mediated collagen contraction is converted into a force reading via the force 
transducer and an external microprocessor.
Force Transducer Calibration
To ensure stable operation the CFM was calibrated regularly. The force transducer 
from each machine was positioned horizontally, and was calibrated against a set o f 
known weights. First readings were taken when no weight was applied to the beam,
i.e. zero force. Then five known weights (29.4, 49, 196, 294 and 490g) were placed 
consecutively on the hook at the tip of the transducer. The weights caused 
displacement of the Cu-Berrylium beam which was converted into a corresponding 
force, as described earlier. Force readings were recorded for 5 minutes for each mass.
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The calibration curve was plotted as average force (pN) against applied weight (g). 
The force transducer was operating normally if the relationship between force and 
weight is linear. Adding a trend line to the acquired data points revealed a linear 
relationship by regression analysis, i.e. if  the value is close to 1 the relationship is 
linear (Figure 12). If the was less that 0.95 the force transducer was deemed 
unstable and unsuitable for use. The Cu-beryllium beam was sent to the manufacturer 
to replace the damaged strain gauge.
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Figure 12: A typical force transducer calibration curve plotted as force (pN) 
against weight (grams). The displacement of the force transducer following the 
application of known weights enabled the calibration of the CFM.
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i .  RNA Extraction
All CFM experiments ran for 24 hours. The collagen 
gels were then flash frozen in liquid nitrogen and 
stored at -80°C to prevent RNA degradation.
The Qiagen RNeasy® (Qiagen, UK) procedure is an 
established technology for RNA purification and the 
manufacturers protocol was followed (Figure 13). In 
addition to this kit FastRNA® Pro Green Kit 
(Qbiogene, Inc., CA) containing Lysing Matrix D 
beads were used together with the FastPREP® 
instrument (a homogenizer for isolating RNA;
Qbiogene, Inc., CA) to completely break up the 
collagen gel.
The cell-seeded collagen gels were then lysed in the 
presence of a highly denaturing guanidine-
Figure 13: RNA extraction
thiocyanate containing buffer (RLT). lOOOpl of RLT Handbook
buffer was added to the collagen gel in the Lysing
Matrix D tube. The tube was processed in the FastPrep® instrument for 40 seconds at 
6.0ms'* then allowed to cool on ice for 5 minutes. The tube was returned to the 
instrument for a further 40 seconds at 6.0ms'*, then removed and centrifuged at 
13000rpm for 5 minutes. lOOOpl of the homogenised supernatant was added to an 
equal volume of Ethanol and mixed well by pipetting. Ethanol was added to provide 
appropriate binding conditions. 600pl of the sample was transferred to an RNeasy
t
EluTe
Ibkal RNA
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spin column and centrifuged at lOOOOrpm for 15s. The RNeasy Mini spin contains a 
silica based membrane which binds total RNA. The flow through was discarded and 
successive aliquots were centrifuged. Contaminants are efficiently washed away 
using a specialized high-salt buffer (RW l and RPE) system. First, 600pl of Buffer 
RWl was added to the RNeasy spin column and centrifuged for 15s at lOOOOrpm. 
Again the flow through was discarded. The next buffer, RPE was added to the 
RNeasy spin column in a new 2ml collection tube and centrifuged at lOOOOrpm for 
15s. Followed by a second wash with RPE buffer this time centrifuged at lOOOOrpm 
for 2 minutes. The longer time period ensured that any possible carryover ethanol or 
buffer was eliminated.
The RNeasy spin column was then placed in a new 1.5ml collection tube. To elute 
the RNA 30pl o f RNase-ffee water was added to the column and placed on ice for 5 
minutes to allow the water to soak through the silica-membrane. The column was 
then centrifuged for 1 minute at 10000 rpm. A further 20pl of RNase-ffee water was 
added to the column and again centrifuged for 1 minute at lOOOOrpm. Giving a total 
o f 50pl eluted, o f which 3 pi was used to measure RNA quality. RNA is inherently 
fragile and therefore subject to degradation process during preparation and handling, 
therefore the integrity o f extracted RNA was monitored using the Agilent 2100 
Bioanalyser (analyses quality and quantity of RNA; Agilent, US) together with the 
RNA 6000 Nano LabChip® Kit (Agilent, US). The manufacturers’ protocol were 
carefully followed, including decontaminating the electrodes, preparing the gel dye 
mix, loading the gel dye mix and loading the RNA 6000 Nano LabChip® onto the 
Biolanalyser.
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1. Decontaminating the Electrodes
Before each use the electrodes of the bioanalyser were decontaminated. The electrode 
cleaner provided was filled with 350pl o f RNaseZAP® and placed in the bioanalyser, 
the lid was closed and left for 1 minute. The electrode cleaner was removed and a 
second electrode cleaner filled with 350pl o f RNase-fi’ee water was placed in the 
machine the lid was closed and left for 10 seconds. The second cleaner was removed 
and the electrodes were now decontaminated and ready for use.
2. Preparing the Gel-Dye Mix
550pl of RNA 6000 Nano gel matrix was placed into the top receptacle of the spin 
filter and centrifuged at 4000rpm for 10 minutes. 65 pi o f the filtered gel was then 
added to Ipl o f RNA 6000 Nano dye concentrate in a 0.5ml RNase-ffee microfuge 
tube and vortexed thoroughly.
3. Loading the Gel-Dye Mix
A new RNA Nano chip was taken out o f it’s sealed bag and placed in the Chip 
Priming Station (need to go to website for picture). The Chip Priming Station is used 
to dispense the gel-dye mix by pressurization. 9pl of the gel-dye mix was pipetted 
into the well marked ‘g’ and the priming station is closed. The plunger was then 
pressed until it was held in position by the syringe clip for exactly 30 seconds. The 
plunger was then released with the clip release mechanism. After 5 seconds the 
plunger is slowly pulled back into the starting position. 9pl of the gel-dye mix were 
also pipetted into the other wells marked ‘g’. The remaining gel-dye mix was 
discarded.
55
Materials and Methods
4. Loading the RNA 6000 Nano Marker, Ladder and Samples 
5|il of the RNA 6000 Nano Marker was then pipetted into each of the 12 sample wells 
as well as the well marked with the ladder symbol. The ladder was heat denatured at 
70°C for 2 minutes, then 1 pi o f the ladder was pipetted into the well marked with the 
ladder. Similarly, Ipl of each RNA sample was pipetted into each of the 12 sample 
wells. The chip was then placed in the adapter of the vortex mixer and mixed for 1 
minute at 2400rpm. The chip was then placed into the bioanalyser where the 
electrodes in the cartridge fit into the wells of the chip. The 2100 expert software 
showed that the chip was inserted correctly and proceeded to run the analysis, the 
output was an electropherogram summary (Figure 14 (a)). Only high quality RNA 
(ratio in the range 1.6-2.0) was used for subsequent cDNA synthesis.
High quality RNA
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Figure 14: Example Electropherogram Summary, (a) High quality RNA 
demonstrated 2 intact RNA species, the 18S and 28S ribosomal RNAs. RNA 
concentration and quality were determined by the ratio of 18S and 28S. (b) An 
extreme example of degraded RNA (due to contamination or handling error) is
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also shown (Source: http://www.primerdesign.co.uk/RNA_quaiity_control-
technical bulletin.asp)
4. cDNA Synthesis
RNA was reverse transcribed into cDNA using Expand Reverse Transcriptase (Roche 
Diagnostics, East Sussex, UK). This step synthesised a complementary strand of 
DNA to the RNA in the sample. For cDNA synthesis a master mix was prepared 
containing; oligodeoxythymidylic primer (Oligo dT Primer), deoxynucleoside 
triphosphates (dNTPs), Moloney Murine Leukemia Virus (MMLV reverse 
transcriptase). Magnesium Chroride (MgCb), first strand buffer and RNase inhibitor, 
according to volumes shown in Table 1.
Oligo dT Primer (0.5pg/pl) 0.5pl
dNTPs (5mM) 0.4pl
MMLV (200U/pl) 2 pl
First Strand Buffer 5pl
MgCb (25mM) 3pl
RNase inhibitor (40U/pl) 0.25pl
Table 2: cDNA Synthesis Master Mix
The primers bind to target sites and dNTP’s provide the additional bases required to 
produce the complementary strand. The MMLV reverse transcriptase is the enzyme 
that synthesises first strand cDNA. 11.15 pi of the master mix was added to a 0.5ml 
eppendorf tube and 2pg of RNA was added to the appropriate amount o f RNase-ffee
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water to give a total reaction mix of 50^1. A drop o f molecular grade mineral oil 
(Sigma, Dorset, UK) was added on top o f the mix and the lid gently closed. The 
thermo-cycler (Hybaid OMN-E) was programmed according to the sequence: 25°C 
for 10 minutes, 42°C for 60 minutes and 94°C for 5 minutes (to denature the RT 
enzyme).
5. Polymer Chain Reaction (PGR)
PCR amplifies specific DNA sequences. This technology is based on the use o f DNA 
polymerase to copy a DNA sequence in repeated cycles o f replication. Each cycle 
doubles the amount o f DNA synthesised in the previous cycle.
Taq polymerase is a thermostable DNA polymerase isolated from the thermophilic 
bacterium Thermus aquaticus; this polymerase is stable at much higher temperatures 
than eukaryotic DNA polymerases, so is not denatured by heat treatment.
Figure 15: Forward and reverse primers hybridized to the DNA sequence guide 
the polymerase to the sequence to be amplified (adapted from Applied 
Biosystems® Chemistry Guide).
The polymerase is guided to the sequence to be copied by short primer 
oligonucleotides (relatively short single-stranded nucleic-acid chains usually 
consisting of up to approximately 20 nucleotides) that are hybridized to the DNA 
template at the beginning (forward primer) and end (reverse primer) of the desired
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DNA sequence (Figure 15). These primers are designed so that they provide a primer 
for DNA replication on each strand of the original double stranded DNA to be 
amplified (Alberts et al, 1998).
PCR is extremely sensitive it can detect a single copy of a DNA sequence in a sample 
by amplifying it so much that it becomes detectable. Using this technique a given 
nucleotide sequence can be selectively and rapidly replicated in large amounts from 
any DNA that contains it.
Real-time PCR is the ability to monitor the progress of the PCR as it occurs rather 
than at the end o f the reaction. The development of fluorogenic labeled probes 
enabled the detection o f only specific PCR product as they accumulated during the 
reaction.
( R NFQXMGB
R = Reporter Dye (FAM™ and VIC^ Dyes) 
NFQ = Non-Fluorescent Quencher 
MGB = Minor Groove Binder (T^ enhancer)
Figure 16: TaqMan fluorogenic labeled probe. An oligonucleotide probe is 
constructed containing a reporter dye at the 5’ end, a minor-groove-binder 
moiety and a non-fluorescent quencher dye on the 3' end (adapted from Applied 
Biosystems® Chemistry Guide).
The TaqMan (Applied Biosystems®) probes used in this study are fluorogenic- 
labelled probes (Figure 16). While the probe is intact, the proximity of the quencher 
dye greatly reduces the fluorescence emitted by the reporter dye by fluorescence 
resonance energy transfer (FRET) through space.
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If the target sequence is present, the probe anneals downstream from one of the 
primer sites and is cleaved by the 5 ' nuclease activity of Taq DNA polymerase as this 
primer is extended.
  ? _____9 ,
Figure 17: A fluorescent reporter (R) dye and a quencher (Q) are attached to 
the 5’ and 3’ ends of the TaqMan® probe. When the probe is intact, the reporter 
dye emission is quenched (adapted from Applied Biosystems® Chemistry Guide).
This cleavage of the probe separates the reporter dye from the quencher dye, 
increasing the reporter dye signal (Figure 18). Further, it removes the probe from the 
target strand, allowing primer extension to continue to the end of the template strand,
i.e. inclusion of the probe does not inhibit the overall PCR process.
..________'Æ:___ 9,-------------------------------------
Figure 18: During each extension cycle the DNA polymerase cleaves the reporter 
dye from the probe. Once separated from the quencher the reporter dye emits 
its characteristic fluorescence (adapted from Applied Biosystems® Chemistry 
Guide).
Additional reporter dye molecules are cleaved from their respective probes with each 
cycle, resulting in an increase in fluorescence intensity proportional to the amount of 
amplicon (synthesised segments of DNA) produced.
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The specific probes selected for this study were:
1. Myogenin (assay ID: Hs01072232_ml; GenBank mRNA sequence: 
X17651.1);
2. Myosin Heavy Chain (MyHC) two isoforms:
a. MyHC-p (slow MHC7; assay ID: Hs00165276_ml; GenBank mRNA 
sequence: M58018.1);
b. MyHC-IIX/C (fast M HCl; assay ID: Hs00428600_ml; GenBank 
mRNA sequence: AFl 11785.1);
3. MMP-2 (gelatinase A,72kDa type IV collagenase; assay ID: Hs00234422_ml ; 
GenBank mRNA sequence: J03210.1); and
4. GAPDH (glyceraIdehyde-3-phosphate dehydrogenase; assay ID: 
Hs99999905_ml; GenBank mRNA sequence: M33197.1).
These probes were optimised to universal cycling conditions by Applied Biosystems®.
RT-PCR was performed using Applied Biosystems 7300 Real-Time PCR System 
(Applied Biosystems, California, USA). This system combines thermal cycling, 
fluorescence-dye technology, and application-specific software. All sample wells 
were illuminated with a tungsten halogen lamp and fluorescence emission was 
detected through four filters to a camera.
The universal thermal cycling parameters presented in Table 3 were used for the 
reaction. This protocol was designed by Applied Biosystems® for use with all assays 
designed according to Applied Biosystems assay design guidelines i.e. no 
optimization of the thermal cycling parameters was necessary for probes used.
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Times and Temperatures
InlHal Steps PCR (40 Cycles)
AmpErase UNG 
Activation
AmpHTaq Gold 
DNA Polymerase 
Activation
Men Anneal/Bctend
HOLD HOLD CYCLE
2 rrtn 0  50 ®C 10mln@95 *C 15 sec O 95 X 1 min Ô 60 ®C
Table 3: Thermal cycling parameters for quantification assays when using 
TaqMan Universal PCR Master Mix
PCR products are detected cycle-by-cycle in a single reaction tube. The components 
o f this reaction are listed in Table 4 below. The TaqMan® Universal PCR Master Mix 
(Applied Biosystems, California, USA) contained AmpliTaq Gold® DNA polymerase, 
AmpErase® UNG, dNTPs with dUTP.
Reaction Component
Volume/Well
(25pl
Reaction)
TaqMan® Universal PCR Master Mix 12.5
2 0  X Assays-on-Demand^*^ Gene Expression Assay Mix 1.25
cDNA diluted in RNase-ffee water 11.25
Total
25
Table 4: Components of the PCR reaction
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Data is collected throughout the PCR process, rather than at the end. Compared with 
manual PCR quantitation techniques, RT-PCR has greater sensitivity and precision. 
RT-PCR is characterised by the point in time during cycling when amplification of a 
target is first detected rather than the amount of target accumulated after a fixed 
number of cycles. An amplification plot graphically displays the fluorescence 
detected over the number of cycles that were performed (Figure 19).
Delta Rn M Cvcle
Threshold
1 Oe+OOO Amplification Curves
1 .06-001
I
1 Oe-002
I.Oe-003
1 06-004
1 2 3 4 5 6 7 8 9 10 11 1213 14 15 16 17 18 1920 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
Cycle Number
Figure 19: Data is collected throughout the Real Time PCR process and the 
fluorescence detected is graphically displayed over the number of cycles that 
were performed (amplification curves). The threshold at which a sufficient 
amount of target is amplified and the corresponding cycle numbers (Ct) are also 
highlighted.
In the initial cycles of PCR, there is no significant change in fluorescence signal. This 
predefined range of PCR cycles is called the “baseline”. The Sequence Detection
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Software (SDS®) generates a baseline subtracted amplification plot by calculating a 
mathematical trend using Rn (the emission intensity of the reporter dye) values 
corresponding to the baseline cycles. Then an algorithm searches for the point on the 
amplification plot at which the delta ARn value crosses the threshold. The threshold 
cycle or C t value is the cycle at which a statistically significant increase in ARn is first 
detected.
Relative Quantification using the comparative Cj  method (AACt)
Relative quantification (RQ) determines the change in expression of a nucleic acid 
sequence (target template) in a test sample relative to the same sequence in a 
calibrator (the sample used as the basis for comparative results). When using the 
comparative Ct method with real-time PCR, the endogenous reference can be 
normalized using data generated during the PCR experiment. This is especially useful 
when there is a limited amount of RNA or when high-throughput processing o f a large 
number of samples is performed (Livak and Schmittgen, 2001).
Finally, to use the comparative Ct method, the efficiencies of the target and 
endogenous control amplifications should be approximately equal -  this was verified 
by Applied Biosystems®. The advantage of using the comparative CT method is that 
the need for a standard curve is eliminated. This increases throughput and also 
eliminates the adverse effect of any dilution errors made in creating the standard 
curve samples.
Therefore, the comparative Ct method was used. The amount of target (eg. MMP2) 
normalised to an endogenous reference (GAPdH) and relative to a calibrator is given 
by the equation:
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2  —A A C y
The AACt method was used to calculate the fold differences in the target genes 
between samples. Four steps were used to perform this analysis.
Step 1 : Calculate the average Ct 
Step 2: Calculate the ACt value
A C %  -  C t  ta rge t “  Ct t '-»T re ference
Step 3: Calculate the AACt
AACt = ACt test sam ple -  ACt calibrator sam ple
Step 4: Calculate the RQ fold increase
2  —A A C ^
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Experiment
Average C t A C t -A A C t RQ
Target
Gene
(MMP2)
Endogenous
Control
(GAPDH)
C t (MMP2) - 
C t (GAPDH)
-(A C t,x -
A Ct, calibrator)
^*AACt
Untreated
sample
24.310 19.304 5.006 2.856 7
Treated sample 21.692 20.068 1.624 6.238 75
Calibrator 27.068 19.206 7.862 0 1
Table 5: Data analysis using Ct values obtained from PCR. The comparative 
method was used to calculate the relative gene expression.
The average Ct was obtained from the PCR run. The ACj value was determined by 
subtracting the average GAPDH C i from the average MMP2 C j value. From Table 5, 
A C t treated = 21.692 -  20.068 = 1.624
-AACt was calculated by subtracting the ACt calibrator value from the ACt target 
value. From Table 5,
-A A C t =  - (A C t treated - A C t calibrator)
= -(1 .624 -7 .862) = 6.238
The RQ for the ‘treated’ relative to calibrator was calculated using the equation:
2 -AACt Following this example through: 2^^^* = 75. Indicative o f a relative up- 
regulation o f the gene in the treated sample compared to the gene expression in the 
untreated sample.
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6. Statistical Analysis
Statistical analysis o f data (minimum of n=3 for all the experiments) were performed 
using the non-parametric, ANOVA (analysis of variance) testing (Kruskal-Wallis), 
using GraphPad Prism (Graphpad Software, San Diego, USA). Briefly, the purpose o f 
ANOVA was to test for significant differences between means. If only two means are 
being compared, ANOVA will give the same results as the t-test.
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C h a p te r  1: Cell separation  and m arkers of m yogenic 
differentiation in 2D 
Introduction
To date, the in vitro 2D culture and differentiation of skeletal muscle myoblasts has 
been an invaluable technique to explore many facets o f skeletal muscle physiology 
and pathology, providing an isolated myogenic system, free from the complexity of 
whole animal studies (Cooper et a i ,  2004). Upon enzymatic dissociation single 
mononuclear cells are able to migrate out from scissor-minced biopsies of human 
craniofacial masseter muscle (Mouly et a l ,  1993; Sinanan et al., 2004). These 
mononuclear cells are a heterogenous mixture o f myogenic (giving rise to or forming 
muscle) and non-myogenic cells (Yaffe and Saxel, 1977; Blau and Webster, 1981; 
Stewart et al., 2003; Cooper et al., 2004; Sinanan et al., 2004). This heterogenous 
mixture o f cells is due to the amount and distribution of connective tissue which 
results in the inevitable combination o f primary myoblast cultures with other cells (i.e. 
fibroblasts) (Yaffe and Saxel, 1977).
The ratio of myogenic to non-myogenic cells in primary cell cultures has been 
demonstrated to influence the muscle cells present, making it difficult to distinguish 
between the properties intrinsic to the myogenic cells and the effects exerted by other 
cell types (Yaffe and Saxel, 1977; Blau and Webster, 1981). Webster et al. (1988) 
reported that the presence o f fibroblasts (non-myogenic cells) inhibited the 
biochemical differentiation of satellite cells. On the other hand. Cooper et al. (2004) 
recently reported that primary myoblasts cultures that are contaminated by fibroblasts
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fared better in culture than do C2C12 cells, suggesting that fibroblasts secrete 
extracellular matrix components and growth factors that may contribute to the 
survival and differentiation of myoblasts. The purity o f the cell population is 
important (Bonavaud et al., 2002; Sinanan et al., 2004) and little attention has been 
paid to the interactions between muscle fibres, myogenic cells and other (non- 
myogenic) cells such as fibroblasts (Singh et al., 2000).
The ability to obtain large homogenous cell populations which undergo differentiation 
in controlled culture conditions would enable comparative studies at the cellular and 
biochemical levels of the intrinsic properties of myogenic cells obtained from muscle 
biopsies. To this end a number o f researchers have reported several myoblast 
purification procedures including density centrifugation, selective adhesion, 
fluorescence activated cell sorting (FACS), size separation based flow cytometry and 
chemical use o f fibroblast growth inhibitors (Kao and Prockop, 1977; Yablonka- 
Reuveni et a/., 1987; Webster et al., 1988; Baroffio et al., 1993; Blanton et al., 1999 
Immuno-magnetic techniques have recently been reported (Lequerica et a l,  1999; 
Sinanan et a l ,  2004; Park et a l ,  2006) to purify myoblasts from primary cultures by 
magnetic activated cell sorting (MACS) with good yields. Sinanan et al (2004) 
reported a purified myoblast subpopulation which expressed desmin in at least 95% of 
the cells. Desmin is a cytoplasmic intermediate filament protein that is expressed by 
myogenic myoblasts and myotubes (Kaufman and Foster, 1988; Lewis et a l ,  2000; 
Bonavaud et al., 2002).
Kaufman and Foster (1988) first noted that fibroblasts do not express desmin and this 
can be utilised as a way of distinguishing them from myoblasts in vitro. Desmin
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labelling has been particularly instructive in identifying myoblasts because it is one o f 
the first muscle-specific proteins to be produced in myoblasts (Lawson-Smith and 
McGeachie, 1998). Single desmin negative (non-myogenic) cells in muscle derived 
cultures are either (i) quiescent myoblasts that have not entered myogenic 
differentiation or (ii) infiltrating intramuscular fibroblasts (van der Ven et al., 1992; 
Lewis et al., 2001). Desmin was used in this study to determine the percentage of 
myogenic cells within the muscle derived cell cultures used for further 
experimentation.
The first aim o f  this study was to separate the heterogenous mixture o f  mononuclear 
cells derived from  craniofacial muscle into purified subpopulations o f  myogenic and 
non-myogenic cells using immuno-magnetic techniques (MACSf^). CD56 was chosen 
for positive sorting as it recognizes a cell-surface epitope that is highly expressed on 
the target cells (and not expressed at all on the non-myogenic cells) and is non-labile 
under processing conditions (Sinanan et al., 2004). CD56 is a cell adhesion molecule 
(CAM), also known as antigen Leu-19 (leucocyte differentiation antigen 19) that is 
expressed constitutively in proliferating myoblasts (Ilia et al., 1992; Belles-Isles et a l ,  
1993). Other cells also express CD56, including certain lymphocytes and neurons, 
but not fibroblasts (Stewart et al., 2003).
The central event in skeletal muscle development is the fusion (differentiation) of 
myoblasts to form multinucleated myotubes (Lewis et a l,  2000). This phenomenon 
can be exploited in vitro. Myogenic MDGs isolated from the human masseter muscle, 
grown under permissive culture conditions can fuse and form myotubes (Sinanan et 
a l,  2004). The onset and progression of fusion of myoblasts in vitro is controlled by
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a set of complex interactions between myoblasts and their environment (Melo et al., 
1996). The mononucleated cells undergo a series of events including cell fusion and 
the synthesis o f a new set o f proteins, such as a-sarcomeric actin an established 
marker o f terminal differentiation (Sinanan et al., 2004). The second aim o f  this study 
was to test that myogenic cells fuse to form  multinucleated myotubes in 2D and 
express a-sarcomeric actin.
The terminal differentiation of myogenic cells begins with their withdrawal from the 
cell cycle. It remains unclear what the stimulus for fusion is and how these events are 
regulated (Schultz and McCormick, 1994). O f particular interest however, is the 
expression of myogenin mRNA observed when myoblasts were induced to 
differentiate (Melo et a l, 1996). Myogenin is a DNA binding transcriptional 
regulatory protein. Work both in vitro and in vivo has found that myogenin is up- 
regulated during the differentiation of skeletal myoblasts (Sassoon et a l  1989, Wright 
et a l 1989). Nabeshima et al. (1993) investigated the role o f myogenin in mice by 
disrupting the myogenin gene, their results showed normal numbers of proliferating 
myoblasts, however they failed to differentiate, concluding that myogenin may have a 
role in the transition from myoblasts to differentiated myotubes. Myogenin is well 
established as a secondary myogenic regulatory protein expressed prior to fusion of 
myoblasts to form myotubes (Rawls et a l 1995). The final aim o f  this part o f  the 
study was to test whether multinucleated 2D cell cultures express myogenin. The 
objective was to quantitate myogenin mRNA expression in cultures containing single 
cells and multinucleated myotubes using quantitative RT-PCR.
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Materials and Methods
Cell Separation
The primary human craniofacial muscle derived cells (MDC) that migrate off the 
biopsy are a mixture of myogenic and non-myogenic cells. In order to obtain a 
purified myogenic cell population from the mixed population of primary MDCs, a 
magnetic sorting system was selected. MACS® is a magnetic separation technology 
designed to magnetically separate cells in suspension according to cell surface 
antigens. It has been shown that the super-paramagnetic MACS® MicroBeads at 
about 50nm diameter do not significantly change the scatter properties of the cell or 
their light microscopic appearance. Further, they are biodegradable due to their small 
size and biochemical composition (iron oxide and polysaccharide), degrading during 
subsequent culture such that cell function and viability were preserved.
Principals of MACS® separation
First the target cells are magnetically labeled and then the cell suspension is loaded 
into a MACS® Column which is placed in the magnetic field of the MACS® separator 
(Figure 20).
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Figure 20: Schematic showing the principles of MACS separation. First the 
cells are magnetically labeled with the antigen specific MicroBead (CD56+) and 
then the cells are passed through a magnetic field. The positively (magnetically 
labeled) selected cells are retained in the column isolated from the original 
mixture of cells.
1. Magnetic labeling of myogenic cells (CD56+)
MDCs were magnetically labelled according to the manufacturers protocol (Miltenyi 
Biotech, USA). Phosphate buffered saline pH 7.2, was supplemented with 0.5% 
bovine serum albumin (Sigma, Poole, UK) and 2mM EDTA. This specially prepared 
phosphate buffer (PB) was degassed using a vacuum pump. The mixture of myogenic 
and non-myogenic cells was suspended in SOpl o f PB and 20pl of anti-human CD56+ 
MicroBeads per 10  ^ total cells, mixed well and allowed to incubate for 15 minutes at 
4-8°C. The cells were then washed in l-2mls of PB per 10  ^ total cells and
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centriftiged at 1390rpm for 10 minutes. The cells were resuspended in 500pl o f PB in 
preparation for magnetic separation.
2. Magnetic separation of MDCs
A MACS® LS column supplied was placed into the magnetic field of the MACS® 
separator (Figure 21). The column was then rinsed with 3mls of PB. The 
magnetically labeled cell suspension was applied to the column. The column was 
washed three times with 3mis of PB to give the unlabeled, or negative (CD56-) 
fraction.
N
Figure 21: Picture showing the magnetic separation apparatus. The (a) MACS' 
column was placed into the magnetic field of the (b) MACS® Separator.
The column was then removed from the magnetic field and the positive fraction 
(magnetically labeled cells; CD56+) was flushed out of the column by flowing 5mls 
of PB through the column and firmly applying the plunger supplied with the column. 
Both the labeled (myogenic) and unlabeled (non-myogenic) fractions were used for 
subsequent culture and studies.
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Immunostaining
The purity (% myogenic cells) of the co-culture and the magnetically separated cells 
was evaluated using immunohistochemistry and fluorescent microscopy techniques. 
The single cells were plated at a density of 25,000 cells/well (in a 6  well plate) and 
fixed after 24hours. Cells were fixed with 2% paraformaldehyde for 5-10 min 
followed by post-fixation with ice-cold 20% methanol for 10 min. The aim of cell 
fixation is to preserve cell structure and to present target antigens available to the 
antibodies. Aldehydes (eg. paraformaldehyde) fix cells by cross-linking proteins. 
Alcohols (eg. methanol) effect rapid fixation by dehydration, lipid extraction and 
protein precipitation. Alcohols are the preferred fixative in the combined analysis o f 
cytoskeletal antigens and DNA.
Myogenic MDGs were induced to form multinucleated myotubes in 2D; initially 
seeded at a density of 25,000 cells/well (in a 6  well plate), the cells were allowed to 
reach confluence at which point standard growth medium was changed to low-serum 
differentiation medium (2% PCS also supplemented with IGF-1 (lOng/ml; PeproTech 
EC Ltd., London, UK), Insulin (5ng/ml; Sigma, Poole,UK), 0.5% BSA (Sigma, Poole, 
UK) and DMEM) to stimulate incorporation o f myoblasts into multinuclear myotubes 
(Sinanan et a i,  2004), which were identified by optical microscopy. Myotubes were 
similarly fixed with 2% paraformaldehyde for 5-10 min followed by post-fixation 
with ice-cold methanol for 1 0  min.
The single cells and myotubes were then detergent permeabilized with 0.25% Triton 
X-100 (Sigma, Poole, UK) in antibody diluting solution (ADS; phosphate buffered 
saline, 10% inactivated PCS (@60°C for 30 minutes), 0.0625% NaNs, O.IM lysine
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(Sinanan et a i,  2004)) for 10-15 minutes. Detergents can dissolve the cell 
membranes by forming detergent-lipid and detergent-lipid-protein mixed micelles. 
The single cells were incubated overnight (room temperature) with the skeletal 
muscle specific primary antibody: mouse monoclonal anti-human desmin (Clone: 
033, Isotype: IgG, Dako, Glostrup, Denmark) which was diluted 1:2000 in ADS. 
Myotubes were further incubated overnight with anti-a-sarcomeric actin (Clone: 5C5, 
Isotype: IgM Sigma-Aldrich, Poole, UK) which was diluted 1:12000 in ADS.
After overnight incubation, single cells and myotubes were washed in PBS and 
incubated with the secondary antibodies. Anti-mouse IgG class specific FITC was 
diluted 1:200 in ADS and anti-mouse IgM specific Cy3 diluted 1:1000 in ADS for 30 
minutes at room temperature, enabling visualisation o f desmin and a-sarcomeric actin 
respectively. Nuclei were identified using the fluorescent DNA binding probe DAPI 
(4’,6-diamidino-2-phenylindole; 1.0 ng/ml; Sigma-Aldrich, Poole, UK) which was 
diluted 1:10,000 in ADS. The coverslips were washed in PBS and were mounted with 
the glycerol-based anti-fade media, Citifiuor™ (Citifluor Ltd., London, U.K.) and 
sealed with clear nail varnish.
The samples were visualised using an inverted Leica DMIRB microscope; cell- 
associated fluorescence was visualised with epifluorescence using the following 
filters: FITC (narrow band excitation at 485nm and emission at 520nm), Cy3 
(excitation at 550nm and emission at 570 nm) and DAPI (UV excitation at 372nm and 
emission at 456nm). The cells were imaged with a x63-oil immersion lens and 
captured using Leica FW4000 image-processing software (Shah et al., 2005).
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The proportion o f myogenic cells in the primary heterogenous mixture of MDCs and 
the separated myogenic and non-myogenic subcultures, were determined for at least 
ten fields (n=10+) for each sample (n=3), which were viewed in a systematic manner. 
The total number of stained nuclei (cells) was counted in each field (Shah et al., 
2005). Within the same field of view, cells which expressed desmin were also 
counted. The proportion o f myogenic cells was calculated as the number of cells 
expressing desmin over the total number o f cells in the field o f view according to the 
equation:
no. cells ejgyressing desm n
Proportion (%) m yogem c cells = ---------------------------------------
total no. o f  stained nuclei
This was averaged for the number o f fields evaluated.
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Results
The primary human craniofacial MDC cultures used in this study contained a mixture 
of myogenic and non-myogenic cells. These cells are indistinguishable in size and 
shape under phase contrast light microscopy (Figure 22A). Myogenic cells were 
distinguished from non-myogenic cells in vitro by their ability to express desmin 
(Figure 22B). Previous researchers have established the proportion of myogenic cells 
to non-myogenic cells in cultures derived from human masseter muscle biopsies, from 
more than 15 different donors, to range from 5 to 45% (Lewis et al., 2000; Singh et 
al., 2000; Sinanan et al., 2004). The proportion of myogenic cells within the 
heterogenous culture used in this study was 19 ± 4.9 % (n=10+) falling within the 
range of previously published results.
Figure 22: Primary human craniofacial MDCs are a heterogenous mixture of 
mononuclear cells that are indistinguishable from one another in size and shape 
under phase contrast (outlined with white dotted lines) (A) light microscopy 
(63X). Myogenic cells (B) are immunoreactive for desmin (green; indicated by
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arrow). In contrast, non-myogenic cells are negative for desmin and are denoted 
by DAP! nuclear labelling (blue).
Skeletal muscle cells differentiate upon confluency, however fusion can be induced 
before myotubes become visible, by changing the high-nutrition culture medium to 
low-nutrition medium (ven der Van et al., 1992; Mouly et al., 1993; Sinanan et al., 
2004; Riboldi et al., 2005). When the cells in this study were 70-80% confluent and 
the culture conditions were changed from standard growth medium to differentiation 
medium, some of the myogenic cells within the heterogenous MDC culture fused to 
form multinucleated myotubes.
Figure 23: Myogenic primary human MDCs fuse to form multinucleated 
myotubes. This immuno-fluourescent micrograph depicts a multinucleated 
(blue; indicated by arrows) myotube that is immunoreactive for the cytoskeletal
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protein desmin (green) and a-sarcomeric actin (red); a-sarcomeric actin is a 
marker of terminal differentiation in striated muscle (magnification x63).
Fusion was defined as the formation of myotubes containing 3 or more nuclei. 
Myotubes were easily identified at the light microscope level both by the 
configuration of nuclei and their cellular components. These cultures immunostained 
positive for the cytoplasmic protein a-sarcomeric actin (Figure 23), an established 
marker o f terminal differentiation in striated muscle (Sinanan et al., 2004).
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Figure 24: Gene expression plot showing the relative quantification of myogenin 
expression in multinucleated cell (myotube) cultures (M l-M3; n=3) and single 
cell (SI-S3; n=3), obtained from the Applied Biosystems® Sequence Detection 
System (SDS) Software. The ‘x’ indicates no detection of the gene. Error bars 
represent standard error of the mean expression level calculated from a group of
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three replicates. Optical micrographs (x20) o f a multinucleated cell culture (A) 
and a single cell culture (B) are also shown.
RNA was extracted from cultures which contained myotubes visible under the light 
microscope as described in Materials and Methods. RNA was also extracted from 
single cell cultures and myogenin expression o f both cultures was quantified using 
RT-PCR. The Applied Biosystems® Sequence Detection System (SDS) Software gene 
expression plot (Figure 24) shows the expression o f myogenin in multinucleated cell 
cultures, but no myogenin was detected in single cell cultures. These results 
confirmed and established in 2D that a-sarcomeric actin and myogenin are markers of 
myogenic differentiation.
Magnetic Activated Ceii Sorting (MACS)
In order to obtain purified myogenic and non-myogenic cell subcultures a magnetic 
activated cell sorting (MACS®) system was used. After magnetic separation both the 
positive myogenic fraction (CD56+) and the negative non-myogenic fraction (CD56-) 
were immunostained for desmin (Figure 25). Immunostaining for desmin was used to 
determine the proportion o f myogenic cells present in the respective MDC cultures 
before (Figure 25A) and after (Figure 25B and 25C) magnetic sorting.
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Figure 25: Isolation and purification of myogenic cells from the heterogenous 
mixture (A) of MDCs was achieved by magnetic cell sorting. These immuno- 
fluorescent micrographs illustrate desmin expression in cultured human 
masseter muscle cells before and after separation. The green arrow indicates the 
purified positive myogenic (CD56+) fraction (B); the blue arrow indicates the 
negative non-myogenic fraction (C).
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Figure 26: This graph shows the proportion of myogenic cells in the pre-sorted 
heterogenous mixture of MDCs (n=10+; sd ±  4.9%), the sorted CD56+ myogenic 
cells (n=10+; sd ±5.8%) and negatively selected non-myogenic cells (n=10+; sd 
±1.6%). There was a significant difference (p<0.0001) in the percentage of 
myogenic cells between the pre sorted and magnetically sorted MDC cultures.
The proportion o f myogenic cells (Figure 26) in the pre-sorted heterogenous mixture 
(19 ± 4.9 %; n=10+) and the two sub-cultures of myogenic (85 ± 5.8%; n = 10+) and 
non-myogenic (1 ± 1.6%; n=10+) cells were significantly different (p<0.0001), this 
indicated that we now had three distinct cell lineages we could use for further testing: 
1 ) Myogenic cells 2) Non-myogenic cells and 3) the original heterogenous mixture o f 
myogenic and non-myogenic cells.
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Discussion
Characterisation o f skeletal muscle cell cultures has been the topic o f much study in 
attempts to recapitulate muscle development, adaptation and regeneration. CD56 and 
desmin are both considered reliable markers for myoblasts among cells cultured from 
skeletal muscle (Stewart et al., 2003; Sinanan et al., 2004)). Desmin was used in this 
study to establish the percentage o f myogenic cells within the primary human MDC 
cultures and the magnetic antibody (CD56) cell sorting system MACS® was utilized 
to successfully obtain two distinct populations o f purified 1) myogenic cells and 2) 
non myogenic cells.
Under phase contrast it was impossible to distinguish myogenic from non-myogenic 
cells by size or shape (morphology), therefore, immunohistochemical techniques were 
employed. Antibodies to muscle cell antigens have become increasingly useful for 
studying the distribution and behaviour o f these cells both in vitro and in vivo (Schultz 
and McCormick, 1994). When a myogenic cell in culture is stained with an antibody 
to a cytoplasmic intermediate filament protein such as desmin, a delicate network of 
threadlike filaments is usually seen surrounding the nucleus and extending through 
the cytoplasm to the plasma membrane as depicted in Figure 22. Further, when single 
primary myogenic MDCs reached confluence and standard growth medium was 
changed to differentiation medium multinucleated myotubes were present in the 
cultures (within 1 day after the change o f medium) and immunostaining for a- 
sarcomeric actin confirmed terminal differentiation.
Skeletal myogenesis is a highly ordered process within a given cell. Although some 
aspects o f muscle differentiation and cell cycle control have been elucidated, the
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temporal relationships among the events that govern the transition from proliferative 
myoblasts to terminally differentiated multinucleated myotubes have remained 
controversial (Andrés and Walsh, 1996). Using molecular probes, Andrés and Walsh 
(1996) showed that after the onset o f terminal differentiation, as indicated by the 
expression o f myogenin, a myoblast withdraws from the cell cycle, then 
phenotypically differentiates, and finally, fuses to form a syncytial myotube. The 
present study showed that in 2D there was no myogenin mRNA expressed in single 
cell cultures; however myogenin mRNA was expressed in cultures containing 
terminally differentiated multinucleated myotubes.
Sinanan et al., (2004) highlighted the importance o f obtaining cultures that are as near 
to 100% myogenic as possible for the study o f the molecular and cellular events 
involved in human myotube formation and to investigate efficiently the interactions 
between myoblasts and other cells. Using immunomagnetic cell sorting techniques 
two subcultures o f myogenic MDCs and non-myogenic MDCs were obtained. 
Myogenic purification yields were consistent with those reported by previous 
researchers (Lequerica et al., 1999; Sinanan et al., 2004). Lequerica et al. (1999) 
reported an increase in the percentage o f myoblasts in mixed culture from 8.4% to 
more than 90% using this technique. We obtained a purified myoblast subpopulation 
which expressed desmin in at least 85% o f the cells (Figure 26).
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Conclusions
■ This study has demonstrated that cells derived from the human masseter 
muscle are a heterogenous mixture o f myogenic and non-myogenic cells that 
are indistinguishable under phase contrast. By using immunohistochemical 
techniques the percent o f myogenic cells o f the primary heterogenous mixture 
o f MDCs was determined.
■ Under known fusion conditions o f confluence and reduced serum in the 
medium it was confirmed that primary human craniofacial MDCs differentiate 
to form multinucleated myotubes, verified by immunostaining for a- 
sarcomeric actin.
■ The myogenic regulatory factor myogenin is a marker for muscle cell 
differentiation being expressed in differentiated multinucleated cell cultures 
but not expressed in single cell cultures.
In conclusion, using MACS® we successfully obtained and quantified two purified 
subcultures o f myogenic and non-myogenic cells from the heterogenous mixture o f 
primary human MDCs. This study was important, as a necessary pre-requisite for the 
thesis to follow, establishing the skeletal muscle markers o f myogenic cells (desmin) 
and differentiation (a-sarcomeric actin and myogenin) in 2D which will be used for 
subsequent 3D culture studies to indicate differentiated myogenic cells (myotubes).
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Ch 2: 3D MDC cultures, matrix remodelling and 
expression of muscle specific genes
Introduction
Understanding aspects o f cell behaviour in terms o f changing morphology, 
biochemistry and genetics has all has been made possible by our ability to remove 
cells from their native environment and culture them in vitro. The majority o f cell 
culture work is carried out in 2D, with cells grown on flat, stiff plastic surfaces. 
These cultures are not only easy to maintain, but easy to visualise and study. With 
this ease has come a much greater understanding o f fundamental muscle cell biology. 
However, these 2D cultures, though conveniently used for the maintenance o f cells 
and for developmental studies, impose highly unnatural geometric and mechanical 
constraints on the cells (Beningo et al., 2004). Such models cannot replicate the 
mechanical responses and signaling contexts that occur when muscle cells are 
completely surrounded by a matrix that can be remodeled, such as occurs in the 3D 
native tissue environment (Grinnell, 2003).
It is becoming apparent that the circumstances related to the behaviour of cells in 
three-dimensional scaffolds in vitro are revealing aspects o f the phenotypes o f cells 
and insights into cell behaviours that would have otherwise escaped view (Bach et al.,
2004). Cytomechanics (cell-level mechanics) characterises the complex interplay o f 
cell forces and the material through which they operate (Brown, 2006). By 
understanding this interplay o f cell-level forces with extracellular matrix material 
properties novel insights into skeletal muscle adaptation and remodeling are possible.
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also this knowledge can be harnessed in applications like developing 3D in vitro 
models for tissue engineering o f skeletal muscle.
To study cell cytomechanical physiology, three dimensional (3D) cultures o f 
myoblasts have been developed by a number o f groups (Vandenburgh and Karlisch, 
1989; Dennis and Kosnik, 2000; Cheema et al., 2003). The pivotal feature for cells in 
a 3D matrix is that substrate attachment cues act through all 3 axes of the cell, 
generating completely new directional information, physiologically comparable to 
that in tissues (Brown and Philips, 2007). Further, use o f 3D culture models are 
central to the hypothesis that tension is crucial for normal muscle development, 
function, and myoblast differentiation (Cheema et al., 2003).
Collagen I is a structurally important component in the interstitial extracellular matrix 
o f skeletal muscle (Shah et al., 2005). The use o f collagen as a 3D matrix support is 
consistent with its role in normal muscle (Cheema et al., 2005). In this study primary 
human MDCs were seeded in a 3D collagen type 1 construct. The objective was to 
quantitate mechanical remodelling o f a 3D matrix by MDCs on the culture force 
monitor (CFM; Eastwood et al., 1994, 1996) using isometric conditions (i.e. attached 
which is closer to the physiological setup than a free floating matrix).
Using the CFM, previous workers have established that contractile forces are 
primarily generated as cells attach to the collagen fibrils within the 3D construct 
(Eastwood et a i ,  1994; Brown et ai., 1998; Mudera et al., 2000; Cheema et al., 2003; 
Karamichos et al., 2006). The peak force depends on cell type, attachment, density.
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growth factors and matrix stiffness (Karamichos, 2006). Many cell types generate a 
characteristic force contraction profile described by three distinct phases (Figure 27):
Phase 1: Traction Phase 2: Contraction P hase 3: Equilibrium
«
50-
Figure 27: The CFM allows force measurement of cell populations in uniaxially 
tethered collagen lattices. This characteristic force-time plot indicates three 
distinct phases of cell force generation. In phase 1 the cells exert tractional 
forces on the collagen matrix as they attach. In phase 2 the cells generate 
contractile force that is maintained relatively constant. Phase 3 is when 
equilibrium (tensional homeostasis) is reached (adapted from Tomasek et a/., 
2002).
1. Traction (0-8hrs): initial force generation is thought to be due to traction as 
cells attach and spread through the collagen constructs (Tomasek et al, 2002). 
Understanding this traction phase is important since it both facilitates and 
perhaps predicts the level o f force generation and matrix remodelling 
(Tomasek et al, 2002).
2. Contraction (8-20hrs): a linear increase in force generation is observed as 
cells continued to remodel the matrix and
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3. Equilibrium (20-24hrs): or tensional homeostasis is attained when the cells 
have established an equilibrium tension within their extracellular collagen 
matrices. This is evidenced by a characteristic ‘plateau’ on the force 
contraction profile.
Cheema et al. (2003) quantified the force generation and initial rates o f contraction 
between three different cell types in 3D culture, including smooth muscle cells, 
human dermal fibroblasts and immortalised skeletal muscle myoblasts (C2C 12). The 
results revealed significant differences in peak force generated and the rate of 
contraction between the cell types, emphasising the importance o f understanding the 
behaviour o f single cell types in cytomechanical studies before using mixed cell 
populations or co-cultures, like primary muscle cultures (Cheema et a l ,  2003). It is 
presently uncertain whether the forces generated by the heterogenous mixture of 
myogenic and non-myogenic cells are simply additive or if  they act synergistically 
(i.e. combined effect is greater than sum o f their individual effects) (Cheema, 2004). 
The first aim o f  this study was to quantitate the forces generated by the heterogenous 
mixture o f  myogenic and non-myogenic primary human craniofacial MDCs embedded 
within the 3D construct (collagen) as these cells remodelled the matrix over a period  
o f  24 hours. To test the hypothesis that the forces generated by isolated myogenic 
(CD56+) and non-myogenic cells during remodeling were cumulative (as opposed to 
synergistic).
Remodeling o f skeletal muscle connective tissue is required as part o f that tissues 
adaptive response and it is known that the MMP family o f enzymes is required for 
such tissue remodeling (Auluck et al., 2005). MMPs play an essential role in the
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maintenance o f surrounding connective tissue by regulating the integrity and 
composition o f the ECM in skeletal muscle (Matrisian, 1992; Carmeli et al., 2004).
There is evidence o f extensive remodeling o f the ECM by muscle cells during 
myoblast fusion (Chen, 1977) and during regeneration (Gulati et al., 1983); however, 
little is known o f the ability o f myoblasts to secrete ECM-degrading enzymes and to 
participate directly in the remodelling o f their ECM (Guerin and Holland , 1995). 
One o f the most important MMPs associated with skeletal muscle function and 
dysfunction appears to be MMP2, a known mechanoresponsive gene that has been 
used as a marker o f ECM remodeling (Mudera et al., 2000; Auluck et al, 2005). It has 
been suggested that both myogenic and non-myogenic cells participate directly in 
remodeling o f the ECM during myogenesis and the regeneration o f skeletal muscle 
(Tippett, 1997). However, the relative contribution o f these two cellular components 
to the overall MMP activity in muscle is unknown (Singh et al., 2000; Lewis et al., 
2001). The activity o f the MMPs at both mRNA and/or protein levels modulates the 
degradation o f the ECM components (Corcoran et al., 1996; Lluri and Jaworski, 
2005). The second aim o f  this study was to quantitate the expression o f  MMP2 mRNA 
as a marker o f  matrix remodeling in 3D cultures o f  primary human MDCs and  
establish the relative contribution o f  the isolated subpopulations o f  myogenic and  
non-myogenic cells. Testing the hypothesis that both myogenic and non-myogenic 
cells contribute to the regulation o f  MMP2 gene expression.
Skeletal muscle differentiation entails the coordination o f muscle-specific gene 
expression and terminal withdrawal from the cell cycle (Halevy et al., 1995). 
Myogenin is required for formation o f differentiated muscle fibers and activates a
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broad array o f muscle specific genes in cultured cells (Hasty et a i ,  1993). Andrés and 
Walsh (1996) suggested an overall order o f marker expression (Figure 28) during in 
vitro myogenesis:
1. Entry o f myoblasts into the differentiation pathway, as indicated by the 
induction o f myogenin; and.
2. Phenotypic differentiation, as indicated by the induction o f myosin heavy 
chain (MyHC).
However, they do not rule out that these processes are stochastic at the level o f the 
individual cell (Andrés and Walsh, 1996). Myogenin and MyHC are established 
markers o f differentiation in 2D (Hasty et a l ,  1993; Halevy et a l ,  1995; Andrés and 
Walsh, 1996) and expression o f these genes will be monitored in 3D MDC cultures in 
the studies to follow as a quantitative measure o f myogenic cell differentiation.
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Figure 28: Marker expression during 2D in vitro myogenesis (adapted from 
Andrés and Walsh, 1996). Proliferating myoblasts do not express myogenin or
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MyHC. Upon terminal differentiation myogenin is expressed. MyHC is induced 
in the differentiated myocyte and determines the contractile phenotype of the 
resulting syncytial myotube which expresses both myogenin and MyHC.
As stated in chapter 1, there are no reports in literature that have investigated the 
interactions between muscle fibres, myogenic cells, non-myogenic cells and the ECM 
(Tippett, 1997; Lewis et al., 2000, Singh et al., 2000). Tippett (1997) suggested that 
the nature and level o f interactions between the cellular components and their 
environment may well determine the expression of muscle specific proteins (e.g. 
myogenin, MyHC). The fina l aim o f  this study was to quantify the molecular output 
(muscle specific gene expression i.e. myogenin, MyHC-fi and MyHC IIX/D) o f  the 
heterogenous mixture and the separated myogenic cellular component o f  MDCs 
seeded in a 3D collagen gel using relative quantitative RT-PCR. To test the 
hypothesis that after 24 hours in 3D culture isolated myogenic cells express 
significantly increased levels o f  muscle specific mRNA in 3D culture than the 
heterogenous mixture containing non-myogenic cells.
Materials and methods
Briefly, the heterogenous mixture o f primary human MDCs and the subcultures o f 
purified myogenic and non-myogenic cells were seeded in collagen type 1 constructs 
as previously described. They were then tethered to the CFM for 24 hours to monitor 
matrix remodeling and the molecular output was quantified using RT-PCR as 
previously described.
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Results
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Figure 29: Comparison of the force contraction profiles obtained as the three 
types of MDCs remodelled a 3D extracellular matrix. The contraction profiles 
were obtained by seeding 5 million cells into a 5mL collagen gel (n=3). 
Immediately following gelling, the contraction of the collagen matrix by the 
resident cells was measured using the CFM instrument over a 24 hour period.
Matrix remodeling was quantified by measuring the force generated (Figure 29) as 
primary human MDCs attached to (Figure 30) and remodeled the 3D collagen gel. 
Two significant cytomechanical properties were established; firstly, the peak force 
generated over 24 hours and secondly, the initial rate o f force generation. The initial 
rate of force generation was calculated as the change in force over time from 0-60 
minutes o f monitoring. The non-myogenic cells had the highest initial rate of 
contraction (Figure 32; 4.4 ± 1.69pN/min; n = 3), though, this cell type did not 
generate the corresponding highest peak force (Figure 31 ; 465 ± 56pN; n = 3).
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Figure 30; Optical micrographs (%20) showing the bipolar morphology 
(indicated by arrows in dotted region) of myogenic and non-myogenic cells 
attached (evidenced by the extended cell processes) to the 3D collagen matrix 
after 24 hours.
The myogenic cells were classified as low contractile (Karamichos, 2006) as they 
generated little to no measurable force in the first hour at a rate o f (0.1 ± 0.31pN/min) 
reaching a peak force of 40 ± 50|iN (Figure 31; n = 3) over 24 hours. The 
heterogenous mixture of MDCs embedded in the collagen matrix generated the 
highest peak force (Figure 31; 615 ±  155pN; n = 4), with an initial rate of force 
generation being 1.6 ± 0.34pN/min (Figure 32; n = 4). The peak force attained by the 
heterogenous mixture was greater than the sum (505 pN) of the individual myogenic 
and non-myogenic sub-populations, suggesting force synergism. In summary, the 
typical mean force generation profiles generated by the three cell types (Figure 29) 
studied showed significant differences in peak force attained (p<0.01; Figure 31) and 
the initial contraction rate (evaluated between 0 and 60 minutes) (p<0.001; Figure 
32). This is the first cytomechanical analysis of primary human MDCs embedded in a
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3D matrix and these results indicate that the proportion o f myogenic to non-myogenic 
cells within a 3D matrix affects the cytomechanical response (i.e. rate and peak force 
generation) o f the cultures.
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Figure 31: Graph showing the peak force generated by the three primary human 
craniofacial MDC types. There were significant differences (p<0.01) between the 
peak force attained for the heterogenous mixture (n = 4; sd ± 155pN), myogenic 
cells (n = 3; sd ± 50pN) and non-myogenic cells (n = 3; sd ± 56pN).
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Figure 32: Comparison of mean initial rates of contraction from between 0-60 
minutes (i.e. on an initial time basis) for the three cells types. There were 
significant differences (p<0.001) between the rate at which the heterogenous 
mixture (n = 4; sd ± 0.34pN/min), the myogenic cells (n = 3; sd ± 0.31pN/min) 
and the non-myogenic cells (n = 3; sd ± 1.69pN/min) contracted the 3D collagen 
gel.
To further investigate and quantitate remodelling o f a 3D collagen matrix by primary 
human MDCs, MMP2 mRNA expression o f these cultures after 24 hours was 
quantified. As previously stated, MMP2 is used as a marker o f ECM remodelling 
(Mudera et al., 2000; Auluck et al., 2005). The relative contribution o f MMP-2 
mRNA expression by myogenic and non-myogenic cells to overall expression of 
MMP2 m-RNA by the heterogenous mixture in 3D MDC constructs was evaluated 
using RT-PCR. After 24 hours in 3D constructs the relative MMP-2 mRNA 
expression o f each cell type was determined (Figure 33). Relative to the non- 
myogenic cell populated collagen constructs, MMP-2 mRNA level in the myogenic
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cell populated collagen constructs was 7-fold greater (p=0.0641). Similarly there was 
an 11-fold (p=0.1059) difference in MMP-2 mRNA expression in the heterogenous 
cell populated collagen constructs relative to the non-myogenic populated constructs.
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Figure 33: Graph depicting the relative contribution of MMP-2 mRNA 
expression by myogenic and non-myogenic cells to overall expression of MMP2 
m-RNA by the heterogenous mixture in 3D MDC cultures. Relative mRNA 
expression levels were determined by RT-PCR. Values representing the 
amounts of MMP2 mRNA were relative to GAPDH. Error bars represent 
standard deviation (Heterogenous Mixture ± 8.2; Myogenic cells ± 3.9; Non- 
myogenic cells ± 0.4) and by ANOVA statistical analysis these results were 
approaching significance (p=0.06).
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These results clearly indicate that both myogenic and non-myogenic cells contribute 
to the overall MMP-2 produced in constructs, with the myogenic cells expressing 
relatively more MMP2 mRNA than their non-myogenic counterpart. Further, as with 
overall force generated by the three MDC types, the overall MMP-2 mRNA 
expression in the heterogenous mixture o f cells is greater than the sum o f the 
individual parts, i.e. the proportion o f myogenic to non-myogenic cells within a 3D 
matrix affects MMP-2 mRNA expression.
Figure 34: MDCs seeded at 5 million/5ml collagen gel immunostained 
(magnification 63%) with DAPI (blue) and Desmin (green). The white arrows (a) 
indicate the ‘blurred’ nuclei which belonged to different planes of the 3D gel.
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The white arrows (b) indicate desmin filaments of myogenic cells within the gel. 
The blue and green arrows point to the composite image of (a) and (b) depicting 
the close proximity and possible fusion of two myoblasts within the 3D construct.
The MDC seeded 3D collagen gels were immunostained for desmin (myogenic 
marker; Figure 34) and a-sarcomeric actin (marker o f terminal differentiation) to 
identify myogenic cells and fused multinucleated myotubes respectively, within the 
3D constructs. DAP I was used as a counterstain to identify the nuclei of all cells 
(Figure 34 (a)). Under the fluorescent filter with excitation at 550nm and emission at 
570nm the hydrated collagen gel auto-fluoresced and it was technically impossible to 
image the red a-sarcomeric actin stain or identify multi-nucleated myotubes. The 
desmin filaments shown in Figure 34 (b) reveal two nuclei in close proximity with 
overlapping intermediate filaments indicative o f fusion; however, because there is no 
way of clearly ascertaining whether two cells are truly fused or closely apposed 
(Schuierer et a l ,  2005) a quantitative measure o f myogenic differentiation (i.e. 
myogenin and MyHC gene expression) was necessary to confirm differentiation of 
myogenic cells in 3D collagen constructs.
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Figure 35: Relative muscle specific (Myogenin and MyHC (fast and slow)) gene 
expression is shown for the heterogenous mixture and myogenic cells when 
seeded at a density of 5 miilion/5ml collagen gel (n=3). There was no significant 
difference in gene expression. Standard deviation is used for error bars.
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The nature and level o f interaction between myogenic cells, non-myogenic cells and 
the ECM was investigated in 3D collagen constructs to determine whether 
interactions between the cellular components and their environment affected the 
expression o f muscle specific genes. The hypothesis under test was that after 24 
hours in 3D culture isolated myogenic cells express an increased level of muscle 
specific mRNA, indicative o f differentiated myogenic cells, than the heterogenous 
mixture containing non-myogenic cells. The RT-PCR results showed expression o f 
muscle specific mRNA in the 3D cultures o f both the heterogenous mixture o f cells 
and the myogenic cells (Figure 35). However, although there were less myogenic 
cells present in the heterogenous mixture (19 ± 4.9 %) than the purified subculture of 
myogenic cells (85 ± 5.8%), there was no significant difference in muscle specific 
gene expression (myogenin, p=0.8215; MyHC-IIX/D, p=0.8815; and MyHC-p, 
p=0.7304). Suggesting that the presence o f non-myogenic cells affects myogenic 
cells to induce muscle specific gene expression and ultimately myogenic 
differentiation and cell fusion.
Discussion
Research o f MDCs interacting with 2D substrata has provided many insights into the 
biology of muscle cells and the majority o f work on skeletal muscle myoblasts has 
been carried out using cells grown in monolayers (Seale and Rudnicki, 2000). 
However, most cells are anchorage dependent and by changing the way in which cells 
interact with their surrounding matrix, the morphology is altered (Discher et al.,
2005). 2D monolayer cultures always provide polarised directional cues with a 
‘dorsal’ fluid covered surface and a ‘ventral’ plastic attached surface (Brown and 
Phillips, 2007). Conventional 2D monolayer culture systems recreate only a portion 
o f the cellular environment and there is increasing interest in developing more
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physiologically relevant 3D culture systems (Stegemann et a i ,  2005). Cultured 
within a 3D extracellular matrix such as collagen, primary human MDCs experience a 
richer, more complex physical environment and morphology results displayed a 
markedly different geometry in 3D (stellate/bipolar) than cells on 2D surfaces 
(flattened/spread).
The function and the maintenance o f tissue integrity are dependent on specific 
interactions of cells with the surrounding extracellular matrix (Mayer, 2003). Cell­
cell and cell-matrix interactions are o f vital importance not only for proper cellular 
homeostasis during embryogenesis and development o f an organism, but also in 
growth, regeneration, adaptation and pathological states (Kaushal and Shah, 2000). 
By culturing cells in a 3D matrix the geometry o f the integrins and focal adhesions on 
the cell surface can be mimicked (Grinnell et al., 1999).
The special feature o f biological materials is that the resident cells are not passive, but 
themselves change the material properties in a manner unique to biomaterial science 
(Brown, 2006). Discher et al. (2005) reported how cells feel and respond to the 
stiffness o f their substrate stating that the feedback o f local matrix stiffness on cell 
state has important implications for development, differentiation and regeneration. In 
a standard 2D culture the only dynamic factor is the cells, as the plastic is non- 
deformable. Culturing cells in compliant 3D collagen matrices offers new 
opportunities to understand the reciprocal and adaptive interactions that occur 
between the cells and surrounding matrix in a tissue-like environment (Grinnell, 
2003).
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Collagen is a flexible but inextensible fibrillar structure with a stiffness of 30-100Pa 
as measured by a dynamic mechanical analyzer (Wang et al., 2003) and lies far lower 
than that o f a normal cell culture dish which is not flexible and with a stiffness o f 
more than IGPa (Wang et al., 2003). During cell-collagen matrix remodeling, 
mechanical signals from the remodeled matrix feed back to modulate cell shape and 
behavior (Tomasek et al., 2002). The traction exerted by cells during their migration 
induces not only translocation o f the cells, but also remodeling o f the matrix, as the 
forces generated move both cells and collagen fibrils as depicted in Figure 36.
There is however, the added complexity o f the inherent process o f myogenic cell 
differentiation, for which cell-cell attachment is paramount in muscle derived 
cultures. This presents another mode by which the cells may contract the matrix. In 
summary, there are two proposed modes by which muscle derived cells could 
generate force within a 3D collagen lattice:
1. Directly: in which cells attach directly to fibrils o f the collagen matrix. When 
these cells apply tensile forces to the attachment points the collagen lattice itself 
deforms locally (as depicted in Figure 36; Tomasek et al., 2002).
2. Indirectly: the other possible mechanism of force generation by myogenic cells is 
the transfer o f cell-force indirectly. It has been postulated that skeletal myoblasts 
have a greater tendency to form cell-cell attachments and will deform the collagen 
lattice indirectly as a consequence o f the contraction o f groups o f cells (Cheema et 
al., 2003; Brown, 2006)
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Figure 36: Model of extracellular matrix remodelling mediated by cells 
embedded in a collagen matrix. In a 3D culture, not only can the surrounding 
environment affect the cell phenotype, but the cells can also affect their 
surrounding environment. Cells bind to collagen fibrils which results in local 
matrix contraction. New matrix components are added to stabilise the new 
collagen organisation. This process is repeated and small incremental collagen- 
matrix remodelling occurs (Adapted from Tomasek et al., 2002).
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The current study used the CFM to quantify matrix remodeling by monitoring the 
cytomechanical properties o f primary human myogenic and non-myogenic MDCs as 
they contracted the 3D collagen matrix. Previous researchers have established and 
compared the cytomechanical properties o f a number o f cell lines embedded in a 3D 
collagen matrix including human dermal fibroblasts, rabbit bladder smooth muscle 
cells and C2C12 (immortalised mouse cell line) skeletal myoblasts (Cheema et al., 
2003; Brown et al., 1998; Eastwood et al., 1996, 1998; Mudera et al., 2000; 
Karamichos et al., 2006). The force contraction profiles obtained as the heterogenous 
mixture and non-myogenic cells remodeled the matrix were consistent with the 
typical force contraction profiles obtained from CFM studies described by Tomasek et 
al. (2002) with a traction phase (in which force generation is thought to be generated 
as cells attach and spread through the collagen constructs and indicative o f the level o f 
matrix remodeling), a contraction phase (an increase in force generation is observed 
as cells continue to remodel the matrix) and finally, equilibrium or tensional 
homeostasis (attained when the cells have established an equilibrium tension within 
their matrix evidenced by a characteristic ‘plateau’).
As the non-myogenic cells remodelled the 3D collagen gel, most o f the force was 
generated quite rapidly during the traction phase and the initial rate o f force 
generation was significantly higher than the corresponding initial rate o f force 
generation by the heterogenous mixture o f cells, which contracted the matrix at a 
slower, steadier state, but reached a higher peak force after 24 hours in culture. From 
this we can conclude that the presence o f myogenic cells affects the cytomechanical 
response o f non-myogenic cells and vice-versa. There is cell-cell communication 
resulting in force synergism, i.e., a greater force being generated by the heterogenous
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mixture than the sum of the individual parts. The results obtained indicate that the 
proportion o f myogenic cells in the heterogenous mixture significantly affects matrix 
remodeling.
Enigmatically our results showed that the purified primary human myogenic cells 
generated little to no measurable force over the 24 hours o f monitoring. Interestingly, 
Cheema et al. (2003) noted a delay in force generation or a ‘lag phase’ in C2C12 
myoblast cultures, suggesting that this lag phase is consistent with the idea that 
C2C12 cells may generate force primarily though cell-cell contact. Cellular 
attachment to the extracellular matrix results in clustering o f integrins and assembly 
o f multi-molecular focal complexes associated with the actin cytoskeleton (Hotchin 
and Hall, 1995; Cukierman et al., 2001). It has been widely proposed that integrin- 
matrix interactions influence cell behavior by activating intracellular signal 
transduction events (Burridge et al., 1988; Juliano and Haskill, 1993; Clark and 
Brugge, 1995). Myoblast integrin expression is known to change between the 
differentiated and undifferentiated state (Wakelam, 1985). Morphology after 24 hours 
in culture revealed that the myogenic cells were spread and appeared to be attached to 
the matrix; however, a relatively poor cell-matrix attachment might explain why 
overall contraction was low.
The complex interaction between myogenic and non-myogenic cells derived from 
skeletal muscle has been the subject o f much research over the past two decades. The 
working hypothesis o f Turner (1986) was, in vivo, myogenic cells attach to a 
flbronectin containing extracellular matrix laid down by fibroblasts (non-myogenic), 
and that this interaction contributes significantly to the organization o f muscle. More
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recently, it was proposed that the process o f skeletal muscle regeneration is influenced 
by the composition o f the extracellular matrix and the availability o f growth factors 
produced by non-myogenic cells (Baj et al., 2005). Another reason why little to no 
force was generated as the myogenic cells attached to the 3D matrix might be due to 
the absence o f ECM components and growth factors secreted by the non-myogenic 
cells.
Tissues owe their dynamic structure both to changes in expression of adhesive 
proteins and their receptors and to the regulated action o f secreted proteinases, 
particularly members o f the metalloproteinase family (Kaushal and Shah, 2000). 
MMP expression is regulated at the transcriptional level and expression is induced by 
cytokines, growth factors, chemical agents, and cell-cell or cell-matrix interaction 
(Lluri and Jaworski, 2005). To date, the relative contribution o f the two cellular 
components o f muscle to the overall MMP activity in muscle is unknown (Lewis et 
al., 2001). In the present study to further quantify matrix remodeling and determine 
the relative contribution o f the two cellular components, we monitored the expression 
o f MMP-2 mRNA in 3D cultures o f isolated myogenic, non-myogenic and the 
heterogenous mixture. The results established that the two cellular components 
express MMP-2 mRNA and therefore both contribute to the overall MMP activity in 
muscle. Further, the results indicated that myogenic cells encode for the secretion o f 
more o f the enzyme than their non-myogenic counterpart, as at the transcriptional 
level MMP-2 expression was greater in 3D myogenic cell cultures than in 3D non- 
myogenic cell cultures. There was also relatively increased MMP-2 mRNA in the 
heterogenous mixture than the sum o f the individual components again suggesting
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that cell-cell interaction results in greater remodeling of the matrix than the isolated 
response o f the individual components.
Finally, this study reported for the first time the gene expression o f myogenin and two 
MyHC isoforms (fast (MyHC-IIX/D) and slow (MyHC-p)) after 24 hours in 3D 
culture, indicating the presence o f differentiated myogenic cells within the constructs. 
The fact that there was no significant difference between the muscle specific gene 
expression o f markers o f myogenic differentiation in the heterogenous mixture o f 
cells and the myogenic cells is consistent with the finding o f Cooper et al. (2003) in 
2D who suggested that the presence o f non myogenic cells enhances differentiation of 
myogenic cells. Although there were less myogenic cells in the heterogenous 
mixture, factors secreted by the non-myogenic cells stimulated the differentiation o f a 
similar proportion o f myogenic cells as occurred in the purified myogenic cell 
populated 3D collagen gel.
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Conclusion
Using the CFM, this study characterised for the first time, the forces generated 
as primary human MDCs remodelled 3D collagen gel. The cytomechanical 
properties o f the heterogenous mixture, and the separated cellular (myogenic 
and non-myogenic) components, revealed that both the rate of force 
generation and the peak force generated were not cumulative, but synergistic. 
Concluding that the proportion o f myogenic to non-myogenic cells within the 
3D culture affects the cytomechanical response.
MMP2 mRNA was monitored as a marker o f matrix remodeling and this study 
established that both the myogenic and non-myogenic cellular components 
contribute to the production o f MMP2 in 3D culture. Further, the overall 
MMP-2 mRNA expression in the heterogenous mixture o f cells was greater 
than the sum of the individual parts, concluding that the proportion of 
myogenic to non-myogenic cells within a 3D matrix affects MMP-2 mRNA 
expression.
This study has established that myogenic cells do not express a significantly 
increased level o f muscle specific mRNA in 3D culture than the heterogenous 
mixture containing non-myogenic cells. Concluding that the interactions 
between the cellular components and their environment determine gene 
expression o f muscle specific markers (myogenin and MyHC) of 
differentiation.
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In conclusion, the objective to use 3D MDC cultures, using primary cells from adult 
human craniofacial masseter muscle, to investigate and quantify skeletal muscle 
remodeling and myogenic cell differentiation in 3D culture was achieved. From this 
study we conclude that the two cellular components o f muscle contribute to skeletal 
muscle remodeling and gene expression o f markers o f myogenic differentiation in 3D 
cultures. Future studies to tissue engineer a 3D craniofacial muscle organoid should 
utilize the heterogenous mixture o f myogenic and non-myogenic cells as found in the 
native muscle environment.
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Ch 3: T issue engineering a 3D m uscle  model: 
Mechanical stimulus 
Introduction
To date there have been a number o f attempts to tissue engineer skeletal muscle in 
vitro and many researchers have used a “dynamic culture approach” in bioreactors 
(summarised in Table 5), based on the hypothesis that contractile functional skeletal 
muscle tissue will fully develop in vitro only if subjected to mechanical strains that 
prevail during normal in vivo organogenesis and growth (Riboldi et al., 2005).
Mechanical forces play an important role in modulating the growth of a number of 
different tissues including skeletal muscle, smooth muscle, cardiac muscle, bone, 
endothelium and lung (Vandenburgh, 1992). Both passive and active mechanical 
forces play a role in the transition o f skeletal muscle from the embryonic to the 
mature state (Goldspink et al, 1992). Further, directed mechanical tension is 
important to organise myoblasts into functional aligned myotubes and provides a 
stimulus for the expression of mature iso forms o f myofibrillar proteins (Tatsumi et al,
2001).
It has been shown that mechanical stimulation o f tissue-cultured skeletal muscle cells 
causes changes similar to those seen when in vivo skeletal muscle is mechanically 
loaded (Powell et a i ,  2002). Vandenburgh et al. (1991) showed that repetitive 
stretch/relaxation o f avian skeletal muscle cells in vitro by patterns that simulate in 
vivo skeletal growth and exercise altered the structural organization o f the constructs.
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Unidirectional stretch followed by repetitive stretch o f avian bioartificial muscles was 
shown to lengthen, orient, and organize the myofibers compared with static cultures 
(Vandenburgh et al., 1991). Similarly, stress loading was shown to improve the 
orientation and density o f rodent myofibers cultured in collagen gels (Okano and 
Matsuda, 1997). Cheema et al. (2004) showed that when C2C12 myoblasts were 
grown in 3D culture the insulin-like growth factor (IGF-I; which initiates the fusion o f 
myoblasts to form myotubes (Florini et al., 1991)) gene was upregulated by a single 
ramp load (10% strain o f 1-hr duration). Mechanical stimulation increases cellular 
proliferation (Vandenburgh et al., 1989), myotube organization (Collinsworth et al., 
2000, Vandenburgh, 1982; Vandenburgh et al. 1991; Okano and Matsuda, 1997), and 
extracellular matrix (ECM) composition (Vandenburgh et al. 1991).
Powell et al. (2002) were the first group to attempt to tissue engineer skeletal muscle 
using primary human cells derived from the vastus lateralis. The primary human 
muscle cells were expanded in tissue culture, and statically tissue engineered (in a 
collagen-matrigel^'^ construct) into human bioartificial muscles (HBAM). The 
HBAMs were maintained in growth medium for 3 days, then the medium was 
changed to low serum fusion medium for 5 days. Cheema et al. (2003) also statically 
tissue engineered C2C12 bioartificial muscles (in a collagen constructs) over a 7-day 
period and monitored mRNA levels, reporting a transient elevation of IGF gene 
expression on day 3.
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Literature CellSource Scaffold material Loading conditions
Vandenburgh 
et ai., 1988
Avian
Skeletal
muscle
Collagen coated 
silastic membrane
Three stretch regimens:
1. Slow continuous ramp 
stretch o f the silastic 
substrator at 0.35mm/hour 
for 24 hours
2. Followed by a slower 
0.09mm/hour for an 
additional 24 hours.
3. Then a cyclical stretch- 
relaxation of the 
substratum at 0.5 Hz for 
10s followed by a 150s 
rest period for 40-48 hrs.
Total substratum stretch was 3.5% 
or 17% by using prongs at 
different heights.
Vandenburgh 
et al., 1991
Avian
Skeletal
muscle
Collagen coated 
silastic membrane
Five 20% strain substratum 
stretches and relaxations during a 
20s period followed by 10 s rest. 
Repeated 3 times followed by a 
variable rest period of 0-30 
minutes.
Okano and 
Matsuda, 1998
C2C12 Type I collagen 
gel
Cyclical stretching (frequency 
60rpm; amplitude 5%) for up to 4 
days.
Collinsworth 
et al., 2000
C2C12 Matrigel coated 
silastic membrane
Average strain rate 2.36%/day for 
4 days or 1.77%/day for 6 days 
resulting in 9.5 or 10.6% 
respectively.
Powell et al., 
2002
Human
skeletal
muscle
Matrigel icollagen 
(1:6) gel
500pm/day for 4 days (-3.5 pm 
every 10 minutes) Total 
unidirectional stretch over 4 days 
o f 10% initial length.
Cheema et a l ,  
2004
C2C12 Type I collagen 
gel
Three ramp regimens; 10% length 
change over 12 hrs, 1 hr and 10 
minutes.
Three cyclical loading regimens; 
1, 5 and 10 cycles/hr at strain rates 
o f 4, 20 and 40% / hr respectively.
Auluck et a l ,  
2005
Human
skeletal
muscle
Collagen sponges Rapid ramp stretch or cyclical 
ramp strain with 7.5% or 15%
Table 5: Summary of selected studies illustrating the range of in vitro dynamic 
loading regimens used to develop tissue engineered skeletal muscle constructs.
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Powell et al. (2002) demonstrated that mechanical stimulation improved tissue 
engineered HBAMs; mechanical stretching began at 24 hrs and the HBAMs were 
stretched 500 pm/day for 4 days; at step intervals o f -3 .5pm  every 10 min (with a 
total unidirectional stretch over 4 days o f 10% of the initial length), resulting in 
significant increases in both myofiber diameter and myofiber density (Powell et al.,
2002).
In this study the tensioning-Culture Force Monitor (t-CFM) was used to apply 
mechanical loading regimens (Eastwood et al., 1998; Brown et al., 1998; Prajapati et 
al., 2000; Mudera et al., 2000; Cheema et al., 2004) to the 3D MDC cultures in a two­
fold attempt to develop a tissue engineered skeletal muscle model and to monitor how 
mechanical cues effects the gene expression o f markers o f differentiation (myogenin), 
phenotype (slow MyHC-p and fast MyHC-IIX/D) and matrix remodelling (MMP-2). 
The objective o f this study was to statically engineer the heterogenous MDC 3D 
culture (presented in chapter 2) over 3 days and then apply two continuous ramp 
loading regimens (1. Slow (10% strain applied over a 1 hour period); 2. Fast (10% 
strain applied over a 10 minute period)). The loading regimens implemented in this 
study were consistent with previously reported optimal loading conditions comparable 
to physiological conditions (Cheema et al., 2004; Auluck et al., 2005).
The manner in which cells respond to different mechanical environments has attracted 
wide interest, both the level o f the applied load and the rate o f loading are known to 
be important in eliciting a specific cellular response (Bader and Lee, 2005; 
Karamichos, 2006). Muscle is a tissue in which gene expression is regulated to a 
large extent by mechanical signals (Goldspink et al., 1992). However, little is known
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about the molecular mechanisms by which muscle tension regulates transcription of 
specific genes and future studies will depend greatly on the use o f tissue culture 
mechanical stimulator model systems (Vandenburgh, 1992). Based on the literature 
presented that mechanical stimulation improves tissue engineered muscle constructs, 
the first aim o f  this study was to monitor molecular output using RT-PCR to 
quantitate the maturation and development o f  the muscle construct. To test the 
hypothesis that mechanical stimulation would elicit an up-regulation o f  the muscle 
regulatory factor myogenin, indicative o f  increased myogenic cell differentiation.
An important characteristic o f skeletal muscle is its plasticity. Muscle fibers are 
characterized by an inherent adaptability to environmental alterations by changing 
from one fiber type into another (Adams et a l ,  1993; Goldspink, 1998; Oishi et a l ,  
1998). They are versatile elements, which are capable of modifying their structure 
and properties to physiological and functional demands (Pette & Staron, 1990). This 
is reflected in the composition and level o f expression o f myosin heavy chain 
(MyHC) isoforms within the muscle; which represent the best markers reported of 
muscle fiber adaptive changes (Schiaffino & Reggiani, 1996; McKoy et a l ,  1998; 
Agbulut et a l ,  2003).
Skeletal muscle plasticity has been studied extensively by myosin isoform transitions 
(d’Albis et al., 1989, 1990; Bacou et a i ,  1996; McKoy et a l ,  1998; Baldwin and 
Haddad, 2001). Various factors such as development, innervation, increased and 
decreased neuromuscular activity, physical activity (mechanical loading and 
unloading), hormones and aging have been shown to influence the phenotypic 
expression o f skeletal muscle (Sullivan et a l ,  1995; Schaiffino and Reggiani, 1996;
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Pette and Staron, 2000; Baldwin and Haddad, 2001; Agbulut et al., 2003). These 
factors can induce MyHC isoform expression heading in the direction of either fast- 
to-slow or slow-to-fast. Increased neuromuscular activity, mechanical loading and 
hypothyroidism are conditions that induce fast-to-slow transitions, whereas reduced 
neuromuscular activity, mechanical unloading and hyperthyroidism cause transitions 
in the slow-to-fast direction (Pette and Staron, 2000).
Periasamy et al. (1989) reported that the change in the pattern o f myosin isozymes 
protein expression during skeletal-muscle adaptation to work overload was a 
consequence o f changes in specific myosin heavy chain (MyHC) mRNA levels. 
Physical activity can alter muscle phenotype and contractile function by switching on 
one gene subset and repressing another (Goldspink, 1998). The dynamic nature o f 
skeletal muscle in response to altered functional demands requires switches in gene 
expression o f rapidity and magnitude in response to a changing cellular environment 
(McKoy et al., 1998).
In summary, skeletal muscle changes in phenotype result from differential gene 
expression in response to mechanical signals (Goldspink et al., 1992). A study by 
McKoy et al. (1998) described the switching of all the major MyHCs at the mRNA 
level as an animal matures and individual muscles become adapted to perform highly 
specialized and diverse functions. They also demonstrated that changes in MyHC 
gene expression at the mRNA level correlated strongly with those observed at the 
protein level (McKoy et al., 1998). This indicates that the determination of muscle 
phenotype is controlled at the level o f gene transcription (Goldspink, 1998; Baldwin 
and Haddad, 2001). The objective o f this part o f the study was to use the statically
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developed 3D muscle construct to investigate skeletal muscle plasticity in response to 
specific mechanical loading regimens. The aim was to monitor the effect o f  the 
mechanical loading regimens on the MyHC gene expression (slow MyHC~P and fast 
MyHC-IIX/D). To test the hypothesis that mechanical cues will cause a switching o f  
MyHC gene expression with a fast-to-slow transition, i.e. a relative up-regulation o f  
slow MyHC- p  mRNA and a down-regulation o f  fast MyHC-IIX/D mRNA.
The way in which cells respond to mechanical signals is a new area o f physiology and 
the evidence indicates that this involves the cytoskeleton and the ECM (Goldspink, 
1998). In skeletal muscle, an important interplay between muscle cells and the ECM 
is present, and it has been suggested that in vivo adult human muscle there are 
common mechanical signaling pathways to stimulate contractile and ECM 
components (Kjær, 2004). Currently, little is known about how the muscle ECM 
interacts with proliferating and differentiating muscle cells to influence the formation 
and stabilization of skeletal muscle (Velleman et al., 1998). Further, it is not known 
how the surrounding soft tissues are activated and what the cellular processes are, that 
convert the mechanical signals into those that will influence tissue remodeling and 
adaptation (Auluck et al., 2005).
Signals from mechanical loading will initiate a cascade leading from gene expression, 
transcription, translation, and posttranslational process modification to the integration 
o f events to provide protein synthesis in the ECM (Kjær, 2004). Changing demands 
in skeletal muscle (e.g. increased or decreased contractile activity) promotes 
remodeling of the ECM (Carmeli et al., 2005) and mechanical stress is a potent 
stimulus for ECM reorganization (Ruwhof et al., 2000). The ECM turnover is
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influenced by physical activity and it has been shown both collagen synthesis as well 
as activity o f degrading MMP enzymes increase with mechanical loading (Prajapati et 
al., 2000; Mudera et al., 2000; Kjær, 2004; Auluck et al., 2005; Karamichos, 2006). 
The fina l aim o f  this study was to investigate the effect o f  mechanical loading 
regimens on skeletal muscle ECM remodeling by monitoring the in vitro expression o f  
the mechanoresponsive gene MMP-2 in tissue engineered human muscle constructs. 
To test the hypothesis that MMP-2 expression, and hence ECM  remodeling, is up- 
regulated in response to mechanical loading and is dependent upon the rate o f  
loading to which the muscle construct is subjected.
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Materials and Methods
As previously described the CFM (Eastwood et al., 1994) fundamentally consists o f a 
force transducer at one end and an anchoring point at the other, providing the axis for 
measurement o f the uni-axial endogenous force generated as the embedded cells 
contract the tethered, free floating (practically frictionless) collagen construct. The 
CFM was further developed by Eastwood et al. (1998) into a computer driven 
tensional loading device to apply exogenous mechanical loading regimens.
The t-CFM utilizes the same force transducer, data collection system, and culture well 
as the CFM. However, the additional feature o f the t-CFM is the stepper motor, 
which can be programmed via a computer to apply varying mechanical loads to the 
collagen gel by moving the base uniaxially (Figure 37). Initial positioning o f the 
culture well during the experimental setup is through the moveable “ X-Y” table 
mounted onto the motorized base (Eastwood et al., 1998).
The t-CFM bioreactor enabled precise uni-axial mechanical loads to be applied to the 
MDC seeded collagen constructs, whilst simultaneously recording the total 
mechanical load (Figure 40; Ramp loading regimens). The analogue output signal 
was amplified, digitised and process using Lab View software (National Instruments, 
V .6 , Newbury, UK) and allowed accurate definition of the magnitude and type of 
mechanical loading to which the matrix was subjected (Eastwood et al., 1998).
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Force transducer
m '
Fixed point
Moveable X-Y table
Motorised Base
Stepper motor
Schematic of 
collagen gel 
tethered to 
the t-CFM
Figure 37: This picture shows the t-CFM set up. The additional feature of this 
set up is the stepper motor (indicated by red arrow) which is attached to the 
base. This motor can be programmed via a computer, to apply varying 
mechanical loads to the collagen gel by moving the base uni-axially (indicated by 
the green double headed arrow).
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Collagen gels were cast in the same way as for the CFM set up between 2 floatation 
bars which were in turn attached to stainless steel wire A-ffames, with one slight 
difference, plastic spacer bars were positioned at each of the short ends of the well, 
before collagen incubation (Figure 38), to give 10mm spaces for mechanical 
extension (Karamichos et al., 2006). Once the gel had set the spacers were removed 
from the well.
A-Frame
Floatation
Polyethylene
A-Frame
Figure 38: Before collagen incubation (indicated by pink lines), two plastic 
spacer bars were positioned at each of the short ends of the well (indicated by 
red arrows), to give 10mm spaces for mechanical extension. Spacers were 
removed when added gel was set.
The collagen gels defined in chapter 2 (i.e. MDCs seeded at a density o f 5 million/5ml 
collagen gel) were developed by statically engineering (Powell et al., 2002; Cheema 
et al., 2003) the constructs between two fixed points in a sterile and closed
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environment (Figure 39) for 3 days. To induce myogenic cell differentiation, the 
standard growth medium was changed to differentiation medium after 24 hours. No 
strain was applied to the static control cultures, maintained under endogenous tension 
with no external loading. The constructs which were to be subject to mechanical 
loading were tethered to the t-CFM at 48 hours and exogenously loaded at 60 hours. 
The loading regimens were designed to apply ramp loading to the cultures using the 
X-ware software X I50 (Parker Automation, California, USA).
Polyethylene mould
Fixed point ^Fixed point
A-FrameA-Frame
Cell seeded 
collagen gel
Sterile plastic container
Figure 39: The primary human MDC 3D cultures were statically developed in 
static culture for 3 days to promote differentiation of myoblasts to form 
myotubes.
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Each revolution o f the motor related to a certain distance by which the stage moved. 
The motor had a step angle o f 1.8° and a default set up o f 4000 steps (equivalent to 
one revolution). Further using a screw pitch o f 0.5mm/revolution we could calculate 
the distance the stage needed to move to apply 10% strain to the constructs.
Strain is classically defined as:
s  =
/
Where e is strain, / is length and A/ is change in length (i.e. final length -  original 
length). The original length of the collagen construct was 65mm, so to apply a 10% 
strain distance the stage was to be moved was calculated to be 6.5mm.
Al
Given,
Further,
£ =
I
10% =
M
65mm 
A/ = 65 X10%
.'. A/ = 6.5mm
\rev = 0.5mm
.'. Al = 6.5mm  = \ 3rev
\rev = AOOOsteps
:. Al = \ 3rev = 52000steps
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Therefore, to apply 10% strain the motor was programmed to move 52000 steps. Two 
ramp loading regimens were applied (Figure 40); (a) Fast stretch (over 10 minutes) 
and (b) slow stretch (over 1 hour). To programme the motor the rate o f strain 
(Velocity) had to be determined as revolutions/second. For the two loading regimens 
velocity (F) was calculated as distance (d) over time (/) as follows:
(a) Fast V = - (b) Slow V = -
v  =
6.5mm
lOmin
1 ^ revolutions 
600 sec onds
V = 0.02X61 revs ! s
V =
6.5mm
Xhr
1 ^ revolutions 
3600seconds
.'. V = 0.00361 Irevs / s
After these components o f the loading regimen had been determined, the t-CFM 
motor was programmed. An example program to apply slow stretch, i.e. 10% ramp 
load over 1 hour is given:
ION
T43200
A1
V0.003611
MN
D-52000
G
N
; Energise drive 
; Time delay (wait 12 hours)
; Acceleration rate constant 
; Velocity (revolutions/second)
; Sets the mode to normal preset distance
; Distance measured in steps (start loading 10% strain)
;G o
;End
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Figure 40: The patterns of ramp loading regimens applied to MDC seeded 3D 
collagen constructs cultured for 3-days, (a) Fast ramp regimen: 10% strain 
(6.5mm displacement) was applied to the cultures over a 10 minute period, (b) 
Slow ramp regimen: 10% strain (6.5mm displacement) was applied to the 
cultures over a 1 hour period.
After application o f ramp load over a 1 -hour or 10-minute period, cultures remained 
held at 10% strain over 11 hour or 11 hour and 50 minutes (respectively) after load 
was applied. Gels were then untethered from the t-CFM at 72 hours and processed for 
RNA extraction and RT-PCR. Using the 2'^^* method, the results are presented as 
the fold change in gene expression normalized to an endogenous reference and 
relative to a control. The relative control in this study was a heterogenous MDC 
seeded (5million/5ml gel) collagen construct after 24 hours tethered to the CFM 
(Chapter 2).
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Results
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a catalytic enzyme involved 
in glycolysis and is expressed in all cells. It is important that the internal control gene 
is properly validated for each experiment to determine that gene expression is 
unaffected by the experimental treatment (Livak and Schmittgen, 2001). Figure 41 
shows the expression of GAPDH under each loading regimen. No significant 
difference (p=0.1354) was found in GAPDH expression between static and loading 
conditions. Therefore, GAPDH was used as the reference (housekeeping) gene in this 
study against which all other gene expression markers were compared.
40
fc 30
.Q
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?
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S ta t ic 10% for 10 m inutes 10% for 1 hour 
L o ad in g  R eg im en
Figure 41: The effect of the different mechanical loading regimens on GAPDH 
mRNA expression levels in 3D MDC seeded collagen constructs after 3 days (72 
hrs) in culture. There was no significant difference (p=0.1354) in gene 
expression so GAPDH was used as the housekeeping gene in this study. 
Standard deviation used for error bars (n=3).
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To test the hypothesis that mechanical loading would improve the statically 
engineered tissue constructs and elicit a corresponding gene response that would 
enhance myogenic differentiation, myogenin mRNA was quantified. The results 
showed that mechanical stimulation did not cause an up-regulation of myogenin 
(Figure 42). Both the fast and slow ramp loading rates, at 10% strain, to which the 
construct was subject, caused a down regulation (1.5-fold and 0.9 fold change 
respectively) of myogenin relative to the static control. These changes in gene 
expression were not significantly different (p=0.1767) and the mechanical loading 
regimes applied did not promote myogenic cell differentiation.
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Figure 42: Graph depicting the relative expression of myogenin mRNA before 
(Static) and after application of ramp loading (Fast; 10% for 10 minutes and 
Slow; 10% for 1 hour) regimens. Relative mRNA expression levels were 
determined by RT-PCR. Error bars represent standard deviation (Static (n=3) 
sd ±  1.46; 10% for 10 minutes (n=3) sd ± 0.23; 10% for 1 hour (n=3) sd ± 0.55). 
By ANOVA statistical analysis these results were not significantly different 
(p=0.1767).
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To investigate whether fast ramp loading caused a switch in phenotype, gene 
expression of the relative MYHC isoforms were monitored. The fast ramp loading 
regime had no effect on either the fast MyHC-IIX/D or the slow MyHC-P mRNA 
expression. Further, the results indicated no significant difference (p=0.6047) in the 
MyHC gene expression between the static and fast ramp loaded cultures (Figure 43). 
Therefore, this loading regimen did not cause a change in MyHC gene expression.
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Figure 43: The effect of fast ramp loading on phenotypic gene expression in 3D 
MDC cultures. This graph depicts the relative expression of the fast MyHC- 
IIX/D (red) and the slow MyHC-P (green) mRNA (using the static culture as the 
control) after application of 10% strain for 10 minutes. Error bars represent 
the standard deviation (Fast MyHC-IIX/D; Static (n=3) sd ±  0.80, 10% for 10 
minutes (n=3) sd ±  0.20 and Slow MyHC-P; Static (n=3) sd ± 1.57, 10% for 10 
minutes (n=3) sd ±  1.04). By ANOVA statistical analysis these results were not 
significantly different (Fast MyHC-IIX/D, p=0.3028; Slow MyHC p, p=0.6047).
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However, the slow ramp loading regime elicited a 4-fold (sd ± 5.63) up-regulation of 
the MyHC fast isogene, and a 1-fold (sd ± 0.69) down-regulation o f the slow MyHC 
isogene (Figure 44). These results suggest that different rates of strain alter MYHC 
mRNA expression and this 3D muscle construct could be used as a model to simulate 
skeletal muscle plasticity.
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Figure 44; The effect of slow ramp loading on phenotypic gene expression in 3D 
MDC cultures. This graph depicts the relative expression of the fast MyHC- 
IIX/D and the slow MyHC-p mRNA (using the static culture as the control) after 
application of 10% strain for 1 hour. Error bars represent standard deviation 
(Fast MyHC- IIX/D; Static (n=3) sd ±  0.80; 10% for 1 hour (n=3) sd ± 5.63 and 
Slow MyHC-p; Static (n=3) sd ±  1.57; 10% for 1 hour (n=3) sd ± 0.69). By 
ANOVA statistical analysis these results were not significant (Fast MyHC, 
p=0.3096; Slow MyHC, p=0.4716).
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The final aim of this study was to monitor the response of MMP-2 gene expression to 
strain as a marker of ECM remodelling. Under the mechanical loading regimens 
imposed on the muscle construct the results show no significant (p=0.1184) change in 
MMP-2 mRNA expression. Further, the rate of strain did not significantly effect 
MMP-2 mRNA expression.
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Figure 45: Graph depicting the relative expression of MMP-2 mRNA (using the 
static culture as the control) after application of ramp loading (Fast 10% for 10 
minutes and Slow 10% for 1 hour) regimens. Relative mRNA expression levels 
were determined by RT-PCR. Values representing the amounts of MMP2 
mRNA were normalised to GAPDH. Error bars represent standard deviation 
(Static (n=3) sd ± 0.06; 10% for 10 minutes (n=3) sd ± 0.57; 10% for 1 hour (n=3) 
sd ± 0.42). By ANOVA statistical analysis these results were not significant 
(p=0.1184).
These results suggest that the current loading regimens do not elicit the gene response 
necessary to induce myogenic differentiation or matrix remodelling. Mechanical cues 
did not lead to further maturation of this 3D muscle construct.
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Discussion
Mechanical loading improves tissue engineered skeletal muscle constructs 
(Vandenburgh et al., 1988, 1991; Okano and Matsuda, 1998; Collinsworth et a i ,  
2000; Powell et al., 2002; Cheema et al., 2004). However, to date tissue engineered 
skeletal muscle is still far removed from in vivo skeletal muscle and further 
improvements may be possible by changing the mechanical stimulation pattern or 
improving the ECM that the constructs are engineered with (Powell et al., 2002). 
This study has attempted to use two different mechanical loading regimens to develop 
the statically engineered primary human muscle construct. To monitor the maturation 
o f the construct, myogenin mRNA expression was used as a marker of myogenic cell 
differentiation. In contrast to previous studies, the results presented here reveal that 
the mechanical loading regimens applied to the 3D muscle constructs did not lead to 
an increase in differentiated myogenic cells, with no significant difference in 
myogenin mRNA expression between the static and loaded muscle constructs. This 
study has established that under the defined conditions o f this muscle model, 
mechanical loading did not improve the tissue engineered construct.
Skeletal muscle is a tissue that possesses an intrinsic ability to phenotypically adapt to 
the type of physical activity that it is required to perform, i.e. remodelling by physical 
activity (Yang et al., 1997; Carmeli et al., 2005). The ability o f adult muscle cells to 
modulate the properties o f contractile apparatus in response to environmental and 
physiological stimuli even after terminal differentiation illustrates their remarkable 
plasticity (Periasamy et al., 1989). Pette and Staron (2000) reported that fiber type 
transformations represent highly coordinated processes o f gene up-regulation and 
down-regulation, concluding that future research will be needed to elucidate the
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molecular elements and mechanisms underlying fibre type determination and 
transformation (Pette and Staron, 2000). When subjected to stretch, skeletal muscle 
apparently adapts to a more postural type of role by expressing the slow myosin 
isoform and repressing the fast myosin genes (Goldspink et al., 1992). This part of 
the study investigated the effect o f external mechanical loads on the in vitro 3D 
muscle constructs to simulate skeletal muscle plasticity. The results show that gene 
expression was dependent on the type o f strain applied as the slow mechanical stretch 
did not effect MyHC gene expression, but the fast mechanical loading regimen did 
elicit a change in MyHC gene expression. Suggesting that mechanical loading can 
cause a switch o f MyHC gene expression, however, the slow-to-fast transition with a 
relative up-regulation o f the fast MyHC-IIX/D mRNA, monitored here was not 
consistent with the in vivo finding that mechanical loading induces a fast-to-slow 
transition (Goldspink et al., 1992; Pette and Staron, 2000).
The need for physiologically relevant models with which to study muscle cell biology 
has led to studies in which specific mechanical forces and ECM materials are 
combined to recreate a complex environment. These types o f studies are important in 
the field o f tissue engineering and regenerative medicine, where the ability to 
understand and reconstitute the physiological environment is key to developing 
biologically based tissue substitutes (Stegemann et al., 2005). The mechanisms by 
which cells detect and respond to the mechanical environment are termed 
mechanotransduction pathways (Bader and Lee, 2005). Very little is known about the 
mechanotransduction mechanism involved and what muscle regulatory factors may be 
involved that induce changes in transcription of specific genes (Yang et al., 1997). A 
better understanding o f the relationship between initial application of load and
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effector cell response is necessary for the appreciation o f the growth and adaptation o f 
normal and pathological tissues and will be of use in the development of tissue 
engineered repair systems (Bader and Lee, 2005). As previously stated, MMP-2 is a 
known mechanoresponsive gene (Bolcato-Bellemin et al., 2000; Mudera et al, 2000; 
Auluck et al., 2005) that has been used as a marker of ECM remodeling and was 
monitored in this study to investigate the cellular response to mechanical loading, 
specifically, does exogenous mechanical loading elicit a gene response that stimulates 
matrix remodeling.
Cheema (2004) noted that when muscle cells (C2C12s) were grown in 3D culture and 
subjected to mechanical strains comparable to those generated during early 
myogenesis, total IGF-I mRNA expression was optimally stimulated in the region o f 
10% strain/hour for both ramp and cyclical loading regimens, though the magnitude 
o f stimulation was much greater for ramp loads (Cheema et al., 2004). Concluding 
that, not only does ramp loading invoke a different response, but the strain rate is also 
critical in determining the type and magnitude of mRNA expression (Cheema et al., 
2004). Similarly, Auluck et al. (2005) noted that MMP-2 expression was found to be 
significantly higher in those skeletal MDC cultures strained continuously, compared 
to cyclical strain, and in those strained at 15% compared to 7.5%, concluding that 
skeletal muscle is more likely to respond to a change in the environment if it is carried 
out with a single activation as opposed to a step-by-step activation. Further, Asunama 
et al. (2003) demonstrated that the in vitro response o f vascular smooth muscle cells 
is dependent on the strain regimen, where continuous mechanical strain led to 
enhanced matrix degradation via an increased expression o f MMP-2, however, cyclic 
strain decreased the expression o f MMP-2 mRNA. The type of mechanical load
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applied to cultures is important in determining changes in gene expression and in this 
study, although similar continuous ramp loading conditions were applied MMP-2 
mRNA expression was not altered by the mechanical strain.
Carmeli et al. (2005) explored the effect o f exercise on MMP-2 activity and reported 
that low intensity exercise did not alter the expression o f MMP-2 in any of the 
muscles investigated (Carmeli et a l ,  2005). Yasuda et al. (1998) reported that 
mesangial cells induced by stretch/relaxation showed biphasic changes in MMP-2 
activity; in the first 24 hours after stretch MMP-2 mRNA levels were significantly 
decreased, however, after more prolonged periods of stretch/relaxation, increases in 
MMP-2 mRNA levels were noted. Together with the results presented in this study, 
these observations emphasize the complexity o f the interplay between mechanical 
signals and cellular response.
It is important to note that much o f the data reported in the literature provides 
phenomenological observation, specific to a particular model system, which may not 
be easily translated to other model systems. Only by conducting systematic studies, 
involving the alteration o f one variable at a time, can underlying mechanistic 
parameters be defined leading to the derivation of predictive strategies suitable for the 
optimisation o f bioreactor systems (Bader and Lee, 2005). Future research should be 
carried out on this muscle construct to identify the specific mechanical stimuli 
required to elicit a cellular response that could be harnessed to develop sophisticated 
tissue engineered muscle constructs.
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Conclusions
The mechanical loading regimens implemented in this study did not elicit an 
up-regulation o f the muscle regulatory factor myogenin and did not induce 
myogenic cell differentiation within the tissue engineered 3D muscle 
constructs.
MyHC gene expression was not effected by the fast ramp loading regimen. 
However, the slow ramp loading condition caused a switch in gene expression 
in the slow-to-fast direction, with a relative up-regulation of fast MyHC- 
IIX/D.
MMP-2, the marker o f ECM remodeling was not up-regulated in response to 
the mechanical loading regimens applied. MMP-2 mRNA expression was 
unaffected by the exogenous loading conditions.
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Ch 4: Tissue engineering 3D muscle model: 
The effect of high ceil seeding density 
Introduction
Skeletal muscle tissue engineering represents a scientific approach that attempts to 
create and regenerate skeletal muscle tissue. As previously stated, skeletal muscle 
consists o f long bundles o f densely distributed and highly oriented cells called muscle 
fibers, each o f which is a highly differentiated multinucleated cell derived from 
myoblasts. The muscle fibers in native skeletal muscle are packed closely together in 
a thin layer of extracellular matrix composed mainly of collagen to form a well- 
organized tissue with high cell density and orientation. Tissue criteria for engineering 
muscle constructs structurally bio-mimicking native muscle (in terms o f their ability 
to mediate generate force) must include high cell density, a high degree of cell fusion 
(or extensive myotube formation) and a high degree o f unidirectionality (Okano and 
Matsuda, 1998).
Mao et al., (2006) reported that cell density matters in the tissue engineering o f the 
mandibular condyle and stated that a dissatisfactory feature in their previous work 
was suboptimal tissue maturation. (Alhadlaq and Mao, 2003; Alhadlaq et al., 2004) 
They then attempted to improve tissue maturation and osteochondral integration by 
increasing the cell encapsulation density from the previous 5><10^cells/mL to 
20xl0^cells/mL; at this high density the tissue-engineered mandibular joint condyle 
showed evidence of maturation with phenotypic growth of both cartilage and bone­
like tissues (Alhadlaq and Mao, 2005).
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A ‘simplified method’ for tissue engineering skeletal mammalian organoids in vitro 
by seeding myoblasts at a high plating cell density was published by Shansky et al. 
(1997). Primary myoblasts from the forelimbs and hindlimbs of rat neonates were 
suspended in a 1:6 solution of Matrigel:collagen (Type 1) and plated into tissue 
culture wells at a concentration o f 4 million/0.750mls (5.33 million/ml) gel (Shansky 
et al., 1997). Bach et al (2003) also had a working principle for the preparation o f 
functional muscular tissue based on myoblasts being cultured at high cell density 
(150,000 cells in 125pi growth medium; 1.2 million cells/ml) and seeded in 125pl o f 
fibrinogen.
Further, non-woven arrays o f polyglycolic acid (PGA) fiber mesh sheets (1cm x 1cm 
with fiber diameter approximately 12 pm ) have been used as a scaffold to tissue 
engineer skeletal muscle, in which a high cell seeding density was paramount, 
constructs were seeded with myoblasts at a density o f 2.75-4.75 million cells/polymer 
(Saxena et al., 2001). Thorrez et al. (2008) similarly seeded cells on 13mm poly- 
lactide-co-glycolide PLG scaffolds at high densities ranging from 4-16 million in a 
recent attempt to tissue engineer skeletal muscle.
The objective o f this study was to tissue engineer skeletal muscle constructs using:
1) High cell density to increase the probability o f cell fusion leading to 
multinucleated myotube formation; and
2) Predictive unidirectional cellular alignment facilitating myogenic cell 
fusion and generation o f force.
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In vivo, in developing muscle the cues directing the orientation of myotube formation 
are not well understood, however in repair of muscle, it is evident that the existing 
myofibres may provide cues along which the myoblasts align and fiise (Clark et al., 
1997; Cheema, 2004; Shah et at., 2005). It is possible to align myotube formation 
through providing cues such as physical grooves in culture dishes, and culturing of 
myoblasts in collagen gels and fibronetin gels, where the generation of isometric 
tension in a uni-axial plane provides a direction for orientation (Iseval et al., 1980; 
John et al., 1980; Turner et al., 1983; Cheema, 2004). The CFM system provides 
unidirectional cellular orientation; the cells align themselves along the axis of 
principle strain (Figure 46; adapted from Eastwood et al., 1998), generated by the 
endogenous tension developed as cells contract the matrix (Eastwood et al., 1998; 
Mudera et al., 2000; Cheema et al., 2003; Karamichos et al., 2007).
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Figure 46: The CFM system provides unidirectional cellular orientation through 
alignment of cells along the axis of principal strain. FEA analysis predicted
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perceived strains by the cells within the collagen constructs and morphology 
confirmed a distinct cell alignment in zone 1 (Source: adapted from Eastman et 
aL, 1998).
Cell-generated endogenous force in collagen gels promotes differentiation of 
myoblasts (Vandenburgh et al., 1988). Cheema et al. (2003) showed that where 
contracting gels were tethered uniaxially (in the CFM) C2C12 myoblasts become 
aligned parallel with the long axis o f the gel. The CFM system provides additional 
cues to guide myoblasts in a particular direction, as uniaxial endogenous tension is 
generated. As cells attach to the collagen scaffold fibrils, they generate quantifiable 
contractile forces (measured by the CFM) which depend on cell type, cell attachment, 
cell density growth factors, and matrix stiffness (Karamichos et al., 2007). The first 
aim o f  this study was to use the CFM  to quantify the cell generated endogenous force  
as the heterogenous mixture o f  primary human MDCs were seeded in constructs at 
increasing cell densities (20, 30 and 40 million cells/5ml collagen gel), to test the 
effect o f  increasing cell density on force generation and ECM remodeling.
The use o f an optimal design incorporating tissue engineering principles on the one 
hand and an understanding o f the principles involved in the differentiation process of 
primary myoblasts to oriented functional myofibres on the other hand may yield an 
approach for the repair o f damaged and diseased skeletal muscle in future (Bach et al., 
2003). In in vitro culture, myoblasts begin to differentiate as a function o f their 
density and the extent o f cell-to-cell contact (Gurdon et al., 1993; Cheema, 2004; 
Pedrotty et al., 2005). Known factors influencing myoblast differentiation include:
■ High density o f myoblasts
■ The presence o f extracellular matrix
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■ Application o f mechanical cues and
■ Reduction o f serum level within the media i.e. depletion of serum 
factors (Cheema, 2004).
The hypothesis o f  this study was that increasing cell density will result in increased 
incidence o f  cell-to-cell contact and therefore increased myogenic cell differentiation 
resulting in an up-regulation o f  myogenin mRNA.
As previously discussed, skeletal muscle is able to adapt its fiber type profile to 
physiological and functional demands and that this adaptation is reflected in the 
composition and level o f expression o f MYHC isoforms (Agbulut et al., 2003). 
Further, the ‘community effect’ states that cell interaction is necessary for the 
activation o f certain genes, i.e. large numbers o f cells cooperate to become 
differentiated cells (Gurdon et al., 1993). The second aim o f  this study was to test fo r  
any transition in the level o f  MYHC (-IIX/D fa s t and ~p/slow) mRNA expression with 
increasing cell density in a 3D matrix to determine i f  the ‘community effect’ 
influences muscle fiber phenotype.
Matrix remodeling by resident cells is an important area o f study and MMP-2 is one 
of the enzymes that remodels the ECM. By regulating the integrity and composition 
of the ECM in skeletal muscle, MMP-2 plays essential roles in myofiber proliferation, 
differentiation, fibre healing after injury, and maintenance of the surrounding 
connective tissue (Carmeli et al., 2004). Knowledge o f how the ECM molecules are 
arranged, remodeled, and interact with the contractile apparatus o f craniofacial muscle 
is o f particular interest to those involved in diagnosing and managing craniofacial 
anomalies (Lewis et al., 2001). The third aim o f this study was to test the effect o f
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increasing cell density on matrix remodeling. Testing the hypothesis that increasing 
the cell density would result in increased matrix remodeling and MMP-2 mRNA 
would be up-regulated as a result.
The final objective o f this study was to allow further maturation of the high density 
muscle model by culturing the cells for an extended period in 3D culture; enhanced 
differentiation o f the myoblasts to form myotubes was expected as found in other 
concurrent studies (Vandenburgh, 1991; Dennis et al., 2001; Powell et al., 2002; 
Cheema et al., 2003). Cheema et al. (2003) demonstrated that when C2C12 
myoblasts seeded at a high density o f 4 million/ml o f collagen gel, over a period of 5 
days led to optimum differentiation; some degree o f development of the 3-D culture 
(in terms o f fusion and maturation o f cells to form aligned myotubes) was promoted 
using static uniaxial loading along the long axis o f the culture. This also promoted 
cell elongation and parallel alignment o f myoblasts at high cell density, and myoblast 
fusion to form multinucleated myotubes over a period of 5-6 days (Cheema et al., 
2003). Okano and Matsuda (1998) similarly cultured their “highly dense (cell density 
30 million cells/ml), highly oriented hybrid muscular tissues” for 7 days (first for 3 
days in a growth medium and then for 4 days in a differentiation medium). Bach et 
al. (2003) emphasized the importance o f time-dependent dimensional changes, with 
respect to the differentiation o f myoblasts within a three dimensional matrix. 
Reporting that the myoblasts cultured in three-dimensional mono-cultures (3 million 
cells/ml) stained positively for myogenin after 7 days in 3D muscle-neuronal cultures 
(Bach et al., 2003). The final aim o f this study was to culture the 3D constructs for 6 
days. To test the hypothesis that extended time in culture will result in maturation o f  
the constructs and increased mRNA expression o f  the muscle specific regulatory
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factor (myogenin) and both muscle specific proteins (MYHC-IIX/D and MYHC- 
p/slow). MMP-2 (marker o f  ECM  remodeling) mRNA was also hypothesised to be up- 
regulated as the cells continued to remodel the matrix over the 7 day period.
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Materials and Methods
The heterogenous mixture of primary human MDCs were cultured as previously 
described and seeded at increasing concentrations (20, 30 and 40 million cells) into a 
5ml collagen gel. The gel was then tethered to the CFM to quantify the endogenous 
force generated over 24 hours.
In the second part of this study, cells were seeded at the highest cell density of 40 
million/5ml collagen gel and matured for 6 days (Figure 47). Serum levels in the 
media were dropped from 20% to 2% FCS, at days 2 and 5, to promote myogenic cell 
differentiation.
Ï
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Figure 47: Cells were seeded at a density of 40 miIIion/5ml collagen gel and 
tethered between two fixed points in a closed, sterile environment for 6 days. 
The media was changed from normal media (20% FCS) to differentiation media 
(2% FCS) on day 2, and then another change on day 5, to promote 
differentiation of myoblasts to form myotubes in 3D collagen lattices.
144
Chapter 4
The RNA was extracted from these gels as previously described and was used in the 
subsequent cDNA synthesis. PCR was used to amplify the cDNA and data was 
analysed using the comparative 2'^^^ method.
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Results
The endogenous forces generated as cells seeded at high densities remodeled the 3D 
collagen gel were quantified by the CFM and the resulting force contraction profiles 
obtained are shown in Figure 48.
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Figure 48: These force contraction profiles were obtained by seeding cells at 
high densities ((a) 20 million; purple, (b) 30 million; orange, and (c) 40 million; 
green) into a 5mL collagen gel (n=3). Immediately following gelling, the 
contraction of the collagen matrix by the resident cells was measured using the
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CFM instrument over a 24 hour period. Comparison of the force contraction 
profiles (d) shows the substantial difference in force generation when cells were 
seeded at 30 million/5ml collagen gel.
The force contraction profiles obtained were analyzed from a cytomechanical 
perspective, in terms o f peak force generated and initial rate of force generation (i.e. 
the change in force over time during the first 60 minutes of force generation). When 
cells were seeded at 20 million cells/5ml collagen gel, the initial rate of force 
generation was high (Figure 49; 7.92 ± 2.53pN/min; n=3), however this was not 
indicative of the peak force generated (Figure 50; 622 ± 254pN; n=3) which was not 
significantly different (p=0.9158) from the peak force generated when cells were 
seeded at 5 million/5 ml collagen gel (615± 155pN; n=3).
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Figure 49: Comparison of mean initial (0-60 minutes) rates of contraction for the 
three seeding densities. The initial rate of force generation is shown as cells 
seeded at 20 million (n = 3; sd 7.92 ± 2.53pN/min), 30 million (n = 4; sd 9.58 ± 
2.55pN/min) and 40 million (n = 3; sd 2.50 ± 1.90pN/min) contracted the 3D
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collagen gel (5ml). Asterix’s indicate comparable groups and statistical 
significance (* p<0.05; ** p<0.01).
When cells were seeded at 30 million/5 ml collagen gel, there was a significant 
(p<0.05) increase in peak force generated with the maximal force o f 1373pN (Figure 
50; sd ± 313|iN; n=4) recorded. Similarly, at this density the rate at which the cells 
generated force was the highest (9.58 ± 2.55|iN/min; n=4).
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Figure 50: Graph showing the peak force generated hy the three different 
seeding densities of primary human craniofacial MDC in a 5ml collagen gel. 
There were significant differences (p<0.05) between the peak force attained for 
cells seeded at 20 million (n = 3; sd ± 254pN), 30 million (n = 3; sd ± 313pN) and 
40 million (n = 3; sd ± 249pN) per 5ml collagen gel.
The initial rate o f force generation (Figure 49; 2.50 ± 1.90pN/min; n=3) when cells 
were seeded at 40 million/5ml construct was significantly lower than the rate recorded 
for 20 and 30 million (p<0.05 and p<0.01 respectively) and the peak force (Figure 50; 
926 ± 249pN; n=3) generated was significantly different (p<0.05) and fell between 
the peak forces generated when cells were seeded at 20 and 30 million. However,
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there was a distinctive pattern o f force generation, not reflecting the characteristic 
three phases of traction, contraction and force plateau, but rather a continual 
incremental increase of force generation with time.
From this cytomechanical analysis, it was clear that the optimal cell seeding density, 
with respect to maximal peak force and rate of initial force generation, is 30 million 
cells/5ml construct. However, the distinctive force contraction profile obtained when 
cells were seeded at 40 million/5ml construct is indicative of cell-to-cell interaction 
generating a gradual, but continual increase in force over time.
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Figure 51: The effect of different cell seeding densities (per 5ml collagen gel) on 
the expression of the housekeeping gene GAPDH. Standard deviation was used 
for error bars. There was no significant difference (p=0.3292) in gene expression 
so GAPDH was used as the internal control in this study.
As previously stated, using the 2'^^^ method, the data are presented as the fold 
change in gene expression normalized to an endogenous reference (GAPDH) and 
relative to a control (normal 5 million cells/5ml collagen gel). It was again important
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to establish that the internal control gene was properly validated for each experiment 
to determine that gene expression is unaffected by the experimental treatment (Livak 
and Schmittgen, 2001). Figure 51 shows the expression of GAPDH at each cell 
density. No significant difference (p=0.3292) was found in GAPDH expression 
between experimental conditions. Therefore GAPDH was verified as an appropriate 
housekeeping gene in this study.
To establish that there was evidence o f myogenic cell differentiation within the 3D 
constructs, Figure 52 revealed that after 24 hours in culture and at all three high cell 
densities, the 3D constructs expressed myogenin mRNA. There was an apparent 
relative up-regulation (7-fold change in gene expression) o f myogenin in cells seeded 
at 30 million/5ml collagen gel compared to cells seeded at 20 million/5ml collagen 
gel, however, these results were not statistically significant (p=0.8375) and a larger 
sample size is necessary to establish the validity of these results.
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Figure 52: Myogenin gene expression is shown for MDCs seeded at increasing 
cell densities per 5mi collagen gels (n=3). Standard deviation is used for error 
bars.
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The aim of the next part of the study was to examine any transitions with increasing 
cell seeding density and determine the relative composition of the two MYHC 
isoforms; the fast isoform (MYHC-IIX/D) and the slow isoform (MYH-p). Figure 53 
shows the increasing gene expression of MYHC-P with cell density. There was an 8 
fold increase when MDCs were seeded at 30 million/5ml collagen gel and a 40 fold 
increase when cells were seeded at 40 million/5ml collagen gel. These results were 
significantly different (p<0.05) by One-way ANOVA.
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Figure 53: The mRNA MYHC-p expression was up-regulated with increasing 
cell density (n=3). Standard deviation is used for error bars. Asterix’s indicate 
comparable groups and statistical significance (p<0.05).
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One-way ANOVA revealed no significant difference (p=0.4809) in MYH-IIX/D gene 
expression with increasing cell density. As depicted in Figure 54 the relative fold 
change between the 20 million and 30 million/5ml construct was negligible, 1.95 and 
1.63 respectively. There was a trend suggesting a potential up-regulation of MYHC- 
IIX/D when MDCs were seeded at 40 million/5ml collagen gel with a relative fold 
increase of 4.16, more than double the amount present at lower densities, however, 
these results were not statistically significant and a larger sample size should be 
investigated.
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Figure 54: The gene expression of MYHC-IIX/D varied with increasing cell 
density (n=3 each). Standard deviation is used for error bars. There was no 
significant difference (p=0.4809) in mRNA expression between the groups.
152
Chapter 4
To examine any transitions with increasing cell seeding density the relative 
expression of MYHC-IIX/D and MYHC-P were plotted at each cell seeding density 
(Figure 55). The results suggest a transition with a relative switch from fast to slow 
MYHC isogene expression with increasing cell density indicative of a change in 
phenotype as a result of ‘community effect’.
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Figure 55: The relative gene expression of fast MYHC-IIX/D (red; p=0.4809) 
and slow MYHC-p (green; p<0.05) when cells were seeded at 20 million, 
30million and 40 million cells/5ml collagen gel (n=3 each). Standard deviation is 
used for error bars. The results show a relative fast to slow transition of the 
isogene expression with increasing cell density.
The final gene expression presented in this study is the matrix metalloproteinase-2 
(MMP-2) enzyme; one of the enzymes that remodels the ECM. The results in Figure 
56 show an up-regulation of MMP2 mRNA (3-fold change) when MDCs were seeded 
at 40 million/5ml gel compared to when cells were seeded at 20 million/5ml gel. 
However, due to the lack of statistical significance (p=0.3932), variations in these 
results are only suggestive of a possible trend and again, a larger sample size should 
be considered.
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Figure 56: MMP-2 gene expression is shown for MDCs seeded at increasing cell 
densities per 5ml collagen gels (n=3). Standard deviation is used for error bars
Having established expression of these genes after 24 hours in culture, it was 
hypothesized that maturation of these constructs would result in an up-regulation of 
all the associated genes. Cells were seeded at 40 million/5ml construct and cultured 
for 6 days. RNA was extracted and processed for PGR. After 6 days in culture 
expression of GAPDH was not significantly different (p=0.2421).
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Figure 57: Expression of the housekeeping gene GAPDH after 24 hours and after 
an extended period (6 days) of culture when cells were seeded at 40 million/5ml
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collagen gel. There was no significant difference (p=0.2421) in gene expression 
so GAPDH was used as the internal control in this study.
The results in Figure 58 show that all myogenic specific genes (myogenin and 
MYHCs) were up-regulated as a result of extended time in culture, indicative of 
maturation of the tissue engineered muscle construct. There was a significant 
difference (p<0.05) in the AACt at which the genes crossed the threshold for all 
myogenic specific genes (Table 2).
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Figure 58: The gene expressions of muscle specific genes (myogenin; yellow, 
MYHC-IIX/D; red and MYCH-p; green) were up-regulated with extended time 
in culture. Standard deviation was used for error bars (n=3).
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However, the actual fold change gene expression (myogenin, 1038; MYHC-IIX/D, 
715; and MYCH-p. 1590) was not significantly (myogenin, p=0.2847; MYHC-IIX/D, 
p=0.3061; and MYCH-P p=0.1201 respectively) different for the number o f samples 
evaluated.
Finally, the fold change gene expression of MMP-2 did not significantly (p=0.8354) 
differ between 24 hours (1.24 ± 0.63; n=3) and 6 days (1.36 ± 0.70; n=3) in culture. 
This would suggest that construct maturation occurs in terms of myogenic cell 
differentiation and phenotype determination, however, matrix remodeling is 
unaffected by extended time in culture.
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Figure 59: MMP-2 gene expression is shown when MDCs were seeded at 40 
million/Sml collagen gel after 24 hours and after 6 days in culture. Standard 
deviation is used for error bars (n=3). There was no significant difference 
(p=0.8354) in MMP-2 gene expression.
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A note on statistical analysis of RT-PCR data
The endpoint of real-time PCR analysis is the threshold cycle or Q. In order to 
relatively quantify gene up-regulation/down-regulation Karamichos et al. (2007) 
compared the Threshold Cycle (C J values of the samples of interest with a control or 
calibrator such as a non-treated sample. The Ct reflects the cycle number at which the 
fluorescence generated within a reaction crosses the threshold. The Ct assigned to a 
particular sample reflects the point during the reaction at which a sufficient number of 
amplicons have accumulated, within the well/sample, to be a statistically significant 
point above the baseline (Karamichos, 2006). The Ct values are normalized to an 
appropriate endogenous housekeeping gene (ACt). Karamichos et al. (2007) analysed 
PCR data using ACt values.
MYHC-p ACt AACt 2 ” AACt
24 hours 1 11.88 -4.728 26.50146
24 hours 2 11.261 -5.347 40.70122
24 hours 3 10.762 -5.846 57.52033
6 days 1 7.779 -8.829 454.7721
6 days 2 5.01 -11.598 3099.887
6 days 3 6.59 -10.249 1216.904
Table 6: The endpoint of RT-PCR analysis PCR analysis is the threshold cycle or 
Ct. The raw data for MYHC-P gene expression after 24 hours (n=3) and after 6 
days (n=3) is summarised in this table. The ACt is normalization to the internal 
housekeeping gene GAPDH. AACt is relative to an external control. The Ct 
values are exponential and not linear terms, and it is necessary to convert the 
data into a linear term using the comparative 2^^* method for statistical 
significance.
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However, Livak and Schmittgen (2001) gave an extensive report in which they 
highlighted that the Ct is determined from a log-linear plot of the PCR signal versus 
the cycle number. Thus, Q  is an exponential and not a linear term. For this reason, 
any statistical presentation using the raw Ct values should be avoided (Livak and 
Schmittgen, 2001). Presentation o f relative PCR data is most often calculated along 
with an internal control and/or calibrator sample and is rarely presented as the Ct, an 
exception is when one is interested in examining the sample-to-sample variation 
among replicate reactions, e.g. expression o f a housekeeping gene (Livak and 
Schmittgen, 2001). Statistical data should be converted to the linear form  by the 
2'AACt QQiculation and should not be presented by the raw C t values (Livak and 
Schmittgen, 2001).
AACt Fold Change
M yogenin Significant(p<0.05)
Not significant 
(p=0.2847)
M YHC-IIX/D Significant(p<0.05)
Not significant 
(p=0.3061)
MYHC-p Significant(p<0.05)
Not significant
(p=0.1201)
Table 7: Statistical analysis of AACt vs. fold change (2‘^ ^*) for myogenic specific 
genes. The difference in AACt was statistically significant (p<0.05). However,
the actual fold change (2'^^*) gene expression were not significantly different.
Table 1 shows the raw data for MYHC-P gene expression after 24 hours (n=3) and 
after 6 days (n=3). Notice the small variation in the values o f the exponential terms 
ACt and AACt, these values are statistically different (Table 2; p<0.05). However, due
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to the nature of exponential amplification, when these values are converted to the 
linear form (2’^ ^*) as a true representation o f the fo ld  change in gene expression, the 
values are not significantly different (Table 2). In this study, the lack of statistical 
significance can be explained as a consequence o f converting the results of an 
exponential process into a linear comparison of amounts (Livak and Schmittgen, 
2001).
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Discussion
In vitro tissue engineering of skeletal muscle involves culturing myogenic cells in an 
environment that emulates the 3D in vivo environment so that the cells proliferate, 
fuse, organize in three dimensions, and differentiate into functional skeletal muscle 
capable of generating force (Kosnik et aL, 2003). The development of 3D skeletal 
muscle constructs has made possible the measurement of contractile properties o f 
cultured skeletal muscle cells (Dennis and Kosnik, 2000). In this study the force 
contraction profiles obtained were distinctly different at each cell seeding density. 
When cells were seeded at 20 million/5ml collagen gel, the contraction profile had the 
characteristic phases o f traction, contraction and force plateau and the peak force 
generated was not significantly different from when cells were seeded at 5 
million/5ml collagen gel (Chapter 2).
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Figure 60: Comparison of the published ‘typical myotube contraction curve* 
(Cheema et al., 2003) with the contraction profile obtained when prim ary human 
MDCs were seeded at 30 million/5ml collagen gel.
The force contraction profile obtained when cells were seeded at 30 million/5ml 
collagen gel was comparable (Figure 60) to the ‘typical myotube contraction curve’
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published by Cheema et al. (2003). Cheema et al. (2003) attempted to tissue engineer 
a differentiated skeletal muscle construct using C2C12 mouse skeletal myoblasts 
(seeded at 20 million cells/5ml collagen gel) and monitored the isometric contractile 
properties o f the myotube-rich collagen gels. The peak force generated by the 
C2C12 neo-muscle organoid was 1150pN (Cheema et al, 2003), the peak force 
generated by the primary human MDC neo-muscle organoid in this study was 
1373pN. Further, the initial rapid rate o f force generation/contraction was similar. 
Force generation for myotube gels was characterised by a series o f rapid contractions, 
or jumps, which may represent a form of synchronous myotube contraction (Cheema 
et al., 2003). The distinctive pattern of force generation when cells were seeded at 40 
million/5ml collagen gel, with incremental increases in force generation with time 
may have resulted from the complex interplay between cell-cell and cell-matrix 
interactions o f myogenic cells.
An understanding of the principals involved in the differentiation of primary 
myoblasts to oriented functional myofibres will aid in the development of a tissue 
engineered muscle construct. It is known that myogenesis occurs when myoblasts are 
in close contact to one another (Gurdon et a l ,  1993). Gurdon et al. (1993) stated that 
the ‘community effect’ was necessary for muscle gene activation. The most 
important feature o f the ‘community effect’ is that a large number o f cells are required 
for a muscle response (Gurdon et al., 1993). Myoblast fusion, by which 
mononucleated myoblasts fuse to form multinucleated muscle fibers, is an essential 
early step during skeletal muscle differentiation (Chen and Olsen, 2004). Myoblasts 
recognize one-another, adhere and align to form linear aggregates, and then the cells
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of these aggregates fuse to form a myotube that will mature to a muscle fibre (Clark et 
a i,  2002).
The fusion o f mononucleate precursor myoblasts to form the multiucleated skeletal 
muscle fibre is preceded by a series o f complex cell-cell interactions (Knusden, 1990; 
Dickson et al., 1990). Many changes that accompany fusion have been described. 
For example, during myogenesis in vivo and in vitro, expression of the neural cell 
adhesion molecule (NCAM) undergoes an isoform transition that precisely correlates 
with terminal myoblasts differentiation and myotube formation (Dickson et al., 1990; 
Charlton et al., 2000). Another change accompanying skeletal muscle cell fusion is a 
dramatic increase in synthesis o f muscle specific proteins, e.g. myosin heavy chain 
(Wiid etal., 1984).
Further, it is generally agreed that for membrane fusion to occur, a fluid membrane 
state is needed and previous studies have shown that when cells fuse, the greatest 
changes in membrane fluidity occur in areas of cell contact between fusing cells 
(Herman and Fernandez, 1978, 1982). This increase in membrane fluidity results 
from the redistribution o f surface antigens (Kaufman and Foster, 1985) and changes 
in integrin expression (Clark et al., 1997). The fusion of membranes also involves 
changes in the lipid structure o f the bilayers during the process (Wakelam & Pette, 
1982). It is likely that together, many o f these events favour strong cell-cell 
adhesion over cell-substratum adhesion, enabling the myoblasts to assume the correct 
shape and geometrical arrangement for fusion (Clark et al., 2002).
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During the terminal stage of skeletal myogenesis, myoblasts stop replicating, fuse to 
form multinucleate fibres, and express the genes that encode the proteins (MYHC) 
that convey contractile capacity (Kaufinan and Foster, 1988). The results o f this 
study showed that there was a significant increase in MYHC-P with increasing 
primary human MDC density in 3D collagen gels. Indicative o f increased terminal 
differentiation o f myogenic cells within the muscle constructs, with increasing cell 
density. However, the gene expression of myogenin and MYHC-llXD did not 
significantly differ, nor follow the trend of increased expression with increasing cell 
density. There was also an apparent transition in the fast-to-slow direction of MYHC 
isogene expression with increasing cell density, suggesting that the ‘community 
effect’ influences the determination o f muscle fiber type.
It is axiomatic that for cells to bring about ‘contraction’ of a collagen gel, it is 
essential for them to attach to the matrix or to each other. Although cell-matrix 
adhesion is of importance for the progression of myogenesis, it is not directly 
involved in myotube formation. In the early stages o f myoblast differentiation, when 
cells become postmitotic but have yet to fuse, cell-cell adhesion is probably more 
important than cell-matrix adhesion for efficient cell fusion (Wakelam, 1985; Clark et 
al., 1997). A switch from cell-matrix adhesion to cell-cell adhesion could explain 
why after 6 days in 3D culture the skeletal muscle specific factors (myogenin) and 
protein (MYHC) mRNA were upregulated, but MMP-2 matrix remodeling remained 
constant.
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Conclusions
■ In this study, cell generated endogenous forces as primary human MDCs were 
seeded in constructs at increasing cell densities were quantified. Establishing 
that the optimal cell seeding density for peak force generation and ECM 
remodeling (initial rate o f force generation) was 30 million cells/5 ml collagen 
gel.
■ The hypothesis that increasing cell density would result in increased incidence 
of cell-to-cell contact and therefore more myogenic cell differentiation, 
resulting in a linear upregulation of myogenin mRNA proved to be an 
oversimplification of myogenic differentiation in 3D constructs at high cell 
densities. There was no significant up-regulation of myogenin mRNA as cell 
density increased.
■ The relative expression and switching o f MYHC-llX/D (fast) and MYHC-p 
(slow) mRNA expression was studied in response to increasing cellular 
density within a tissue engineered 3D skeletal muscle model. There was a 
significant increase of MYHC-p mRNA expression with increasing cell 
density. However, there was no significant change in MYHC-llX/D mRNA 
gene expression.
■ MMP-2 was not significantly up-regulated with increasing cell density. 
Therefore, increasing cell density does not result in increased matrix 
remodeling.
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Extended time in culture resulted in an up-regulation o f mRNA expression of 
the muscle specific regulatory factor (myogenin) and the muscle specific 
proteins (MYHC-IIX/D and MYHC-p/slow), indicative of maturation o f the 
constructs by an increase in myogenic differentiation and fibre phenotype 
determination. However, MMP-2 mRNA expression, and ultimately matrix 
remodeling, did not alter significantly over the 7 day period.
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Ch 5: MDC response to increased  matrix stiffness 
Introduction
The native extracellular matrix (ECM) acts as a scaffolding for cells in a tissue, gives 
it structure, and regulates cell phenotype (e.g., tissue-specific gene expression) (Rosso 
et a i ,  2004). Tissue engineering approaches typically employ an exogenous 3D 
matrix to simulate the native ECM and engineer new tissues from native cells 
(Abatangelo et al., 2001). The exogenous matrices are designed to provide an 
appropriate 3D environment for the cells, mechanical strength and structural stability, 
until the newly formed tissues are mechanically stabilized and specific signals occur 
to guide the gene expression o f cells forming the tissue (Putnam and Mooney, 1996).
Numerous forms of scaffold materials are currently under investigation and the 
matrices used in tissue engineering applications are divided into synthetic and 
biologically-derived biomaterials (Freed et a i ,  1994; Grande et al., 1997; Cronin et 
a i,  2004; Bach et a i,  2004). Naturally derived biopolymers have been shown to 
possess potentially excellent characteristics as templates for tissue regeneration (Bitar 
et ai., 2007). Collagen, fibronectin, chitosan, starch, and hyaluronic acid are 
examples o f the many native biopolymers currently in use. These biopolymers, 
whether animal or plant in origin, have attracted much interest due to their low 
immunogenic potential and the capacity o f integrating with the host tissue (Novikova 
et al., 2003).
Collagen directly supports integrin-mediated cell attachment and the subsequent 
expression, and maintenance, o f the seeded cell differentiated state (Bitar et al..
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2007). One of the main advantages o f collagen as a scaffold is its properties as a cell 
substrate; it is biocompatible, has low immunogenicity, is conserved across species, 
and is naturally remodelled by cells (Abou Neel et al., 2006). As the main 
extracellular matrix (ECM) protein in musculoskeletal tissues, collagen has been the 
scaffold material o f choice throughout this thesis. However, owing to an extremely 
low protein to water ratio, these hydrated matrices have no inherent mechanical 
strength thus limiting their immediate in vivo application (Giraud Guille et al., 2005; 
Abou Neel et al., 2006; Bitar et al., 2007; Karamichos et al., 2007). This is true for 
many engineered tissues, in which the mechanical properties remain inferior to those 
o f native tissues (Cao et al., 1994; Kim et al., 1999; Mauck et al., 2000). This has 
necessitated the use o f various methods to enhance the mechanical properties and 
integrity o f such constructs. Several investigators have attempted to improve the 
functionality o f engineered tissues by mimicking the in vivo environment through 
application of external mechanical load to tissues in vitro (Kim et al., 1999; Mauck et 
al., 2000; Banes et a i ,  2003; Karamichos et al., 2007).
Nearly 30 years ago Bell et al. (1979) reported that fibroblasts condensed a hydrated 
collagen gel to produce a denser arrangement o f collagen fibrils, with water being 
excluded in the process. The potential o f this finding was not realized until Brown et 
al. (2005) developed a novel technique to expel the interstitial fluid from 
hyperhydrated collagen constructs producing tissue-like collagenous scaffolds of 
considerable mechanical strength. The process is both simple and rapid, exploiting 
the central property o f the gels wherein compression expels the liquid which does not 
return on removal o f the load, i.e. the gel undergoes a plastic compression (PC) 
(Brown et al., 2005). PC removes fluid from hyper-hydrated gels in a matter o f
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minutes to produce scaffolds that are dense, cellular, and mechanically strong, with 
controllable meso-scale structures (Abou Neel et aL, 2006). Bitar et al. (2007) 
showed that plastic compressed constructs were capable o f supporting cell viability 
and proliferation of human dermal fibroblasts for 5 weeks in culture concluding that 
PC of hydrated collagen gels rapidly produces biomimetic scaffolds of improved 
mechanical properties and these scaffolds can potentially be utilized as cell seeded 
systems for tissue engineering (Bitar et aL, 2007). The objective o f  this study was to 
produce a stiffer matrix fo r  tissue engineering skeletal muscle and study muscle 
derived cellular response. The process o f  plastic compression was utilized and 
methodology was developed fo r  tethered collagen constructs.
The ECM plays a vital role in regulating the response o f cells to signals from their 
microenvironment through mediation o f cell adhesion and regulation of the cellular 
force balance (Simmons and Mooney, 2003). The stiffness o f the matrix can dictate 
the fate and function of a cell, Rowley and Mooney (1999) showed that C2C12 
skeletal myoblasts cultured on modified hydrogels (RGD-coupled alginates) with high 
compressive modulus showed increased proliferation and differentiation compared 
with those on medium and low stiffness gels. Further, the stiffness of the material 
may regulate the ability o f the matrix to resist cell-based tractional forces, thereby 
mediating changes in the force balance between the cell and matrix, and within the 
cell (Simmons and Mooney, 2003). The first aim o f  this study was to test the effect o f  
a stiffer matrix (using PC) on generation o f  cell-based tractional forces. This was 
achieved by measuring the cytomechanical force generated by MDCs embedded in 
plastic compressed collagen. Testing the hypothesis that a stiffer matrix would result 
in a reduced generation o f  quantifiable force.
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As discussed in chapter 2, there is a force balance between the tension generated by 
the cytoskeleton of a cell and the resistance provided by the cells adhesion to its 
matrix that determines the shape o f the cell (Simmons and Mooney, 2003). Cell 
shape correlates with several cellular behaviours, including growth, differentiation, 
apoptosis, motility and signalling (Chen et aL, 1997; Ingber, 1990; Mooney et aL, 
1992) and it has been suggested that the fate of a cell may be regulated by the 
stiffness of the substrate to which it is adhered (Simmons and Mooney, 2003). The 
second aim o f  this study was to use TEM to qualitatively analyse the effect o f  plastic 
compression on cell shape and collagen fibril density.
Hydrogels enable specific cell-matrix interactions, which has the potential to allow for 
control o f gene expression o f cells within the matrices (Simmons and Mooney, 2003). 
For tissue engineering strategies it is essential to know how cells interact with the 
ECM and transduce the information received by the extracellular molecules into an 
intracellular event (Rosso et aL, 2004). Further, cell-matrix actions regulate gene 
expression and ultimately tissue development and function (Streuli, 1999). Because 
the matrix plays a significant role in regulating tissue development, defining the roles 
of the matrix and its interaction with cells are critical to designing tissue engineering 
matrices that present the signals necessary for appropriate gene expression and 
functional tissue development (Simmons and Mooney, 2003). The third aim o f  this 
study was to quantify the gene expression o f  the muscle specific factor, myogenin, and 
the muscle specific proteins, MYHC-IIX/D and MYHC-p using RT-PCR, to determine 
whether the process o f  plastic compression promoted the expression o f markers o f  
myogenic terminal differentiation by increasing the incidence o f  cell-to-cell contact in
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the 3D collagen construct. Testing the hypothesis that muscle specific gene expression 
will be up-regulated in PC constructs.
The ability o f the matrix to regulate the cellular microenvironment can be exploited 
by designing matrices that present the appropriate signals necessary to direct cell 
function to engineer functional tissues (Simmons and Mooney, 2003). Huang and 
Ingber (1999) suggested that the ability of cells to respond to the stiffness of their 
substrate may play a critical role in regulating tissue remodeling. Further, 
Karamichos et al. (2007) suggested that increasing the stiffness o f collagen constructs 
will allow the tailoring of specific cellular responses in tissue engineering 
applications. The final aim o f  this study was to quantitate the effect o f  increased 
stiffness (due to PC) on the expression o f  the matrix remodeling gene MMP-2 in PC  
MDC seeded constructs. Testing the hypothesis that the stiffer matrix will induce a 
significant up-regulation o f  MMP-2 gene expression in primary human MDC seeded 
constructs.
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Materials and Methods
Methods development
Plastic compression of hydrated collagen gels rapidly produces biomimetic scaffolds 
of improved mechanical properties (Brown et aL, 2005; Abou Neel et aL, 2006; Bitar 
et aL, 2007). In this study we developed the methodology for applying the novel 
process of plastic compression to tethered collagen constructs. This enabled the force 
contraction profile of a tethered plastic compressed MDC seeded collagen construct to 
be measured on the CFM.
Nylon mesh positioned on 
top of stain less steel mesh
Blotting paper »  %
Collagen gel fixed 
between two A-frames
Nylon mesh, pressure 
plate & 50g load
Figure 61: This picture depicts the pre-compressed set up. Collagen gels were 
prepared as normal in the CFM mould between two A-frames and immersed in 
20ml of medium. The blotting paper and meshes (stainless steel and nylon) were 
positioned in the centre of the blotting paper and the pressure plate and load are 
also shown before the process of plastic compression.
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Figure 62: Plastic Compression (PC) schematic (Adapted from Brown et aL, 
2005) showing the combination of compression (load on pressure plate) and 
blotting (mesh and paper blot layers) to sandwich a collagen gel and remove the 
excess interstitial fluid.
Collagen gels were prepared as previously described in the CFM mould attached to 
two A-frames (Figure 61). Primary human MDCs were seeded at an initial cell 
seeding density o f 30 million/5ml collagen gel. Following setting and incubation gels 
were routinely compacted by a combination o f compression and blotting using layers 
of mesh and paper sheets as shown in the schematic o f Figure 62. A 165pm thick 
stainless-steel mesh (mesh size ~ 300pm) and a layer o f nylon mesh (-50pm; to 
prevent sticking) were placed on a double layer absorbent paper (Brown et aL, 2005). 
The tethered collagen gel was placed on the nylon mesh, covered with a second nylon 
mesh, pressure plate and loaded with a 50g flat stainless steel block for 5 min at room
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temperature leading to the formation of a flat collagen sheet (~20-40pm thick) which 
was returned to the CFM mould and immersed in 20mls medium (Figure 63).
i Æ
The collagen gel, se t betw een 
tw o A-frames, w as removed from 
th e  CFM mould and placed on the  
m eshes.
The collagen gel w as then plastic 
com pressed for 5 m inutes 
beneath  th e  pressure plate and 
50 g load.
The PC collagen gel w as returned  
to  th e  CFM mould and im m ersed 
in medium.
Figure 63: The PC process. The attached collagen gel was carefully removed 
from the CFM mould and placed on the nylon mesh (a). The second nylon mesh, 
pressure plate and 50g load were carefully placed on top of the collagen gel and 
plastic compressed for 5 minutes (b). The plastic compressed collagen sheet was 
then returned to the CFM mould (c) and immediately attached to the CFM.
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The PC collagen sheet was returned to the mould and then tethered to the CFM to 
quantitate the force contraction profile generated as the cells responded to the PC 
matrix. After 24 hours the gels were removed from the CFM and RNA was extracted, 
converted into cDNA and amplified using RT-PCR as previously described.
Transmission Electron Microscopy (TEM) was used to qualitatively analyse the effect 
o f the PC process on MDCs seeded within a collagen gel. TEM is a powerful tool for 
high magnification and high resolution image analysis giving information of cells and 
organelles. Specimens of normal and PC collagen constructs were washed in O.IM 
phosphate buffer, fixed in 2.5% gluteraldehyde in O.IM phosphate buffer for 1 hour at 
4^C. This was followed by two phosphate buffer washes and a secondary fixation 
with 1% osmium tetroxide in a 0.1 M cacodylate buffer, for 1 hour at room 
temperature. The specimens were then dehydrated through an increasing acetone 
series. The final series was 100% acetone, which was then infiltrated with 1:1 
acetone: araldite CY212 resin overnight in a specimen rotator. The resin was then 
replaced by fresh resin twice, each change for a minimum o f 3 hours. Once this 
procedure was complete, specimens were embedded in araldite CY212 resin and 
blocks were polymerised at 60^C for 18 hours. Semi thin (1pm) sections were cut 
from the specimens using a Reichart-Jung Ultracut E ultramicrotome and floated onto 
distilled water and collected on glass slides. Ultra-thin sections (80-100nm) were cut 
using a Diatome diamond knife, floated onto distilled water, collected on copper grids 
and stained with 2% uranyl acetate and lead citrate for 10 minutes in each solution. 
The stained sections were viewed on a Phillips CM 12 electron microscope. (All the 
reagents used in the TEM procedure were from Agar Scientific Ltd., Essex, England).
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Results
Primary human MDCs were seeded at a density o f 30million/5ml collagen gel, the gel 
was then plastic compressed and tethered to the CFM to measure the force generated 
over 24 hours. The resulting force contraction profile obtained is shown in Figure 64 
and contrasted with the force contraction profile obtained from a normal 
(hyperhydrated) collagen gel with cells seeded at the same initial density.
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Figure 64: The force contraction profile obtained when 30 million MDCs were 
seeded in (a) plastic compressed (PC) and (b) normal ‘hyper-hydrated’ collagen 
gels. The initial negative force generation of the PC gel is due to stress-relaxation 
of the collagen gel after the process of plastic compression. The green arrow 
indicates onset of force generation. The force-time profiles are an average of 3 
separate experiments.
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The results show that the peak force generated as MDCs remodelled the PC collagen 
gel was 206pN (±20pN) this was significantly (p<0.05) lower than the peak force 
generated (1372pN) when the same number of cells remodelled the Normal (hyper­
hydrated) collagen gel. The initial negative force generation is due to the stress- 
relaxation o f the construct. Stress-relaxation was defined by Cheema (2004) and 
Karamichos (2006) as the unloading or continued deformation of the material 
(collagen gel) after loading. Initiation o f contraction by the cells within the PC matrix 
began 6 hours (± 36 minutes) after being tethered to the CFM (as indicated by the 
small green arrow in Figure 64). These results showed that the stiffer matrix resulted 
in a reduced generation of quantifiable force.
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Figure 65: TEM images showing the effect of plastic compression on cell shape 
and collagen flhril density. MDCs were seeded at an initial density of 30 
million/5ml collagen construct and images were taken after the gels were 
tethered to the CFM for 24 hours: (a) depicts cells seeded in the normal (hyper­
hydrated) collagen gel and (b) the PC collagen gel. The embedded cells in the
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normal gel are larger and contain more than one nuclei (shown by black 
arrows). However, the cells in the PC gel are smaller, with less cytoplasm. In the 
plastic compressed constructs there is an increased number of collagen fibrils 
clearly identifiable by the white arrow heads.
The next part o f this study was to investigate and qualitatively analyse the effect of 
the process o f plastic compression on cell shape and collagen fibril density. From the 
TEM images in Figure 65 (b) it can be clearly seen that the process of eliminating 
liquid from the hyper-hydrated collagen gel resulted in an increase in both cellular 
and collagen fibril density. Further, cell shape is affected by the process o f PC, the 
cells in the normal ‘hyper-hydrated’ collagen constructs are larger, and in some cases, 
contain multiple nuclei, whereas the cells in the PC constructs are smaller, more 
compact, with less cytoplasm.
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Figure 66: The average Ct of the internal control gene. GAPDH was validated to 
ensure that the experimental treatment did not effect its expression. Standard 
deviation was used for error bars (n=6+). There was no significant difference in 
gene expression so GAPDH was used as the internal control in this study.
The final aspect o f this study was the molecular output. The hypothesis was that the 
process of plastic compression would promote the expression of muscle specific 
genes by increasing the incidence of cell-cell contact. Real time quantitative polymer 
chain reaction was used to test this hypothesis using the gene expression of myogenin 
and the myosin heavy chain isoforms (MYHC-IIX/D and MYHC-p) as markers of 
myogenic cell differentiation. As discussed earlier, the internal control gene was 
properly validated for each experiment to determine that gene expression was 
unaffected by the experimental treatment (Livak and Schmittgen, 2001). No 
significant difference (p=0.3505) was found in GAPDH expression between normal 
and PC collagen constructs (Figure 66). Therefore GAPDH was verified as an 
appropriate housekeeping gene in this study.
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Figure 67: Myogenin gene expression is shown for MDCs seeded at 30 
miliion/Sml collagen gel (n=6+) in Normal and PC constructs. Standard 
deviation is used for error bars.
The results in Figure 67 suggest that PC causes a down-regulation of myogenin after 
24 hours in culture. However, these results were not statistically significant 
(p=0.3379) and no solid conclusions can be drawn from the data presented. Figures 
68 (a) and (b) show that the gene expression of MYHC-IIX/D (p=0.6286) and 
MYHC-p (p=0.3837) were not significantly different in normal or plastic compressed 
constructs. These results suggest that the process of plastic compression does not 
promote the gene expression of markers of myogenic differentiation and a larger 
number of samples should be investigated. This could be correlated with the 
compacted cell shape which may hamper cell-cell communication within the stiffer 
matrix and thus reduce expression of the gene milieu that encodes for myogenic cell 
differentiation.
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Figure 68: The gene expression of myosin heavy chain isoforms (a) MYHC-IIX/D 
(fast; red) and (b) MYHC-p (slow; green) for normal and plastic compressed 
MDC seeded constructs. Standard deviation is used for error bars (n=6+ each).
The final aspect of this study was to test the hypothesis that the gene expression of the 
matrix degrading enzyme MMP-2 would be up-regulated in response to the stiffer 
plastic compressed matrix. The results in Figure 69 show that the gene expression of 
MMP-2 in Normal and PC MDC seeded collagen gels were not significantly different
(p=0.2668).
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Figure 69: MMP-2 gene expression is shown for MDCs seeded at 30 miliion/Sml 
collagen gel (n=6+) under Normal and PC conditions. Standard deviation is used 
for error bars.
Discussion
The ability o f the stiffness o f the ECM to control cell phenotype has important 
implications for the design of tissue engineering matrices. Controlling material 
stiffness may allow one to regulate several cell responses, in essence tailoring the 
material properties to elicit the desired cell response. In this study the novel process 
of plastic compression was used to rapidly improve the material strength of the 
scaffold for skeletal muscle tissue engineering applications. The TEM images 
showed increased collagen fibril density of the stiffer matrix, cell shape was also 
affected by PC resulting in compact cells with smaller nuclei and cytoplasm. The 
response of the cells to this new, stiffer matrix resulted in significantly reduced 
measurable force and a delayed onset o f force generation. Karamichos et al. (2007) 
similarly showed that increasing the stiffness of collagen type 1 lattices by uniaxial 
loading resulted in higher fibril orientation within it which resulted in significantly 
lower measurable contraction forces generated by the embedded cells (human dermal
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fibroblasts). There is an evident correlation between matrix stiffness and endogenous 
cell generated force, in which increased matrix stiffness inhibits cell force generation. 
The ultimate goal is to develop a scaffold with improved mechanical properties, 
without inhibiting the embedded cell cytomechanical or molecular response.
Modulation o f the extracellular matrix affects its function and the consequent 
behaviour o f cells residing on or within it (Strueli, 1999). The cells composing the 
engineered tissue must express the appropriate genes to maintain the tissue specific 
function o f the engineered tissue (Rosso et a/., 2004), for example, MDCs within an 
engineered muscle tissue construct must be induced to express the genes encoding 
terminal myogenic cell differentiation. The stiffer plastic compressed matrix 
implemented appeared to inhibit muscle specific gene expression. The hypothesis 
was that the process o f plastic compression would both increase matrix stiffness and 
increase the incidence o f cell-cell contact within the matrix, subsequently increasing 
myogenic cell differentiation and expression o f myogenin. However, the results 
showed no significant difference in the gene expression o f myogenin, or the myosin 
heavy chain isoforms, suggesting that the improved quality o f matrix stiffness actually 
impedes development o f myotubes, and subsequent myofiber types, in the 3D 
construct.
ECM remodeling through its synthesis, restructuring as well as degradation, is the key 
to understanding how different cell types maintain tissue integrity in vivo (Strueli, 
1999). MMP-2 is the matrix degrading enzyme that has been monitored throughout 
this thesis as a marker o f extracellular matrix remodeling. This study has shown that 
when primary human MDCs were seeded in stiffer matrices the levels o f MMP-2
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mRNA were not significantly altered. Karamichos et al. (2007) recently used 
mechanical loading to increase the stifïhess o f collagen constructs (seeded with 
human dermal fibroblasts) and showed that gene expression of MMP-2 was 
significantly up-regulated in stiffer constructs. In contrast, the results presented in 
this study indicate that increased stiffness does not elicit a matrix remodeling cellular 
response. Clearly, MMP-2 mRNA expression, in response to increased matrix 
stiffness, is dependent on cell type (e.g. MDCs) and experimental methodology (e.g. 
PC). In terms o f experimental methodology, Karamichos et al. (2007) used 
mechanical pre-loading to increase matrix stiffness, these mechanical cues may have 
been responsible for the up-regulation o f MMP-2 mRNA rather than the ensuing 
matrix stifftiess per se. This study highlights the importance of investigating the 
molecular response of different cell types to the increased stiffness of the scaffolds 
used in tissue engineering applications.
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Conclusions
■ This study utilised the process o f plastic compression to create a stiffer matrix 
for tissue engineering applications. The forces generated by MDCs seeded 
within this matrix were significantly reduced, compared to the forces 
generated when MDCs were seeded in normal ‘hyper-hydrated’ collagen 
matrices. That is, a stiffer matrix resulted in a reduced generation of 
quantifiable force.
■ Using TEM this study qualitatively showed that the process o f plastic 
compression caused an increase in collagen fibril density and the embedded 
cells were more compact, smaller, with visibly less cytoplasm, in PC gels.
■ The process o f plastic compression did not promote the expression o f markers 
o f myogenic terminal differentiation (myogenin, MYHC-IIX/D and MYHC-
p).
■ The mechanosensitive gene MMP-2, an established marker of matrix 
remodeling, was not upregulated in stiffer plastic compressed constructs.
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General Discussion
Tissue engineering skeletal muscle involves inducing the fusion of myoblasts to 
myotubes in vitro, recapitulating the in vivo conditions during myogenesis. The tissue 
engineer attempts to guide the cellular organization and development in 3D tissue 
culture by providing the myogenic cells with the appropriate environmental cues 
(Kosnik et al., 2003). However, to date, a functional tissue substitute for skeletal 
muscle has not yet been developed and to achieve this goal it is necessary to 
investigate new approaches for culturing differentiated skeletal muscle tissue in vitro 
(Bach et al., 2004). To successfully tissue engineer skeletal muscle a number of 
parameters must be considered including cell source, scaffold, gene expression, 
biological cues (cell-cell interactions) and mechanical cues (cell-matrix interactions). 
In this study primary human craniofacial muscle derived cells were seeded in a 3D 
collagen type I scaffold to tissue engineer a craniofacial muscle construct and 
investigated the effect o f biological and mechanical cues on cellular cytomechanical 
(force generation) and molecular (gene expression) response.
1. Cell Source
The source o f the cells used for skeletal muscle tissue engineering depends on the 
intended use o f the tissue engineered construct. Myogenic cells lines, including the 
C2C12 cell line from mouse muscle sarcoma (Okano and Matsuda, 1998; van 
Wachem et al., 1996; Vandenburgh et al., 1998, Cheema et al., 2003) and the murine 
G8 cell line (Mulder et al., 1998), have been used for their cost effectiveness, ease of 
use and uniformity. However, these cells have disadvantages, primarily, they are 
essentially immortalised cells and it is not possible to use such cells in clinical
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applications. In the absence o f immune suppression, non-autologous cells will be 
identified by the host and rejected within several weeks (Kosnik et al., 2003). 
Another limitation o f using cell lines is that the cells do not exhibit all of the same 
behaviours as primary myogenic cells in vitro (Imitchev et al., 1998). For example, 
Dennis et al., (2001) showed that muscle constructs engineered from myogenic cell 
lines exhibited significantly lower contractility and prolonged relaxation times after 
cessation of electrical stimulation compared with constructs engineered from primary 
adult rodent cells. The use o f myogenic cell lines for muscle tissue engineering 
studies must be complemented with primary cell studies.
Autologous cells are required for clinical applications in which engineered skeletal 
muscle can be implanted into the host without a barrier to immune response or the 
need for immune suppression (Kosnik et al., 2003). Consequently, three dimensional 
skeletal muscle constructs have been engineered from primary cultures of avian 
(Strohman et al., 1990; Swasdison and Mayne, 1992; Vandenburgh et al., 1991), 
rodent (Dennis and Kosnik, 2000; Powell et al., 1999; Vandenburgh et al., 1996, 
1999) and human (Powell et al., 1999) myogenic cells. A unique aspect of this study, 
considering the potential clinical application of the tissue engineered craniofacial 
muscle construct, was the use o f primary human masseter muscle derived cells 
(MDC).
Critical choices on the source o f cells for the ideal tissue engineered muscle construct 
should have a combination o f fibroblasts, myoblasts and satellite cells (Lewis et a l,
2008). Immunostaining for desmin showed that the MDC cultures derived from the 
human masseter were a co-culture o f myogenic and non-myogenic cells. However,
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primary myoblasts cell cultures need to be expanded to a great extent in order to 
obtain large volumes o f tissue engineered skeletal muscle (Bach et al., 2004). 
Further, the processes o f isolation, purification and proliferation o f primary myoblast 
are labour intensive and costly (Kosnik et al., 2003). This was one of the major 
limitations o f this study. The process o f culturing and isolating the required volume 
o f primary human myogenic cells for tissue engineering craniofacial muscle 
constructs was labour intensive and expensive, future research should scale down the 
muscle model an order o f magnitude (i.e. from mis to pis and fi*om millions of cells to 
hundred thousands o f cells).
Only one other group has attempted to use primary human muscle cells to tissue 
engineer skeletal muscle. Powell et al. (1999; 2002) seeded MDCs from the vastus 
lateralis muscle into a matrigel'.Collagen gel mixture. However, matrigel™ is an 
extract from the Engelbreth-Holm-Swarm mouse sarcoma and contains extracellular 
matrix proteins and growth factors in undefined concentrations. Further, it has the 
ability to change gene expression in cells (Bach et al, 2004). Due to its origin its 
utility, matrigel™ is not appropriate for a clinical setting and thus limited to 
experimental models. A distinctive aspect o f the model presented in this study was 
the choice o f scaffold material.
2. Scaffolds
Scaffolds are artificial extracellular matrixes (ECMs) that define the initial geometry, 
structure and mechanical properties o f the engineered skeletal muscle construct, they 
also have an essential role in the control and maintenance o f cellular function.
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including proliferation and fusion (Kosnik et al., 2003; Lewis et a l ,  2008). Ideally, 
matrices should provide a high surface area for cell-matrix interactions, sufficient 
space for extracellular matrix (ECM) regeneration and minimal diffusion constraints 
during in vitro culture (Rebel et al., 1994; Y q et al., 2000a). Moreover the matrix 
should be resorbable once it has served its purpose o f providing a basic structure for 
the developing tissue (Freed et al., 1994; Mikos et al., 1994).
Myogenic cells exhibit anchorage dependent growth (Stoker et al., 1968) and do not 
proliferate in the absence o f a suitable substrate on which to adhere. They can be 
cultured on substrates o f plastic, glass, or flexible membranes that have been coated 
with collagen, fibronectin, laminin, matrigel^^, or combinations of these molecules 
(Chiquet et al., 1979; Turner, 1986). Scaffolds used in skeletal muscle tissue 
engineering include collagen gels (Chromiak et al., 1998; Okano and Matsuda, 1997; 
Vandenburgh et al., 1999), collagen-matrigel gels (Powell et al., 1999; 2002), alginate 
hydrogels (Rowley et al., 1999), polyurethanes (Mulder et al., 1998) and phosphate- 
based glass fibers (Shah et al., 2005)
In this study type I collagen was the scaffold o f choice, it is the most abundant and 
best studied collagen, and it is also highly conserved across species. In most organs 
and notably in tendons and fascia, type I collagen provides tensile stiffness and in 
bone, it defines considerable biomechanical properties concerning load bearing, 
tensile strength, and torsional stiffness (Gelse et al., 2003). In addition to their key 
functional role as biomechanical structures, the collagens interact directly with cells to 
influence adhesion, growth, differentiation and many other cellular activities (Brown 
and Phillips, 2007). Collagen provided the ideal starting point as a scaffold to tissue
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engineer a new muscle construct and this study showed that primary human MDCs 
could be embedded in the 3D matrix with cell viability being maintained (Chapter 2). 
Further, we showed that increased matrix stifïhess resulted in a reduction in 
endogenous cell generated force and no significant change in gene expression of 
markers o f myogenic cell differentiation and matrix remodeling (Chapter 5). Future 
investigations to improve the material strength of scaffolds used in tissue engineering 
should investigate the correlation between matrix stiffness and cellular response, 
testing a range o f matrix stifftiess to cellular response to establish the threshold at 
which matrix stifftiess begins to inhibit cellular cytomechanical response.
3. Gene expression
Skeletal myogenesis is the process by which myoblasts proliferate, organize in three 
dimensions, and differentiate to form skeletal muscle tissue de novo (Kosnik et al., 
2003). Many o f the steps involved in the differentiation o f myoblasts to their 
subsequent fusion into multinucleate muscle fibers can be studied in molecular terms, 
with expression o f specific transcription factors controlling each developmental event 
(Bach et al., 2003). Molecular biology is guided by the desire to understand how cells 
and tissues develop their unique organic qualities, including the ability to change 
shape, move and grow (Ingber, 1998). Skeletal myoblasts express their genes in the 
context of their environment and developmental history (Kosnik et al., 2003). In the 
first part o f this study (Chapter 1) it was shown that in 2D cultures containing 
differentiated myogenic cells expressed myogenin (the established marker of 
myogenic cell differentiation), whereas, cultures containing single cells did not 
express the gene. Therefore, myogenin was used in subsequent 3D studies as a
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quantitative marker o f differentiation. In the chapters that followed the effect of 
specific environmental cues were tested, including biological cues (i.e. cell separation, 
increased cell density and extended time in culture) and mechanical cues (external 
mechanical loading and plastic compression), on expression of this gene in a 3D 
matrix, further, additional genes MYHC-P, MyHC-IIX and MMP-2 were evaluated to 
monitor fiber type determination and matrix degradation. The focus o f this thesis was 
to quantitate the cytomechanical and molecular response of MDCs embedded in 
collagen type I constructs, however, qualitative analysis was limited due to time and 
resources. Future investigations could utilize qualitative measures, such as confocal 
microscopy, to visually identify multinucleated cells within the 3D constructs.
The tissue engineer uses environmental cues to direct the three-dimensional 
organization, proliferation, and differentiation of the cells that will form the 
engineered skeletal muscle. The appropriate environment cues lead to changes in 
gene expression within the cell, which results in changes in cellular metabolism, 
growth, and organization (Figure 70). The key to controlling the three dimensional 
organization, proliferation, and differentiation o f the cells is to provide the appropriate 
cues that will result in the desired outcome for the tissue (Kosnik et al., 2003).
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Figure 70: Cells are guided by mechanical and biological cues received from 
their environment. Upon cell adhesion to 3-D matrices, a spatial redistribution 
and clustering of transmembrane receptors occurs, which in turn triggers the 
restructuring of the cytoskeleton. Cell signaling pathways can be triggered that 
regulate gene expression and ultimately cell migration and differentiation. 
Cytoskeletal reconfiguration leads to the remodeling of the ECM. Cells are then 
able to physically remodel the ECM, which in turn changes the set of cues cells 
receive from their environment (Adapted from Vogel and Baneyx, 2003).
4. Biological cues (cell-cell interactions)
The fusion of myoblasts is central to the successful differentiation of skeletal muscle 
(Lewis et a l ,  2001 ; Cheema, 2004). During fusion in vitro, myoblasts undergo partial 
detachment from their plastic substratum forming long linear arrays and it has been 
suggested that cell-cell interactions are more important than cell-matrix interactions at
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this stage (Gu et al., 1994). Cell-cell contacts are mediated by transmembrane 
adhesion molecules such as cadberins that allow cells to bind to and interact with 
other cells. Cadberins have extracellular domains that adhere to the extracellular 
domains o f cadberin molecules on other cells and have intracellular domains that are 
continuous with the cytoskeleton (Goicbberg and Geiger, 1998). Proteins such as 
cadberins, catenins, and desmosomal proteins, that bind cells together, are 
intrinsically important in resisting forces generated in tissues (Banes et al., 2003).
Muscle cell-cell interactions involve cells in physical contact. However, cells may 
also interact with each other in different ways, such as when neighbouring cells (i.e. 
fibroblasts/non-myogenic cells) secrete mitogens, growth factors or ECM molecules 
that affect other cells (Kosnik et al., 2003). Dennis et al. (2001) defined in vitro 
skeletal muscle tissue engineering as culturing isolated myoblasts and fibroblasts in 
an environment conducive to the formation o f a three-dimensional tissue construct 
(myooid) (Dennis et al., 2001), highlighting the critical role that fibroblasts have in 
assisting in extracellular matrix formation during in vitro myogenesis (Mayne et al., 
1989; Shansky et al., 1997; Dennis et al., 2001). Their results indicated that C2C12 
myoblasts did not form myooids when monocultured, yet they formed myooids with 
some success when cocultured with fibroblasts, substantiating the critical role of 
fibroblasts in the formation o f myooids (Dennis et al., 2001).
Throughout this thesis biological cues have been investigated in the development o f a 
tissue engineered craniofacial muscle construct. Firstly, cell-cell interactions between 
myogenic and non-myogenic MDCs were studied. Only one study has previously 
investigated the role o f primary human myogenic and non-myogenic cells in 2D
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myogenesis (Sinanan et al, 2004) and no studies have been reported on the separation 
and culture o f these cells in a 3D-matrix. The results o f this study (Chapter 2) have 
shown that the presence o f non-myogenic cells in 3D muscle tissue engineering 
enhances force generation and gene expression o f muscle specific genes. The 
significant impact o f this work is that it has added to current understanding of the 
interplay between myogenic and non-myogenic cells for successful in vitro 
myogenesis. Indicating that future attempts to tissue engineer skeletal muscle should 
utilize the heterogenous mixture o f primary human MDCs so that the appropriate 
biological cues are maintained.
The next aspect o f cell-cell interaction investigated in this thesis was the effect of 
increasing the incidence o f cell-cell contact o f myogenic cells by seeding the cells at 
high densities. An important finding o f this study (Chapter 4) was the significant up- 
regulation o f the MyHC-p gene expression with increasing cell density indicative o f a 
‘community effect’ influencing the composition o f the gene milieu that determines the 
resulting muscle fiber type.
The final biological cue investigated was the effect of extending the period of time 
that the cells were in culture to encourage maturation of the constructs through cell­
cell interactions. The results showed an apparent up-regulation o f all muscle specific 
gene expressions (i.e. myogenin, MyHC-IIX and MyHC-p). Indicating that future 
attempts to tissue engineer skeletal muscle should employ longer periods (> 6 days) in 
3D culture.
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5. Mechanical cues (cell-matrix interactions)
Tissues depend on mechanical cues for homeostasis and matrix remodeling (Banes et 
al., 1995; 2001; Frost, 1988). Mechanical forces generated in the growing embryo 
and in the active adult play a crucial role in organogenesis as complex patterns of 
mechanical loading are applied to skeletal myoblasts and myofibres through the 
elongating skeleton and by foetal movements (Lewis et al., 2008). Vandenburgh et 
al. (1987) showed that repetitive loading stimulated muscle cell hypertrophy, whereas 
no loading results in tissue atrophy. Vandenburgh et al., (1991) went on to show that 
in tissue engineered muscle constructs mechanical stimulation encouraged cell 
proliferation, myotube orientation and myotube longitudinal growth. Another group 
has shown that mechanical stimulation o f 3D collagen constructs o f fused C2C12 
myoblasts resulted in up-regulation o f IGF-I gene splicing and production, and it is 
likely that changes in myofibre size may be affected through this mechanism (Cheema 
et al., 2004). However, the mechanisms by which mechanical cues lead to eventual 
biochemical and molecular responses remain undefined, and further studies will 
undoubtedly provide new insight into constructing tissues for artificial organs (Huang 
et al., 2004).
An important element in the design o f functional engineered skeletal muscle is an 
understanding o f the force transmission from muscle cells to the surrounding matrix 
(Faulkner and Dennis, 2003). The process o f converting physical forces into 
biochemical signals and integrating these signals into the cellular responses is referred 
to as mechanotransduction (Figure 71; Huang et al., 2004).
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Figure 71: Mechanotransduction is the process of converting extracellular
mechanical signals into an intracellular response. Transmembrane proteins 
include mechanosensitive ion channels (green) and signaling molecules such as 
integrins (blue). Clusters of integrins form focal adhesions, which play a vital 
role in mechanotransduction. (Key: FN, fibronectin; a and p, a- and p-integrin 
dimer subunits; TEN, tensin; FAK, focal adhesion kinase; VIN, vinculin; PAX, 
paxillin; FIM, fimbrin; TAL, talin; ERM, ezrin-radixin-moesin proteins). Image 
is not drawn to scale (Source: Huang et a/., 2004).
Cell-cell and cell-matrix interactions are transmitted to the internal cellular structures, 
such as the cytoskeletal components (Huang et al., 2004). One common pathway for 
force transmission is via the focal adhesions (clusters of integrins). Integrins, provide 
a direct mechanical linkage between the matrix and cell interior, they constitute a 
primary pathway for intracellular force transmission and therefore have been viewed 
as likely candidates for the initiating mechanosensing event (Huang et al., 2004).
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Extracellularly, integrins bind to short amino acid sequences, such as sequences in 
collagens, to the cytoskeletal network (Burridge and Chrzanowska-Wodnicka, 1996, 
Clark and Brugge, 1995). Another pathway for force transmission in skeletal muscle 
is the dystrophin-dystroglycan complex (DGC) which mediates cell-matrix 
interactions (Figure 72). The DGC is a multi-subunit protein complex that spans the 
sarcolemma connecting the cytoskeleton to the surrounding ECM (Lewis et a/., 2001). 
Since the cytoskeleton is in contact with the nucleus, this organization allows for the 
transduction o f extracellular signals directly to the nucleus o f the cell, where the 
signal can effect gene expression (Wang et a l ,  1993).
Extracellular Matrix
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Figure 72: Cell-matrix interactions between skeletal muscle and its surrounding 
connective tissue are mediated via integrins and the dystrophin-dystroglycan 
complex (Source: Lewis et al., 2001).
Further, mechanotransduction can be regulated outside the cell by extracellular matrix 
proteins and proteolytic enzymes, more specifically, proteolytic degradation (by 
MMP-2) o f the ECM is an essential feature o f repair and subsequent remodelling
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stages (Karamichos, 2006). MMPs are known for their role in wound healing, 
angiogenesis, embryogenesis, and in many pathological process such as tumour 
metastasis (Stetler-Stevenson, 2001). Clearly therefore, protease production is 
essential in ECM remodeling and understanding o f the process and the specific 
proteases involve in mechano-responsive changes will be critical in in vitro and/or in 
vivo models (Karamichos, 2006).
The primary mechanical cue investigated in this thesis was the effect o f external 
mechanical loading (Chapter 3) on muscle specific (myogenin, MyHC~P and MyHC- 
IIX/D) and MMP-2 gene expression in the MDC seeded 3D construct; the results 
indicated no significant change due to the applied mechanical cues. On the cellular 
level, responses to mechanical loads are now well documented and the challenge is to 
apply the appropriate strain (there will be an optimum magnitude, frequency, duration 
and type o f load) to cells and measure tissue-specific outcomes (Banes et al., 2003). 
Future studies are required and one must test a number o f responses and gene read­
outs before a general statement can be made with certainty. Understanding the 
hierarchy o f load signals required to achieve a positive outcome is also an important 
consideration.
The matrix-integrin-cytoskeleton linkage also exerts force from the inside outward, 
onto the matrix (Banes et al., 2003). Cells can apply measurable mechanical forces to 
substrates resulting in contraction o f the matrix. Throughout this study we quantified 
these forces and characterised for the first time the force contraction profiles of 
primary human MDCs seeded in 3D constructs at different densities, establishing the 
optimal cell seeding density (30 million/5 ml collagen construct) for maximum force
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generation. The secondary mechanical cue investigated in this thesis was the effect of 
increasing matrix stiffness by application o f the novel process o f PC (Chapter 5). The 
results indicated that the cells in PC constructs generated less measurable force and 
there was no significant difference, though an apparent down-regulation, in all gene 
expressions measured, concluding that the stiffer matrix did not promote myogenic 
cell differentiation, nor matrix remodelling.
Conclusions and Future Research
From all the above studies it can be concluded that cell-cell signals (biological cues) 
are more important than cell-matrix signals (mechanical cues) in 3D myogenic cell 
differentiation. The important aspect o f this study is that it extends our limited 
knowledge o f the parameters that define successful craniofacial skeletal muscle tissue 
engineering. Progress has been made in the construction o f muscle organoids by 
application o f mechanical and biological signals to ensure correct alignment and 
fusion, however, a fully functional skeletal muscle needs to be able to interact and 
respond to its environment (Lewis et al., 2008). The primary human neo-muscle 
model presented in this study was extremely basic. There was no neural input, and no 
effects o f systemic regulation. However, the advantage it offers over the in vivo 
situation is that it is possible to alter one parameter at a time and therefore it is 
possible to begin to understand the mechano-transduction mechanisms of muscle 
derived cells. By understanding this basic model, advances can be made in the future.
Skeletal muscle tissue engineering has become a general model for understanding 
many fundamental principals o f development, including mechanisms for cell
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differentiation, morphogenesis and the antagonism between growth and 
differentiation (Bach et al., 2004). Further, successes to date have indicated that the 
ideal solution will probably entail a combination o f approaches that recognize the 
system requires directional cues generated by non-permanent stimuli (e.g. scaffolds), 
mechanical pre-conditioning, the correct combinations o f cells (e.g. myogenic, 
connective tissue, vascular), attachments to nerve and bone (via tendons) and a neural 
input (Lewis et al., 2008).
While the goal o f using in vitro engineered skeletal muscle for functional work in vivo 
is still years away form clinical use, near term applications o f the rapidly evolving 
tissue engineered skeletal muscle technology are possible (Kosnik et al., 2003). 
These include their use as implantable protein delivery devices (Vandenburgh et al., 
1996), high content drug screening for skeletal muscle wasting disorders 
Vandenburgh et al., 1999) and as mechanical ex vivo actuators, and for pharmaco- 
genomic screening for testing patient’s reactions to drugs.
In conclusion, the most important area for future research on functional tissue 
engineering o f skeletal muscle is in the provision o f optimum environmental cues to 
ensure optimum development o f muscle constructs (Faulkner and Dennis, 2003). 
Requirements are for a better understanding o f the control o f the gene expressions of 
the transcriptional factors and proteins that control the specification and 
differentiation o f muscle cells (Sabourin and Rudnicki, 2000) in 3D cultures. This 
investigation o f mechanical and biological cues, and the resulting gene expression, 
presented in the current thesis has added significant knowledge to the field of tissue 
engineering a functional skeletal muscle construct.
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